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ABSTRACT OF THE DISSERTATION 
THE EFFECTS OF AGE, ETHNICITY, SEXUAL DYSFUNCTION, URINARY 
INCONTINENCE, MASCULINITY, AND RELATIONSHIP WITH THE PARTNER 
ON THE QUALITY OF LIFE OF MEN WITH PROSTATE CANCER 
by  
Suha Ballout 
Florida International University, 2013 
Miami, Florida 
Professor Anahid Kulwicki, Major Professor 
Professor Carol A. (“Pat”) Patsdaughter, Co-Major Professor 
Prostate cancer, the leading cause of cancer in men, has positive survival rates and 
constitutes a challenge to men with its side effects.  Studies have addressed the bivaritate 
relationships between prostate cancer treatment side effects masculinity, partner 
relationship, and quality of life (QOL).  However, few studies have highlighted the 
relationships among prostate cancer treatment side effects (i.e., sexual dysfunction, 
urinary incontinence), masculinity, and relationship with the partner together on QOL in 
men.  Most studies were conducted with predominately Caucasian sample of men.  
Miami is a unique multiethnic setting that hosts Cuban, Columbian, Venezuelan, Haitian, 
other Latin American and Caribbean communities that were not represented in previous 
literature.  The purpose of this study was to examine relative contributions of age, 
ethnicity, sexual dysfunction, urinary incontinence, masculinity, and perception of the 
relationship with the partner on the quality of life in men diagnosed with prostate cancer.  
Data were collected using self-administered questionnaires measuring demographic 
xii 
variables, sexual and urinary functioning (UCLA PCI), masculinity (CMNI), partner 
relationship (DAS), and QOL (SF-36).  A total of 117 partnered heterosexual men 
diagnosed with prostate cancer were recruited from four urology clinics in Miami, 
Florida.  Men were 67.47 (SD  =  8.42) years old and identified themselves to be of 
Hispanic origin (54.3 %, n = 63).  Findings demonstrated that there was a significant 
moderate negative relationship between urinary and sexual functioning of men.  There 
was a significant strong negative association between men’s perceived relationship with 
partner and masculinity.  There was a weak negative relationship between the partner 
relationship and QOL.  Hierarchal multiple regression showed that the partner 
relationship (β = -.25, t (91) = -2.28, p = .03) significantly contributed overall to QOL.  
These findings highlight the importance of the relationship satisfaction in the QOL of 
men with prostate cancer.  Nursing interventions to enhance QOL for these men should 
consider strengthening the relationship and involving the female partner as an active 
participant. 
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CHAPTER I 
INTRODUCTION 
Cancer is a major public health concern that has steadily increased in incidence 
rates and prevalence of diagnosed cases.  The American Cancer Society (ACS) has 
estimated the incidence rate of prostate cancer in 2013 to be 151.4 in 100,000 with an 
estimate of 238,590 new diagnosed cases (ACS, 2013).  Over the past decade, there has 
been a significant increase in the prevalence of the annual cancer incidence (Jemal, 
Siegel, Xu, & Ward, 2010; Siegel, Naishadham, & Jemal, 2013).  The increased 
prevalence is attributed to improved awareness and diagnostic technology (Jemal et al., 
2006).  The majority of cancer sites have reported a slight decrease in mortality rates in 
recent years which may be due to the advancement of diagnostic and treatment options 
(Jemal et al., 2010).  With the advancement of technology, cancer treatment options are 
widely available.  However, the majority of these treatments are accompanied by side 
effects that encompass physical (e.g., body image and physical changes, sexual 
dysfunction, anemia), psychological (e.g., anxiety, depression), social, economic, and 
other consequences. 
With increased prostate cancer prevalence, more people are living with their 
disease, symptoms, and treatment side effects that are interrupting their lives and 
expected social roles and responsibilities.  As a result, these men are suffering from 
physical conditions (i.e., the cancer, its physiological symptoms, and treatment side 
effects) and compromised social expectations (i.e., ability to meet their socially 
constructed roles at home, work, and among friends).  This disruption is affecting cancer 
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patients’ physical functioning, relationships, social roles, quality of life (QOL) (Kaasa, 
Mastekaasa, & Lund, 2003) and contributing to their mortality (Chida & Steptoe, 2008).   
Statement of the Problem 
Prostate cancer accounts for 238,590 (28%) of cancer incidence and is the leading 
cancer in men.  It is estimated that one in six men will have prostate cancer in their 
lifetimes (National Cancer Institute [NCI], 2013; Siegel et al., 2013).  The ACS reported 
that 241,740 new cases were diagnosed in 2012 in the United States, and the estimates for 
2013 are about 238,590 new diagnosed cases of prostate cancer (ACS, 2013).  In 2013 in 
Florida, the incidence of prostate cancer was 137.7 in 1000,000, and it was estimated that 
17,330 new cases were diagnosed with prostate cancer (ACS, 2013; Siegel et al., 2013).  
The majority of prostate cancer was localized (80%), followed by regional (12%) and 
distal (6%) (Altekruse et al., 2010).  Epidemiologic trends have shown that more men are 
living longer with prostate cancer (Jemal et al., 2006; Jemal et al., 2010; Siegel et al., 
2013).  Unlike other cancers, the 5-year survival rate of 100% is a positive aspect of the 
disease (Jemal et al., 2010; Siegel et al., 2013).  Being the leading cause of cancer in 
men, it is essential to examine the impact of prostate cancer and treatment on men’s 
QOL, especially since they are living longer after the diagnosis of cancer.  
Prostate cancer treatment options vary, and research has not yet provided 
evidence of differential outcomes of surgery, radiation, hormonal therapy, or watchful 
waiting (Hoznek, Menard, Salomon, & Abboud, 2005; Wei et al., 2002).  Nevertheless, 
there is a growing number of studies that have documented the side effects of these 
treatments including sexual dysfunction (30-80%), urinary incontinence (30-74%), and 
bowel incontinence (3-10%) (Hoznek et al., 2005; Wei et al., 2002).  Most studies have 
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identified sexual dysfunction to be the most significant and bothersome side effect of 
prostate cancer treatment (Hoznek et al., 2005; Wei et al., 2002).   
Research that has examined the impact of side effects of prostate cancer treatment 
on QOL in men has addressed the challenge to masculinity that may influence the 
relationship with their partner (Sanders, Pedro, Bantum, & Galbraith, 2006).  With 
masculinity being identified as a major concern, sexual dysfunction may create a 
dilemma for these men (Oliffe, 2005).  This dilemma arises from the premise that 
sexuality and sexual functioning are imperative for a man’s wellbeing.  Studies have 
accounted for QOL, sexuality, and relationship with the partner as being the main 
outcome indicators of prostate cancer treatment (Badr & Carmak Taylor, 2009; Giarelli, 
McCorckle, & Monturo, 2003).  The impact of prostate cancer treatment side effects on 
QOL (Howlet et al., 2010; Monga, Kerrigan, Thornby, Monga, & Zimmermann, 2005), 
masculinity (Burns & Mahalik, 2006; Fergus, Grey, & Fich; 2002), and partner 
relationship (Galbraith, Pedro, Jaffe, & Allen, 2008; Sanders et al., 2006) have been 
examined.  However, research has not highlighted the relationships among prostate 
cancer treatment side effects (i.e., sexual dysfunction, urinary incontinence), masculinity, 
and relationship with the partner together on QOL in men.  Also, the majority of studies 
have been conducted with predominantly Caucasian samples.  As a result, the 
experiences of men from other ethnic populations have not been adequately represented 
in the literature, despite ethnicity being a major risk factor for the disease (Jemal, Siegel, 
Xu, & Ward, 2010; Siegel, Naishadham, & Jemal, 2013).  Age is also a major risk factor 
since older men are at a higher risk for developing prostate cancer (Prostate Cancer 
Foundation [PCF], 2011).  However, studies have documented that prognosis in addition 
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to development of sexual dysfunction and urinary incontinence was not affected by age 
(Bill-Axelson et al., 2005; Sacco et al., 2006; Sanda et al., 2008).  On the other hand, 
research has suggested that the experiences of men diagnosed with prostate cancer may 
differ by age (Harden, Northouse, & Mood, 2006; Oliffe, 2005).  Examining the factors 
that contribute to QOL in men diagnosed with prostate cancer is important especially 
since they are living longer with treatment side effects. 
Research Purpose 
The purpose of the this study was to examine the relative contributions of age, 
ethnicity, sexual dysfunction, urinary incontinence, masculinity, and perception of the 
relationship with the partner on the quality of life in men diagnosed with prostate cancer. 
Research Problem 
Age 
 There is an exponential increase in the risk of prostate cancer diagnosis with 
increased age (PCF, 2011; Siegel et al., 2013) and an increased risk of acquiring the 
disease after the age of 50 years in general.  In African American men, the risk increases 
after the age of 40 years (PCF, 2011; Siegel et al., 2013).  Around 65% of men diagnosed 
with prostate cancer were 65 years and older (PCF, 2011; Siegel et al., 2013).  It was 
estimated that 80% of men reaching 80 years old have cancer cells in their prostate (PCF, 
2011; Siegel et al., 2013).  However, the prognosis of prostate cancer does not differ by 
age at diagnosis.  Studies that have examined long term outcomes and 10 years life 
expectancy have suggested that age was not a predictor of prostate cancer survival (Bill-
Axelson et al., 2005; Wong et al., 2006).  Nevertheless, age was found to contribute to 
incontinence (Sacco et al., 2006) and sexual functioning (Rondorf-Klym & Colling, 
5 
2003; Sanda et al., 2008).  On the other hand, Stanford and colleagues (2000) suggested 
that age was a significant contributor to sexual and urinary functioning after the surgery 
in men undergoing prostatectomy.  These results were also reported from a similar study 
that used a sample of men undergoing nerve sparing prostatectomy (Penson et al., 2005).  
With sexual functioning as a major concern, the effect on sexual performance of men 
may differ by age.  The notion that sexual dysfunction does not affect older men may be 
the result of stereotypes that suggest that older men are expected to engage less and be 
less interested in sexual activities.  From a qualitative study, Oliffe (2005) reported that 
older men were expected to have less emphasis on sexuality and therefore were reluctant 
to expand the discussion about the impact of decreased sexuality on their perceived 
masculinity.  However, younger men discussed the importance of their sexuality more 
openly (Oliffe, 2005).  Another qualitative study that explored the experiences of men 
with prostate cancer and their partners by age showed that younger couples had more 
positive perspectives of their relationship, intimacy, and changing priorities.  Older men, 
on the other hand, focused on their perceived social roles and their family roles and 
discussed these roles as their main concerns (Harden et al., 2006).  Despite common 
treatment side effects, each age group had different issues or major areas of concern 
regarding their relationships, intimacy, changing of priorities, and distress (Harden at al., 
2006). 
Ethnicity 
 Race and ethnicity are associated with incidence, response, and outcomes of 
cancer and its treatment.  In the case of prostate cancer, it was reported that African 
American men have the highest incidence of the disease followed by Hispanic men 
6 
(Edwards et al., 2010).  Very few studies have explored differences in outcomes among  
different racial and ethnic groups.  Stanford and colleagues (2000) identified a difference 
in sexual functioning among ethnicities where African American and Hispanic men 
reported better erectile functioning compared to Caucasian men 18 months after radical 
prostatectomy.  Studies that have examined masculinity and partner relationships were 
also conducted among samples that were predominantly non-Hispanic Whites or 
Caucasians.  Therefore, the combined concepts of masculinity, QOL, and partner 
relationships have not been explored with different racial or ethnic groups.   
Population estimates and percentages in Miami show that a multiethnic Hispanic 
community includes Cuban, Columbian, Venezuelan, Haitian, other Latin American and 
Caribbean communities; hence, exploring these concepts in special populations or ethnic 
groups in a unique environment will contribute to the literature.  In a Hispanic 
community that emphasizes the concepts of machismo and caballerismo, masculinity of 
men experiencing sexual dysfunction may be challenged.  Machismo is a socially 
constructed phenomenon that emphasizes the Hispanic male gender role of being strong, 
a family protector and provider, and sexual prowness (i.e., sexual stamina) (Arciniega et 
al., 2008).  The concept of machismo is closely related to hypermasculinity and 
traditional masculine roles (Connell, 1995).  Within different cultures, the emphasis of 
masculine roles and sexuality may vary.  Consequently, it is important to examine the 
QOL in men with prostate cancer in a unique multiethnic Hispanic community with 
respect to age, urinary incontinence, sexual dysfunction, masculinity, and partner 
relationship. 
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Prostate Cancer Treatment Side Effects 
Prostate cancer treatments vary from surgery, radiation therapy, hormonal 
therapy, or watchful waiting.  The goal of treatment is either cure, prolong survival, or 
palliation depending on the staging of the tumor at diagnosis (Hoznek et al., 2005).  
Randomized trials conducted to compare the different treatments for prostate cancer have 
not suggested guidelines for which option provides better outcomes (Wei et al., 2002; 
Wilt et al., 2008).  Irrespective of treatment preference, the most reported side effects are 
sexual dysfunction (30-80% erectile dysfunction [ED], diminished desire, and 62% 
impotence), urinary incontinence (30-74% incontinence, urethral stricture), and bowel 
incontinence (3-10%) (Hoznek et al., 2005; Palmer, Fogarty, Somerfield, & Powell, 
2003; Potosky et al., 2000; Sanda et al., 2008).  Despite latest approaches that have 
attempted to use robotics or nerve sparing techniques to minimize sexual dysfunction, 
studies have reported minimal improvement in sexual functioning at six, 12, and 18 
months post nerve sparing surgery (Penson et al., 2005).  Studies have shown that sexual 
dysfunction and urinary incontinence were the most commonly reported side effects and 
have the most impact on QOL in men with prostate cancer (Penson et al., 2003; Potosky 
et al., 2004).  Also, these side effects (i.e., sexual dysfunction and urinary incontinence) 
have been reported to be the most bothersome symptoms that distress QOL in men 
diagnosed with prostate cancer (Howlett et al., 2010; Penson et al., 2003; Sanda et al., 
2008; Weber, Roberts, Chumbler, Mills, & Algood 2007).  Accordingly, this study 
focused on these side effects as the main symptoms of men with prostate cancer. 
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Masculinity 
Men with prostate cancer suffer from emotional and social burden as a result of 
the treatment side effects of sexual dysfunction and urinary incontinence (Wei et al., 
2002).  As a result of decreased sexual functioning, these men’s perceptions of 
masculinity are affected which consequently may influence the relationships with their 
partners (Sanders et al., 2006).  Studies on masculinity and sexual functioning of men 
with prostate cancer generally have used qualitative designs and have reported themes of 
distress, despair, shame, and impaired social functioning (Fergus et al., 2002; Khan et al., 
2008).  In these qualitative reports, sexual performance was reported to be an essential 
component of a man’s socially expected role (Burns & Mahalik, 2006).  Studies have 
highlighted the effect of these symptoms on men’s wellbeing but have not emphasized 
the effects on these men’s relationship with their partners and QOL (Burns & Mahalik, 
2006; Fergus et al., 2002; Khan et al., 2008). 
Relationship with Partner 
Men and their partners are affected by the diagnosis and treatment of prostate 
cancer (Galbraith et al., 2008).  With sexual dysfunction as a main side effect of prostate 
cancer, relationship issues and concerns arise.  Emotional distance, decreased intimacy, 
emotional burden, and other struggles between couples occur (Badr & Carmak Taylor, 
2009; Hawkins et al., 2009).  Studies have shown that erectile dysfunction was associated 
with increased conflict and decreased relationship satisfaction (McCabe & Matic, 2008).  
Relationship troubles were found to be due to communication issues and perceived 
changes of roles of both partners (Galbraith & Crighton, 2008; Giarelli et al., 2003).  The 
decreased expression of emotions and experiences among men were also explained by the 
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concept of masculinity.  Men did not express their emotions and experiences because 
they did not want to be stigmatized as being weak.  As a result, couples living with 
prostate cancer experience challenges from the time of diagnosis and throughout the 
treatment phase (Gray,	  Fitch, Phillips, Labrecque, & Fergus, 2000).  Also, the feeling of 
fatigue as a result of the disease and some of the treatment (i.e., radiation and hormonal 
therapy) prohibits men from continuing their planned activities with the partners and 
families which added to the relationship challenges (Sanders et al., 2006).  
Communication between couples was identified as an integral component to the survival 
of the relationship (Badr & Carmack Taylor, 2009).  However, many couples did not 
have the information or guidance to manage their relationship after prostate cancer 
(Sanders et al., 2006). 
Quality of Life 
 Quality of life (QOL) is an essential indicator for survival and treatment outcomes 
(Johnson & Temple, 1985; Montazeri, 2009).  QOL is measured in terms of social, 
physical, and psychological wellbeing.  Men with prostate cancer generally do not look 
sick when compared to men with other cancers and undergo chemotherapy treatment.  
However, irrespective of the choice of treatment, urinary incontinence and sexual 
dysfunction were identified to be the main side effects of prostate cancer (Penson et al., 
2003; Potosky et al., 2004).  These side effects were found to have negative effects on 
sexual functioning which affected QOL in men with prostate cancer (Howlett et al., 
2010).  Monga and colleagues (2005) suggested that after the treatment of prostate 
cancer, time may contribute to improvement in QOL although not to baseline status.  
QOL outcomes were identified in the physical, psychological, and social wellbeing 
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subscales of QOL instruments as well as the measures of partner distress (Sanda et al., 
2008).  Confirming the findings from another quantitative study, Korfage, Hak, de 
Koning, and Essink-Bot (2006) reported that some men rationalized that, despite the 
inconvenience, older age and the aging process may contribute to reaching acceptance of 
men’s condition after the treatment of prostate cancer.  In other words, older age was 
used by these men as a rationale that helped them reach acceptance of sexual dysfunction 
and/or urinary incontinence.  As a result, men reported discomfort from urinary 
incontinence and sexual dysfunction but may not have considered their condition as a 
decrease in their health status because they thought that they could get used to their 
symptoms and were appreciative to be alive (Korfage et al., 2006).  QOL studies have 
emphasized the impact of treatment side effects.  Studies have also discussed the 
association between the treatment side effects and masculinity and relationship with the 
partner.  However, studies have not expanded on the relative contributions of masculinity 
and relationship with the partner in addition to the treatment side effects (i.e., sexual 
dysfunction and urinary incontinence), age, and ethnicity on QOL in men diagnosed with 
prostate cancer. 
Significance of the Study 
Research to date has examined the concepts of masculinity, sexual dysfunction, 
urinary incontinence, and relationship with the partner and their independent effects on 
QOL in men with prostate cancer.  Research has identified that sexual dysfunction and 
urinary incontinence impact QOL in these men (Howlett et al., 2010; Monga et al., 2005; 
Penson et al., 2003; Potosky et al., 2004).  Qualitative studies have documented that men 
with prostate cancer believe that sexual dysfunction made them feel as if they were less 
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of a man; however, masculinity was not quantitatively measured.  The relative 
contributions to QOL of masculinity with other variables such as age, ethnicity, urinary 
incontinence, sexual dysfunction, and partner relationship has not been examined. 
Relationship with the partner has been found to be affected by decreased intimacy 
and shift of the partner image from the lover to the caregiver (Galbraith & Crighton, 
2008; Giarelli et al., 2003).  The relationship between ethnicity and QOL in men 
diagnosed with prostate cancer has not been extensively examined, especially in a unique 
multiethnic Hispanic community that is includes Cuban, Columbian, Venezuelan, 
Haitian, other Latin American and Caribbean communities.  Nevertheless, the 
independent and combined contributions of age, ethnicity, sexual dysfunction, urinary 
incontinence, masculinity, and perception of the relationship with the partner together on 
QOL in men diagnosed with prostate cancer have not been reported in the literature. 
This study examined the contributions of age, ethnicity, sexual dysfunction, 
urinary incontinence, masculinity, and perception of the relationship with the partner on 
QOL in men diagnosed with prostate cancer.  The significance of this study is that it 
examined the contributions of a different combination of concepts (i.e., age, ethnicity, 
sexual dysfunction, urinary incontinence, masculinity, and perception of the relationship 
with the partner together) on QOL in men with prostate cancer from what has previously 
been published in the literature.  With the majority of the studies conducted among White 
non-Hispanic samples, this study was conducted in Miami, Florida and included a sample 
predominantly of men who are of unique multiethnic Hispanic communities that is 
includes Cuban, Columbian, Venezuelan, Haitian, other Latin American and Caribbean 
communities.  Findings of this study identified the major contributors of QOL in men 
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with prostate cancer.  These results will help identify areas where interventions might be 
developed to improve the quality of care and enhance the QOL in men with prostate 
cancer. 
Theoretical Perspective 
The theoretical perspective of this study was based on the revised Wilson and 
Cleary’s (1995) conceptual framework on QOL (Ferrans, Zerwic, Wilbur, & Larson, 
2005).  Wilson and Cleary (1995) identified health related QOL as the outcome of the 
quality care provided to patients.  The authors defined health related QOL to include the 
dimensions of physical functioning, social functioning, role functioning, mental health, 
and general health perception.  The original model presented the physiological variables, 
symptoms, functional status, and general health perceptions as a continuum that 
contributed to the overall QOL.  Wislon and Cleary (1995) suggested that individual 
characteristics (e.g., symptom amplification, values, preferences, personality motivation) 
and characteristics of the environment (e.g., psychological support, social and economical 
support) affect the continuum dimensions (i.e., physiological variables, symptoms, 
functional status, and general health perceptions) and overall QOL (Wilson & Cleary, 
1995). 
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Figure 1.  Wilson and Cleary’s (1995) conceptual framework on QOL.  
Ferrans and colleagues (2005) modified the Wilson and Cleary model and 
suggested supplementary explanations of the constructs of the model.  The model 
identified health related QOL as a multidimensional concept that was determined by 
individual and environmental characteristics (Ferrans et al., 2005).  Ferrans and 
colleagues (2005) further defined individual and environmental characteristics.  The 
revised model modified the presented relationships between biological functioning and 
individual (i.e., demographic, developmental, psychological, and biological factors) and 
environmental (i.e., social or physical characteristics including interpersonal or social 
influences) characteristics.  The revised model deleted the suggested nonmedical factors 
that were considered to affect quality of life (Ferrans et al., 2005).  Also, the original 
model included labels on the relationship arrows that defined and restricted the 
characterization and direction of the relationship.  Ferrans and colleagues (2005) 
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suggested deleting these labels to facilitate the application of the model to a variety of 
cases. 
 
Figure 2.  Ferrans et al. (2005) revised Wilson and Cleary model. 
This study examined the contributions of individual (i.e., age, ethnicity), 
environmental (i.e., masculinity, partner relationship), and symptom characteristics (i.e., 
sexual dysfunction, urinary incontinence) on overall QOL in men with prostate cancer. 
Individual Characteristics 
 Ferrans and colleagues (2005) classified individual characteristics as 
demographic, developmental, psychological, and biological factors that contribute to the 
overall QOL (Ferrans et al., 2005).  With this modification, demographic characteristics 
such as age, gender, race/ethnicity, marital status, presence of disease, and comorbidities 
are recognized as influences on overall QOL.  The individual or demographic variables 
considered as independent variables in this study were age and ethnicity.  Other 
demographic variables such as marital status and presence of disease were not included 
as major study variables since the study sample only included married or partnered men 
diagnosed with prostate cancer.  The majority of studies on the QOL in men with prostate 
15 
cancer have not emphasized the contribution of age and ethnicity to overall QOL.  
However, studies have documented that age is a significant contributor to sexual and 
urinary functioning after the treatment of prostate cancer (Penson et al., 2005; Sacco et 
al., 2006; Stanford et al., 2000).  The majority of research with men with prostate cancer 
has been conducted with samples that were predominantly Caucasian or non-Hispanic 
White.  Few studies have included samples from ethnically diverse backgrounds to 
compare QOL or treatment outcomes (Sanda et al., 2008).  Epidemiologic studies have 
documented that African American men have a higher incidence of prostate cancer, 
followed by White, Hispanic men (Jemal et al., 2010).  However, Sanda and colleagues 
(2008) suggested that African American men with prostate cancer were less likely to be 
satisfied with treatment outcomes (e.g., urinary incontinence, sexual dysfunction).  
Environmental Characteristics 
 Environmental factors were defined as characteristics including interpersonal or 
social influences on health outcomes (Ferrans et al., 2005).  The influence of the social 
environment on healthcare has been identified to affect healthcare access and perception 
of healthcare outcomes (Ferrans et al., 2005).  For men with prostate cancer, studies have 
documented that sexual dysfunction resulting from treatment led to emotional distress 
and distancing between couples (Hawkins et al., 2009).  Sexual functioning was found to 
be related to relationship satisfaction; therefore, men with prostate cancer with resultant 
sexual dysfunction reported decreased satisfaction with their intimate relationships (Badr 
& Carmack Taylor, 2009).  The contribution of men’s perceptions of their relationship 
dynamics on their QOL is not well understood. 
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 Men with prostate cancer may not communicate their concerns or express their 
emotions as explained by the concept of masculinity (Oliffe & Thorne, 2007).   
Masculinity is a socially constructed that emphasizes the roles and ideologies of men 
(Connell, 1995; Courtney, 2000).  The image of a masculine man is accentuated by the 
concepts of competitiveness, strength, power, and sexual prowness (Connell, 1995, 
Farrell, 1993; Kimmel, 2000).  Sexual dysfunction constitutes a threat to masculinity and 
the socially expected role of men (Gray, Fitch, Fergus, Mykhalovsky, & Church, 2002; 
Kelly, 2009; Oliffe, 2005).  Studies that have examined the effects of prostate cancer 
treatment on masculinity have used qualitative research designs and have reported a great 
sense of shame and embarrassment expressed by men as a result of their inability to 
perform sexually.  Their decreased sense of masculinity arises from their inability to meet 
the perceived socially expected roles of being a man (Chapple & Ziebland, 2002; Fergus 
et al., 2002; Oliffe, 2005).  Masculinity and men’s perception of their relationships with 
their partners were considered as the environmental characteristics and independent 
variables since they represent the social influences on QOL in men with prostate cancer. 
Treatment Side Effects 
 Prostate cancer treatment side effects or symptoms include sexual dysfunction 
(i.e., erectile dysfunction, diminished desire) and urinary incontinence (Wei et al., 2002).  
Studies have documented that these side effects are the main contributors to diminished 
QOL (Hoznek et al., 2005; Sanda et al., 2008).  Also, sexual dysfunction and urinary 
incontinence have been identified to be the most bothersome symptoms that affect QOL 
in men diagnosed with prostate cancer (Howlett et al., 2010; Penson et al., 2003; Sanda et 
al., 2008; Weber et al., 2007).  Anchored in Wilson and Cleary’s (1995) model, prostate 
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cancer treatment side effects were accounted for under the symptoms domain or 
construct.  Symptoms were defined to be the patient’s perceptions of abnormal 
functioning (Ferrans et al., 2005).  However, based on the breadth of research on the 
contribution of sexual dysfunction and urinary incontinence on QOL, prostate cancer 
treatment side effects (i.e., sexual dysfunction and urinary incontinence) were identified 
as a separate domain or construct. 
Quality of Life 
 QOL has been considered to be the subjective well-being or the person’s 
perception of one’s satisfaction with life (Wilson & Cleary, 1995).  The overall 
satisfaction with life includes several domains such as health and functioning as well as 
psychological, family, social, and economic wellbeing (Ferrans et al., 2005).  QOL has 
been used as the outcome measure of disease and treatment hmm not sure what this 
means in healthcare (Ferrans et al., 2005; Wilson & Cleary, 1995).  QOL was considered 
to be the dependent variable of the study.  The contributions of the demographic variables 
(i.e., age and ethnicity), prostate cancer treatment side effects (i.e., sexual dysfunction 
and urinary incontinence), and environmental factors (i.e., masculinity and men's 
perception of the relationship with partner) on QOL were examined.  Identifying the main 
contributors to QOL will help in enhancing the care of men with prostate cancer. 
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Figure 3.  Conceptual framework for variables contributing toward quality of life 
in men with prostate cancer.  
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Research Questions 
This study addressed the following research questions in self identified 
heterosexual and married or partnered men diagnosed with prostate cancer: 
1. Are there relationships among age, ethnicity, sexual dysfunction, urinary 
incontinence, masculinity, and perception of the relationship with the partner, and 
quality of life? 
2. What are the relative contribution of age, ethnicity, sexual dysfunction, urinary 
incontinence, masculinity, and perception of the relationship with the partner to 
men’s quality of life? 
Hypotheses 
The following hypotheses were examined in self-identified heterosexual and 
married/ or partnered men diagnosed with prostate cancer: 
H1:  Are there relationships between age, ethnicity, sexual dysfunction, urinary 
incontinence, masculinity, and perception of the relationship with the partner, and 
quality of life. 
 Age was found to be a risk factor for prostate cancer (PCF, 2011) and the 
consequent experience of men diagnosed with prostate cancer differed by age (Harden, 
Northouse, & Mood, 2006; Oliffe, 2005) especially regarding incontinence (Sacco et al., 
2006) and sexual functioning (Rondorf-Klym & Colling, 2003; Sanda et al., 2008).  
Oliffe (2005) discussed that older men were socially expected to place less emphasis on 
sexuality and therefore were hesitant in discussing the impact of sexual dysfunction.  On 
the other hand, younger men placed great importance on the magnitude of maintaining 
sexuality in the case of prostate cancer (Oliffe, 2005).  Prostate cancer treatment 
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outcomes were not found to be different among racial/ ethnic groups.  Sexual functioning  
was reported to differ by ethnic groups where African American and Hispanic men were 
found to have better erectile functioning as compared to Caucasian men 18 months after 
radical prostatectomy (Standord et al., 2000).  Similar to age, studies examining QOL 
were conducted among samples that were predominantly non-Hispanic Whites or 
Caucasians.  Prostate cancer treatment side effects (i.e., sexual dysfunction and urinary 
incontinence) were documented to distress the QOL in men diagnosed with prostate 
cancer (Howlett et al., 2010; Sanda et al., 2008; Penson et al., 2003; Potosky et al., 2004; 
Weber et al., 2007).  Studies reported that sexual dysfunction was the most significant 
and bothersome side effect of prostate cancer treatment (Hoznek et al., 2005; Wei et al., 
2002).  QOL was documented to be one of the major outcomes of prostate cancer 
treatment, along with sexuality and the relationship with the partner (Badr, Carmak, 
Taylor, 2009; Giarelli et al., 2003).  As a result of decreased sexual functioning, men’s 
masculinity is affected (Sanders, Pedro, Bantum, & Galbraith, 2006).  Studies on 
masculinity and sexual functioning in men with prostate cancer generally have shown 
that men discussed main themes of distress, despair, shame, and impaired social 
functioning (Fergus et al.; 2002; Khan et al., 2008).  Sexual performance was reported to 
be an essential constituent of a man’s socially expected role (Burns & Mahalik, 2006).  
Emotional distance, decreased intimacy, emotional burden, other struggles between 
couples occur after the diagnosis of prostate cancer (Badr, Carmak, & Taylor, 2009; 
Hawkins et al., 2009).  Erectile dysfunction was associated with increased conflict and 
decreased relationship satisfaction (McCabe & Matic, 2008).  Relationship troubles were 
21 
identified to be due to communication issues and perceived changes of roles of both 
partners (Galbraith & Crighton, 2008; Giarelli et al., 2003).   
 The impact of prostate cancer side effects on masculinity (Burns & Mahalik, 2006; 
Fergus et al.; 2002), partner relationship (Galbraith et al., 2008; Sanders et al., 2006), and 
QOL (Howlet et al., 2010; Monga et al., 2005) have been examined.  The relationships 
between sexual dysfunction and urinary incontinence and QOL have been well 
documented (Howlett et al., 2010; Sanda et al., 2008; Penson et al., 2003; Potosky et al., 
2004; Weber et al., 2007).  However, the relationships among age, ethnicity, masculinity, 
and partner relationship, and QOL combined have not been examined.  Based on the 
reviewed literature, it was hypothesized that there was a significant relationship among 
age, ethnicity, sexual dysfunction, urinary incontinence, masculinity, and perception of 
the relationship with the partner, and QOL in men with prostate cancer.   
H2:  Age, ethnicity, sexual dysfunction, urinary incontinence, masculinity, and 
perception of the relationship with the partner independently and combined 
contribute to the quality of life of men diagnosed with prostate cancer. 
Studies on men with prostate cancer have examined the contribution of prostate 
cancer side effects (i.e., sexual dysfunction and urinary incontinence) on QOL (Howlet et 
al., 2010; Monga et al., 2005), partner relationship (Galbraith et al., 2008; Sanders et al., 
2006), and masculinity (Burns & Mahalik, 2006; Fergus et al.; 2002).  The age of men 
contributed to how much emphasis was placed on sexual dysfunction after the diagnosis 
of prostate cancer (Oliffe, 2005).  Older men emphasized sexuality less than younger men 
(Oliffe, 2005).  The impact of sexual dysfunction and urinary incontinence on the QOL in 
men with prostate cancer is well documented in the literature (Hoznek et al., 2005; Wei et 
22 
al, 2002).  Sexual dysfunction and urinary incontinence were found to negatively affect 
QOL in men (Hoznek et al., 2005; Wei et al, 2002).  The socially expected role of men 
was closely related to sexual performance (Burns & Mahalik, 2006).  Research on the 
effects of sexual dysfunction after prostate cancer showed that men felt less masculine 
and subsequently ashamed and embarrassed (Burns & Mahalik, 2006; Fergus et al.; 2002; 
Khan et al, 2008).  In a Hispanic community where men pride themselves with the 
concepts of machismo and caballerismo, masculinity of men experiencing sexual 
dysfunction is a major concern (Araciniega et al., 2008).  The extent to which men feel 
that sexual dysfunction and prostate cancer affects their masculinity and the subsequent 
impact on the QOL in these men was not studied.  Studies have shown that prostate 
cancer side effects challenge the relationship of men with their female partners (Galbraith 
& Crighton, 2008; Giarelli et al., 2003).  However, studies have not examined how men 
have perceived the impact of the challenged relationship with the partner on their QOL.  
Accordingly, it was hypothesized that in addition to age, ethnicity, sexual dysfunction, 
and urinary incontinence, masculinity, and relationship with the partner also contribute to 
the QOL in men with prostate cancer. 
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CHAPTER II 
LITERATURE REVIEW 
 The review of prostate cancer literature conducted as a basis for this study 
included articles published between 2000 and 2013 from the Computerized Index of 
Nursing and Allied Health Literature (CINAHL), PubMed, Sociological Abstracts, 
PsychINFO, MedLine, Health and Psychosocial Instruments (HaPI), and Google Scholar.  
The key words used independently or in combination were: prostate cancer, surgery, 
radiation therapy, watchful waiting, active surveillance, hormonal therapy, treatment, side 
effects, sexual dysfunction, erectile dysfunction, urinary incontinence, masculinity, 
machismo, age, relationship, partner, and quality of life.  A further search was conducted 
to obtain classic writings or research articles published prior to the identified year limits, 
which included essential information that was imperative to the proposed study.  The 
databases were also used to search for theoretical or conceptual frameworks used in QOL 
and prostate cancer research.  Selected journals were browsed for content and relevant 
articles (i.e., Oncology Nursing Forum, Clinical Journal of Oncology Nursing, Urologic 
Nursing, Men and Masculinities, Social Science and Medicine, Urology, Psychology of 
Men and Masculinity, Sexual and Relationship Therapy, Journal of Urology, Journal of 
Aging and Identity, Journal of Men’s Studies, and American Journal of Men’s Health).  
Research articles were also obtained from reviewing the reference lists in articles about 
men with prostate cancer.  
 The literature that has addressed men with prostate cancer has been widespread.  
This review focused on discussions about the epidemiology of prostate cancer; treatment 
options and side effects; masculinity, relationship with the partner; age; ethnicity; and 
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QOL.  These concepts constituted the independent and dependent variables in the 
proposed study’s conceptual framework.  The independent variables were age, ethnicity, 
urinary incontinence, sexual dysfunction, masculinity, and relationship with the partner.  
The dependent variable was QOL.  The sections of the literature review focused on the 
relationship between each of the variables with men with prostate cancer. 
Epidemiology of Prostate Cancer 
Prostate cancer accounts for 238,590 (28%) of cancer incidence and is the leading 
type of cancer in men (Siegel et al., 2013).  In the analysis of data from 1999 to 2005, it 
was estimated that 92% of newly diagnosed prostate cancer cases were local or regional 
cancer, and the corresponding survival rate was 100% (Jemal et al., 2010).  Generally, it 
was estimated that one in six men will acquire prostate cancer in their lifetime (ACS, 
2013; NCI, 2013).  The ACS reported that 238,590 new cases were diagnosed in the 
United States and 29,720 deaths were due to prostate cancer in 2013 (ACS, 2013).  The 
estimates for 2012 were 241,740 new diagnosed cases and 28,170 deaths from prostate 
cancer (ACS, 2012).  Prostate cancer accounted for 10% (29,720) of overall cancer 
deaths which was the second leading cause of death in men (ACS, 2013; Siegel et al., 
2013).  Deaths from prostate cancer were due to the disease progression and metastasis.  
In 2013 in Florida, the prostate cancer incidence was 137.7 per 100,000 and was 
the highest cancer incidence compared to overall rates of breast, colorectal, lung, and 
bladder cancer (ACS, 2013).  The American Cancer Society (2013) estimated that 
238,590 new cases were diagnosed with prostate cancer which was the second leading 
incidence after lung cancer.  It was estimated that 2,200 deaths were due to prostate 
cancer in the state of Florida in 2013 (ACS, 2013).  Prostate cancer was the third leading 
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cause of death of cancer in the U U.S. (ACS, 2013). The majority of prostate cancers 
were localized (80%) followed by regional (12%), and distal (6%) (Altekruse et al.,  
2010).  
The incidence of prostate cancer has been increasing in past decades.  The annual 
percentage change (APC) was significantly positive between 1975 and 1988 (2.6 APC) 
and 1988 and 1992 (16.5 APC) (Edwards et al., 2010).  This increased incidence and 
diagnosis of prostate cancer was attributed to the increased awareness, prostate-specific 
antigen (PSA) screening, and prostate cancer biopsies (Jemal et al., 2006; Penson, 
Rossignol, Sartor, Scardino, & Abenhaim, 2008). 
In 1986, the Food and Drug Administration (FDA) approved the use of PSA to 
monitor the disease status in men diagnosed with prostate cancer (Penson et al., 2008).  
There was a significant decrease in APC (11.7) between 1992 and 1995 followed by a 
nonsignificant annual increase in APC between 1995 and 2000 (Edwards et al., 2010).  
This increase may be explained by the FDA’s 1994 approval of the use of PSA testing for 
the screening of prostate cancer which may have led to the stabilization or nonsignificant 
increase of the incidence rates (Penson et al., 2008).  The incidence of prostate cancer 
between 2000 and 2006 has decreased by 2.4% yearly (Jemal at al., 2010).  This decrease 
may be attributed to the increased PSA screening and the decreased number of 
undiagnosed cases (Espey et al., 2007; Farwell, Linder, & Jha, 2007; Jemal et al., 2004).  
Despite its contribution to the early detection of prostate cancer, some studies have 
debated that PSA testing did not contribute significantly to the decrease in prostate cancer 
specific mortality (Kohli & Tindall, 2010).  This controversy may need further research 
data and analysis.  
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The incidence of prostate cancer varies by race and ethnicity.  The 2002 to 2006 
statistics showed that African Americans had the highest incidence (231.9 per 100,000) 
followed by Whites (146.6 per 100,000), Hispanics (131.1 per 100,000), and others 
(Edwards et al, 2010).  These rates were similarly projected in the mortality rates of men 
in these populations (Jemal et al., 2010; Siegel, Naishadham, & Jemal, 2013).  Disparities 
may be due to variables other than race and ethnicity such as access to care, cultural 
preferences regarding preventive medicine, socioeconomic status, and genetic 
predisposition (Altekruse et al, 2010; Ward at al., 2004). 
Despite being the leading cause of cancer in men, prostate cancer has optimistic 
survival rates.  The optimism has been due to the improvement in early detection and the 
advancement in treatment modalities.  The 5-year survival rate for prostate cancer was 
estimated to be 100%, the 10-year survival rate was 91%, and the 15-year survival rate 
was 76% (Altekruse at al., 2010; Siegel et al., 2013).  These rates have included men who 
have been diagnosed with and treated for prostate cancer controlling for the improvement 
in detection of the disease and treatment technology that may have improved the 10- and 
15-years survival rates (Altekruse at al., 2010; Siegel et al., 2013).  As a result, men live 
longer with prostate cancer and therefore live with the treatment side effects.   
Due to increased survival rates, most men with prostate cancer may die from other 
causes not related to prostate cancer.  Alternatively, some cases of prostate cancer may 
progress due to late detection or the dynamic evolution of the disease.  Mortality rates of 
the most prevalent cancers showed that prostate cancer was the second leading cause of 
death (228,088 annually) for all age groups of men, the third leading cause of death 
(11,717 annually) for men ages 60 to 79 years, and the second leading cause of death 
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(15,099 annually) for men ages 80 years and older (ACS, 2013; Siegel et al., 2013). 
Living longer after the diagnosis of prostate cancer allows men to experience the 
consequences of treatment for extended periods of time and live with challenges and 
changes to their lives which may influence their QOL.  
Prostate Cancer Treatment and Side Effects 
With favorable mortality outcomes of prostate cancer, the consequences and side 
effects of the disease lie in treatment decisions and side effects.  Prostate cancer 
treatments vary from surgery, radiation therapy, hormonal therapy to watchful waiting.  
Current evidence does not provide guidelines regarding which treatment options are 
favored for better outcomes (Resnick et. al., 2013; Wei et al, 2002; Wilt et al., 2008).  
Researchers have investigated the outcomes of treatment options independently (Hoznek 
et al., 2005) and in combination (Milecki, Martenka, Antczak, & Kwais, 2010) or in 
comparisons with each other (Resnick et. al., 2013; Wilt et al. 2008).  The goal of 
treatment of prostate cancer is either cure, prolonged survival, or palliation depending on 
the staging of the tumor at diagnosis (Hoznek et al., 2005; Monga et al., 2005).  Other 
factors considered in treatment choice include patient’s health status, age, and the rapidity 
of tumor growth.  Irrespective of the treatment preference, the side effects are similar and 
include sexual dysfunction (i.e., erectile dysfunction, diminished desire) and urinary 
incontinence (Wei et al, 2002).  The remainder of this section will focus on the different 
treatments and their side effects (i.e., sexual dysfunction and urinary incontinence). 
Surgery 
 Prostate cancer surgery is considered to be one of the curative treatment 
modalities.  Surgery or prostatectomy (i.e., resection of the prostate gland) is an option 
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for patients who are medically cleared and have minimal risk for surgery as a result of the 
side effects of anesthetic agents (Catalona & Bigg, 1990; Corral & Bahnson, 1994).  This 
clearance is an integral consideration especially since many men diagnosed with prostate 
cancer are at an age at which they are at moderate to high surgical risk.  The surgical 
procedure is preferred for localized tumors and can take a perineal (i.e., single incision in 
perineum) or retropubic (i.e., single incision to lower abdomen and may include lymph 
node dissection and nerve sparing) approach (Schuessler, Vancaillie, Reich, & Griffith, 
1991).  The difference between these approaches is in the number of incisions, nerve 
sparing, or lymph node dissection abilities, if possible.  Prostatectomy is valued for its 
reduction of prostate cancer mortality and decreased risk for developing consequent 
metastasis (Bill-Avelson et al., 2008).  A laparoscopic approach may also be performed 
and would yield lower morbidity to the patient (Patel at al., 2004; Schuessler et al., 1991).  
The technologic advancements in laparoscopic procedures such as robotic prostatectomy 
aim to enhance surgical capabilities using the scope to be able to provide a treatment with 
decreased physical burden on men.  Radical prostatectomy is not advised for advanced 
and metastatic cancers where other forms of treatment are preferred such as radiation or 
hormonal therapy (Fair et al., 1997; Witjes, Schulman, & Debruyne, 1997).  In a large 
case series study on undergoing the nerve sparing surgery, 6% of men had to use pads for 
urinary incontinence, and others reported dribbling after the procedure (Catalona & 
Basler, 1993).  Potency for men who did not have sexual problems prior to the surgery 
may be resumed in 40 to 65% of these men.  Despite reported rates that show that most 
men experience at least a partial deficit (i.e., sexual dysfunction), the stage of the tumor 
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and age of the patient were reported to be major determinants in preserving sexual 
potency (Catalona & Basler, 1993). 
The side effects of radical prostatectomy include sexual (i.e., 30-80% erectile 
dysfunction and impotence) and urinary dysfunction (i.e., 30-74% incontinence, urethral 
stricture).  These side effects have shown to impact QOL in men (Hoznek et al., 2005; 
Sanda et al., 2008) and are important to the morbidity of the surgical procedure itself 
(Sanda et al., 2008; Yao & Lu-Yao, 1999).  Latest approaches are attempting to use nerve 
sparing techniques to minimize sexual dysfunction. 
In a population based longitudinal study, the Prostate Cancer Outcomes Study, 
1,291 men diagnosed with prostate cancer who underwent radical prostatectomy were 
followed up for 24 months.  The study examined the urinary and sexual function of men 
after radical prostatectomy for clinically localized prostate cancer.  The sample was 
recruited from six different regions in the United States.  The sample included a variety 
of ethnic/racial backgrounds (i.e., African American, White, and Hispanic).  The age of 
men in this study ranged from 39 to 79 years.  Results showed that 8.4% of men were 
incontinent, and 59.9% were impotent at 18 or more months after the surgery.  The 
potency of men after the surgery varied depending on the type of surgery.  In men who 
were potent prior to the surgery, impotence was reported to be an outcome at 18 or more 
months in 65.6% of nonnerve-sparing, 58.6% of unilateral, and 56.0% of bilateral nerve–
sparing surgeries.  Age was a significant contributor to sexual and urinary functioning 
after the surgery.  Around 39% of men younger than 60 years old were potent at 18 
months or more, whereas only around15% to 21% of older men were potent at the same 
time.  Similar findings were reported for urinary incontinence.  Sexual functioning was 
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found to be significantly different among races/ethnicities.  At 18 or more months, 38.4% 
African American, 25.9% Hispanic, and 21.3% White men reported firm erections.  
Findings from this study documented the significant sexual and urinary side effects 
associated with radical prostatectomy (Stanford et al., 2000). 
In a population based cohort study, Penson and colleagues (2005) investigated 
temporal changes in urinary and sexual function of men up to 5 years following radical 
prostatectomy.  A sample of 1,288 men who were ages 39 to 79 years at diagnosis 
participated in the study.  Data on prostate cancer treatment, medical history, urinary, and 
sexual function were collected using surveys at 6, 12, 24, and 60 month after the 
diagnosis of localized prostate cancer.  The majority of men in this study was younger 
than 65 years (56%), nonHispanic White (74%), and married.  The results showed that 
3.4% of men reported signs of urinary dysfunction at baseline.  Six months after the 
diagnosis, frequent urinary leakage or no control was reported by 25% of men.  This 
percentage decreased to 10.4% by 24 months which, in turn, significantly increased at 60 
months after diagnosis (13.9%).  The majority of men (81%) had erection firm enough 
for intercourse at baseline, whereas 9% reported erection firm enough for intercourse at 6 
months after diagnosis.  The percentage of men with erection firm enough for intercourse 
was at 22% at 24 months and 28% at 60 months.  Similarly, men reported having little or 
no difficulty maintaining erection at 24 months (24%) and 60 months (30%).  The 
percentage change between 24 and 60 months was significantly different (p = 
.003).Nevertheless, men reported no sexual activity at 24 months (44%) and 60 months 
(46%).  The increase in sexual function between 24 and 60 months was not found to be 
significant.  Upon review of the surgical reports of participants, men who had a bilateral 
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nerve sparing surgery were found to report improved erection for intercourse at 60 
months when compared to men with unilateral or nonnerve sparing surgery (40% vs. 
23%, respectively).  Age was a significant contributor to sexual functioning after bilateral 
nerve sparing prostatectomy.  Around 61% of 39 to 54 year old men, 49% of 55 to 59 
year old men, and 44% of 60 to 64 year old men reported erection firm enough for 
intercourse.  Sildenafil (i.e., Viagra®) was the most common erectile aid used (n = 520, 
43%), followed by vacuum erection device (n = 302, 25%) and intracavernous injection 
(n = 204, 17%).  When asked about the success of sexual enhancement methods, men 
reported that these techniques were “a lot” of help (13%, 35%, and 28%, respectively).  
Findings from this study confirmed that urinary and sexual dysfunctions were frequent up 
to 5 years following prostatectomy.  Depending on the type of surgery (i.e., bilateral 
nerve sparing), postsurgery functioning can vary (Penson et al., 2005). 
Sacco et al. (2006) investigated the incidence of urinary incontinence and its 
development over time.  The study compared the effects of alternative definitions of 
incontinence on the incontinence rate and explored risk factors for incontinence after 
radical retropubic prostatectomy.  A sample of 985 men with an average age of 64.5 
years was followed up for 95.5 months and was assessed for urinary continence.  The rate 
of continence was categorized by three definitions: 1 (no or occasional pad use), 2 (0 or 
1 pad used daily for occasional dribbling only), and 3 (0–1 pads daily).  Findings showed 
that 2 years after radical retropubic prostatectomy, men achieved continence 83%, 92.3%, 
and 93.4% according to the definitions 1, 2, and 3, respectively.  The time to recover, 
measured by the date when patients achieved continence, was significantly lower for 
definition 1 in comparison with the other 2 definitions.  Around 90% of men who 
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complained of occasional dribbling (i.e., definition 2) considered themselves continent.  
Continence improved significantly with time up to 2 years after radical retropubic 
prostatectomy.  The criteria or definitions of using pads had a significant impact on the 
QOL in men.  Men conforming to definition 3 reported having lower QOL scores.  
Interestingly, the use of one pad per day was considered to be continent by some men.  
Age, bilateral neurovascular bundle resection, and anastomotic stricture significantly 
predicted incontinence (Sacco et al., 2006).   
In a similar study, Lepor, Kaci, and Xue (2004) documented that continence 
significantly improved between 3, 6, 12, and 24 months following radical retropubic 
prostatectomy.  One year after the surgery, 97.1% of men reported to be continent, and 
97.1%, 94.1%, and 97.1% were found to be continent according to the definitions of 
continence, respectively (Lepor at al., 2004). 
Palmer and colleagues (2003) examined the nature, men’s perceptions, and 
strategies used to manage prostatectomy urinary incontinence.  Men were recruited from 
US TOO, a prostate cancer support group.  The majority of the sample (n = 114) had a 
mean age of 66.4 years old (SD = 7.6), and a large majority were Caucasian (95%) and 
married (83%).  The majority of men reported stress incontinence when lifting (72%), 
coughing (7 2%), and sneezing (72%).  The men in this study used pelvic muscle exercise 
(54%), pads (53%), special undergarments (18%), and other strategies to manage their 
incontinence.  The perceptions of men about the important stressors related to their 
incontinence were also investigated.  The responses were categorized into themes: degree 
of incontinence experienced; precipitants of incontinence; and social, emotional or 
physical effects of incontinence.  Irrespective of the time since surgery, the majority of 
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men (74%) talked about incontinence as being a disturbing symptom that needed to be 
resolved.  Urinary incontinence was prevalent up to 5 years following the surgery.  Some 
men discussed the impact of urinary incontinence on their sexual relations.  Around 11% 
of men reported incontinence when sexually aroused, attempting sex, or having sex.  
There were several strategies that men used to manage their incontinence: preventing 
incontinence, improving incontinence, anticipating leakage, and dealing with complete 
lack of bladder control.  Vigilance and frequent voiding were the major techniques 
followed to prevent incontinence in addition to controlling alcohol, water, and other 
liquid intake.  Kegel exercises were found to be successful in improving incontinence.  
The majority of men complained about endurance incontinence and discussed strategies 
they followed to anticipate leakage.  Consequently, men were prepared with extra 
clothing or backup supplies at all times.  Men with complete loss of control exerted the 
most effort to be able to return to their lives before surgery.  Men talked about the trial 
and error of different procedures and techniques until they found the most appropriate 
method that worked for them.  Most men in this study agreed that they were informed 
about urinary incontinence as a side effect of surgery, but they did not perceive that they 
had enough information to prepare them for the postoperative phase.  The information 
they received was not detailed or precise to help them deal, accommodate, or control their 
incontinence.  Findings from this study highlighted the experiences and perceptions of 
men with urinary incontinence after prostatectomy (Palmer et al., 2003).  These findings 
are important considerations that contribute to the understanding of these men’s 
experiences and help enhance the preoperative preparatory phase.  Nevertheless, a major 
limitation of the study was that the type of surgery performed was not indicated.  This is 
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important to consider in light of the advancement in surgical techniques that are showing 
improved postoperative outcomes. The sample was recruited from a prostate cancer 
support group and may not have been representative of the general population of men.  
The relationship between urinary incontinence and sexual functioning was also a 
distinctive finding reported from this study. 
Meyer, Gillat, Lockyer, and Macdonagh (2003) used an erectile dysfunction 
quality of life measure to assess the effect of erectile dysfunction on QOL in men after 
radical prostatectomy.  Eighty one patients undergoing nonnerve sparing radical 
prostatectomy) participated in the study.  The majority (n = 74) of the men were potent 
before the surgery.  Out of the potent men, 56 were impotent after the surgery.  Men’s 
responses showed that their QOL was significantly affected by erectile dysfunction.  
Around 21% of men blamed themselves for not being able to satisfy their partners and 
felt less of a man.  Findings from this study showcased the importance of erectile 
functioning and sexual potency on QOL in men undergoing radical prostatectomy (Meyer 
et al., 2003). 
Alemozaffar and colleagues (2011) examined long term erectile function 
following prostate cancer treatment based on individual patient and treatment 
characteristics.  Data on pretreatment patient characteristics, sexual health-related QOL, 
and treatment details were collected by the Prostate Cancer Outcomes and Satisfaction 
With Treatment Quality Assessment and Cancer of the Prostate Strategic Urologic 
Research Endeavor (CaPSURE).  Data (N = 1202) were used to predict erectile function 
2 years after prostate cancer treatment.  Findings suggested that 37% (n = 368) of all men 
and 48% (n = 335) of men who reported functional erections before treatment were found 
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to have functional erections post-surgery.  Over half (n = 531; 53%) of men without 
penile prosthesis reported using medications or other techniques for erectile dysfunction.  
Pretreatment sexual health-related QOL, age, serum PSA level, race/ethnicity, body mass 
index, and treatment details were related to functional erections 2 years after prostate 
cancer treatment.  Logistic regression predicted erectile function 2 years after prostate 
cancer treatment to range from 10% or less to 70% or greater depending on the 
individual's pretreatment patient characteristics and treatment details.  Findings from this 
study showed that pretreatment patient characteristics and treatment predict erectile 
functioning 2 years after prostate cancer treatment (Alemozaffar et al., 2011).  
Joseph, Vincente, Madeb, and Patel (2005) compared the outcomes of pure 
laparoscopic radical prostatectomy with robotic assisted radical prostatectomy in 100 
patients with localized prostate cancer.  Findings showed that there were no significant 
differences between both procedures in disease outcomes such as positive margins and 
biochemical recurrence.  Comparing patient functional outcomes, there were no 
significant differences.  Findings from this study suggested that both procedures have 
similar patient outcomes (Joseph et al., 2005).  Interestingly, this study identified unique 
findings about disease outcomes and supported the emphasis of the functional outcomes 
of surgery as major outcome indicators.  These findings suggested that the different 
treatments had similar health outcomes and, therefore, differed only in functional 
outcomes. 
Studies have suggested that men may experience a shortening of the penis by an 
average of 1 to 2 inches after radical prostatectomy (Gontero et al., 2007; McCullough, 
2008; Savoie, Kim, & Soloway, 2003).  The significance of the findings from penile 
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shortening on the sexual functioning of these men is not well studied, but it may be 
assumed that sexual performance may be negatively affected.  
Gontero and colleagues (2007) investigated penile changes after radical 
prostatectomy by serial penile measurements.  With a sample of 126 men, penile 
measurement were documented at baseline (i.e., prior to the surgery) and at 3, 6, and 12 
months after the surgery.  The International Index of Erectile Function was used to 
measure erectile function.  Findings showed that nerve sparing surgery and recovery of 
erectile function predicted the final changes in penile size (Gontero et al., 2007).  In a 
similar study, Savoie and colleagues (2003) measured penile length before and after 
retropubic prostatectomy.  From a sample of 124 men, findings suggested a significant 
difference in size of the penis after prostatectomy for flaccid, stretched, prepubic fat, and 
circumference measurement (Savoie et al., 2003).  Findings from these studies shed light 
on a consequence of prostatectomy that needs to be shared with men prior to them 
deciding whether or not to undergo surgery.  This side effect may affect men’s QOL and 
is an area that is not very well understood. 
Another side effect of radical prostatectomy is inguinal hernia.  Studies have 
shown that 7 to 21% of men may require inguinal hernia repair around 2 years after 
prostate surgery (Lodding et al., 2001; Lughezzani et al.; 2010; Sun et al., 2010).  These 
rates were found to be higher in men after radical prostatectomy as compared to prostate 
biopsy, transurethral resection, or open prostatectomy for a benign disease (Sun et al., 
2010).  Rates were also higher in men who underwent lymph node dissection or radiation 
therapy (Lodding et al., 2001; Lughezzani et al., 2010).   Inguinal hernia is a post 
operative problem that was not emphasized in the literature. 
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Bowel dysfunction is another side effect that may be exhibited by fecal 
incontinence or fecal leakage in moderate to large amounts in 10% and 4%, respectively.  
Fecal leakage was reported by 32% of men after nerve sparing radical prostatectomy and 
17% of men who underwent retropubic radical prostatectomy (Bishoff et al., 1998).  
Although these numbers appear to be low, their significance lies in the fact that fewer 
than 15% of men have discussed this side effect with their physicians (Bishoff et al., 
1998).  As a result, many cases may be unnoticed or undocumented.  Due to lower 
prevalence and reporting of bowel incontinence as compared to sexual and urinary 
dysfunction, this side effect will not be examined in the proposed study. 
Despite numerous side effects, radical prostatectomy is a widely used treatment 
option for localized prostate cancer.  Underlying reasons or rationalization for the 
decision to go for surgery are not well understood.  The assurance of cure may be 
tempting for men who fear the advancement of disease.  In summary, disease outcomes 
have not been emphasized; however, functional outcomes have been the focus of most 
studies.  The impact of sexual and urinary dysfunction on QOL in men after surgery is 
well documented in the literature. 
Radiation Therapy 
 Radiation therapy is advised for men who have been diagnosed with localized 
prostate cancer stages I, II, or III (Asbell et al., 1998).  Treatment can be either external 
(e.g., external beam radiation therapy [ERBT]) or internal (e.g., brachytherapy).  The 
goal of radiation therapy is to irradiate cancerous cells without damaging neighboring 
organs.  Technological advancements in radiation therapy include the emergence of new 
machines and modalities such as intensity modulated radiation therapy (IMRT), three 
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dimensional conformal radiation therapy (3D-CRT) proton beam therapy, and neutron 
beam therapy.  Unlike other cancers, the use of radiation therapy as a prophylactic 
treatment for uninvolved lymph nodes does not enhance the survival of men with prostate 
cancer (Forman, Order, Zinreich, Lee, & Wharam, 1986).  Radiation may also be the 
treatment of choice for men who are not medically cleared for surgical intervention 
(Forman et al., 1986).  Interestingly, the outcomes of radiation therapy were found to be 
positively correlated with the stage of the cancer (Duncan et al., 1993).  Randomized 
control studies that evaluated the impact of higher doses of radiation showed less 
recurrence of prostate cancer compared to the conventional radiation dosages (Peeters et 
al., 2006; Pollack et al., 2002; Zietman et al., 2005).  As a result, protocols have 
suggested the use of higher dosages of radiation. 
Talcott and colleagues (2010) investigated the long term patient reported dose-
related toxicity.  A QOL measure was collected with a sample (n = 280) of men 
undergoing 70.2 Gy and 79.2 Gy of photo and proton radiation for clinically localized 
prostate cancer.  There were no significant differences in urinary, bowel, and sexual 
outcomes between men receiving standard dose and men receiving high dose radiation.  
Findings from this study suggested that treatment with higher doses of radiation does not 
affect treatment related side effects (Talcott et al., 2010). 
Brachytherapy, a form of internal or interstitial radiation therapy, is administered 
to men with early stage cancer through planting a radiation seed into the prostate gland 
using one of two modalities: permanent low dose radiation (LDR) or temporary high dose 
radiation (HDR).  Brachytherapy was considered to be an improvement in radiation 
therapy treatment (Ragde et al., 1997).  Other forms of radiation therapy such as intensity 
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modulated, proton beam, and cyber knife therapies are rather new; therefore, long term 
effects are not well understood.  Similar to development in surgical techniques, 
techologically advanced methods of radiation therapy have been used to improve men’s 
mortality and morbidity rates. 
Radiation therapy, either in the form of brachytherapy or ERBT, was considered 
to be curative in nature.  Main documented side effects have included sexual dysfunction; 
bowel and bladder irritation; and obstruction symptoms such as frequency, urgency, 
incontinence, and incomplete emptying of the bladder (Wei et al., 2002).  External beam 
radiation has been shown to result in acute cystitis, proctitis, and enteritis in a short term 
after the treatment (Catalona & Bigg, 1990; Hamilton et al., 2001; Hanlon et al., 1997; 
Lim et al., 1995; Sanda et al., 2008; Schellhammer, Jordan, & el-Mahdi, 1986).  Despite 
these conditions being reversible and considered to be temporary effects, additional 
interventions were needed for longer periods of time in a few cases.  Sexual potency was 
reported in some instances to be initially preserved but may decrease over time (Hamilton 
et al., 2001). 
Hamilton et al. (2001) examined the impact of radiotherapy for prostate cancer on 
sexual, bowel, and urinary function.  Data were collected from 497 men at 6, 12, and 24 
months after the diagnosis of prostate cancer.  The majority of men treated with ERBT 
were diagnosed between 65 and 74 years of age (80%).  Most men were White 
nonHispanic (82%) and retired (70%).  Results showed that bowel dysfunction increased 
at 6 months and declined by 24 months reaching to a partial resolution.  There was no 
significant change in urinary functioning between baseline and 24 months.  There was a 
significant decline in sexual functioning at 6, 12, and 24 months.  The percentage decline 
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was higher at 24 months among men who reported to be potent at baseline.  Findings 
from this study highlighted the significance of decreased sexual functioning after 
treatment of prostate cancer (Hamiton et al., 2001). 
Zelefsky and colleagues (2002) reported the acute and late toxicity and 
preliminary biochemical outcomes in 772 patients with localized prostate cancer treated 
with IMRT.  Patients reported acute symptoms including urinary symptoms (n = 217, 
28%,), rectal toxicity (n = 35, 4.5%,), and rectal bleeding (n = 11,1.5%,).  Late urinary 
symptoms were reported by 72 men (9%, grade 2).  Findings from this study showed that 
rectal toxicities with IMRT were less likely to occur compared to reported outcomes of 
conventional three dimensional radiotherapy techniques.  Short term PSA levels after 
IMRT treatment were comparable with the other conventional three dimensional 
radiation techniques (Zelefsky et al., 2002). 
Fowler, Barry, Lu-Yao, Wasson, and Bin (1996) studied QOL and possible side 
effects of ERBT for prostate cancer among Medicare-aged men.  Patient data were 
obtained from the Surveillance, Epidemiology, and End Results (SEER) program, and 
men were contacted via mail for additional information.  Results were analyzed from 621 
men and compared with published data on surgical patient outcomes.  Men who 
underwent ERBT reported using less number of pads for urinary incontinence (7%, vs. 
32%), lower rate of impotence (23% vs. 56%), and more bowel dysfunction (10% vs. 
4%) than their surgical counterparts.  Interestingly, patients who underwent radiation did 
not perceive that they were cancer-free unlike surgical patients.  Findings from this study 
showcase the difference in treatment side effects between surgical and radiation patient 
groups (Fowler et al., 1996). 
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Choo and colleagues (2010) assessed the sexual functioning of men diagnosed 
with localized prostate cancer and treated with radiotherapy.  A sample of 117 men 
participated in the study and with ages ranging from 42 to 79.8 years.  Around 64% of 
men reported being sexually active prior to radiation therapy.  Men with erectile 
dysfunction were found to be older and maintained on medications that affected potency.  
Men with erectile dysfunction rated the importance of being sexually active lower than 
men without erectile problems.  After radiation therapy, the brief sexual function 
inventory scores of men who were sexually active without problems at baseline showed a 
major decline at 6, 12, and 24 months.  With time, the degree of decline decreased, but 
there were no noted improvement in sexual functioning.  This decline was associated 
with erectile dysfunction in addition to decreased sexual desire and ejaculation.  Findings 
from this study supported the impact of radiation therapy on sexual functioning of men 
(Choo et al., 2010).  
Similar to surgery, the choice for radiation as a treatment option is not 
understood.  It might be suggested by the healthcare provider due to the absence of 
medical clearance for surgery.  It may also be preferred as a noninvasive treatment 
compared to surgery.  It is important to consider that radiation includes treatment 
appointments several days a week for 5 to 9 weeks as compared to surgery that requires 
one to two hospitalization days followed by the recovery period.  Similar to surgery, the 
focus of research on radiation therapy among men with prostate cancer has been on 
functional and QOL outcomes of the treatment.   
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Hormonal Therapy 
 Hormonal therapy or androgen deprivation therapy (ADT) is another form of 
treatment that aims to stop testosterone production and diminishes the growth of prostate 
cancer.  It is generally used for palliation.  Several approaches include bilateral 
orchiectomy, estrogen therapy, luteinizing hormone-releasing hormone (LHRH) 
antagonists (also called Gonadotropin antagonists), antiandrogens,  ketaconazole, or 
aminogluthemide.  The goal is to slow cancer growth by decreasing testosterone levels as 
a result of depriving cells of androgens (Kohli & Tindall, 2010).  The main side effects 
include hot flashes (55-80%), gynecomastia (13-70%), sexual dysfunction (50-100%), 
weight gain, fatigue, and osteoporosis (Penson & Litwin, 2003).   
Bilateral orchiectomy is considered to be a smooth procedure that decreases 
testosterone levels immediately at a low cost (Catalona & Basler, 1993).  Loss of libido 
and impotence are the main side effects that render this procedure stressful for men 
(Daniell, 1997; Sanda et al., 2008).  Estrogens, administered at levels that immensely 
decrease testosterone levels, are not often used due to their side effects of myocardial 
infarction, cerebral vascular accident, and pulmonary embolism.  The LHRH antagonists 
were found to cause diabetes, cardiovascular disease, and stroke (D'Amico et al., 2007; 
Keating, O'Malley, Freedland, & Smith, 2010; Keating, O'Malley, & Smith, 2006).  The 
side effects of androgen antagonists such as leuprolide, goserelin, and buserelin include 
impotence, hot flashes, and loss of libido (Levine et al., 2010).  Pure antiandrogens 
flutamide and bicalutamide may cause additional diarrhea, breast tenderness, hot flashes, 
loss of libido, impotence, and nausea as reported in case reports (Soloway, 
Schellhammer, Smith, Chodak, & Kennealey, 1996; Wysowski, Freiman, Tourtelot, & 
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Horton 1993).  The other hormonal medications cause similar side effects and impact 
body image, mental health, and other related health related QOL indicators (Fowler, 
McNaughton Collins, Walker Corkery, Elliott, & Barry, 2002; Kirschenbaum, 1995).  
Additionally, androgen deprivation may lead to osteoporosis and bone fractures (19.4 %) 
(Shahinian, Kuo, Freeman, Doodwin, 2005). 
Mittan and colleagues (2002) examined the effects of GnRH analog treatment on 
bone loss and bone reabsorption in with prostate cancer.  Bone mineral density of the hip 
and ultra distal radius and measurements were documented at baseline (i.e., before 
treatment) and at 6 and 12 months.  Findings showed that bone mineral densitometry 
decreased significantly at 12 months.  Bone loss was documented to be 3.3% and 5.3% at 
6 and 12 months, respectively (Mittan et al., 2002). 
Similarly, Greenspan and colleagues (2005) studied bone loss after the initiation 
of ADT.  Bone mineral densitometry was assessed from the hip, wrist, total body, and 
spine.  One year after the initiation of ADT, there was a significant bone loss at the hip, 
trochanter, radius, total body, and posterior spine.  Men who initiated ADT within 6 
months had an increase in total body fat and a reduction in total body lean mass at 12 
months.  Findings from this study suggest that men treated with ADT are at an increased 
risk for fractures.  Maximum bone loss is reached at 1 year after the initiation of therapy, 
therefore suggesting early prevention to enhance patient outcomes and safety (Greenspan 
et al., 2005). 
Tsai, D’Amico, Sadetsky, Chen, and Carroll (2007) studied the relationship 
between ADT and cardiovascular related deaths in men treated for localized prostate 
cancer.  Data were analyzed for 1,015 patients treated with ADT, 3,262 patients treated 
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with radical prostatectomy and 1,630 patients treated with radiation therapy (i.e., ERBT, 
brachytherapy, or cryotherapy).  Competing risks regression analyses were conducted to 
investigate if ADT contributed to early death from cardiovascular causes controlling for 
age and presence of baseline cardiovascular disease.  Findings suggested that ADT and 
age were significantly correlated with increased risks of death from cardiovascular causes 
in patients treated with prostatectomy (Tsai et al., 2007). 
To determine the long term effects of ADT on lean body mass, muscle strength, 
bone mineral density, sexual function, and QOL, Basaria and colleagues (2002) 
conducted a cross-sectional study at a tertiary center.  Men who underwent medical 
castration with GnRH agonists for at least 12 months, men with nonmetastatic prostate 
cancer who were post prostatectomy and/or radiotherapy but had not yet undergone ADT 
(non-ADT group), and healthy and ambulatory men (i.e., control group) were recruited.  
Findings from this study showed that ADT had significantly lower castrate levels of 
serum total testosterone, free testosterone, and oestradiol.  Total body and lumbar spine, 
and body mineral density were significantly lower in the ADT groups.  Also, the ADT 
group had significantly higher fat mass, reduced body strength, and lower sexual 
functioning.  Men in the ADT group reported significantly lower sexual desire, arousal 
and frequency of spontaneous early morning erections.  Consequently, men in the ADT 
group reported lower overall QOL scores especially in the physical function, role 
limitation, and perception of physical health domains (Basaria et al., 2002).  Findings 
from this study showcased that men undergoing ADT have decreased sexual functioning 
and QOL among other symptoms up to 12 months after treatment. 
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DiBlasio and colleagues (2008) examined the incidence of patient-reported 
erectile (ED) and sexual dysfunction after ADT treatment for prostate cancer.  The study 
was a retrospective chart review for men receiving ADT (i.e., medical and surgical) for 
prostate cancer during 1989 and 2005.  A total of 395 patient charts were included in the 
analysis and followed for 87.4 months.  The majority of the sample was African 
American men (59%), followed by Caucasian men (41%).  The majority of men (94.9%) 
received ADT by medical castration, and 20 (5.1%) underwent bilateral orchiectomy.  
Around 30% of men reported erectile dysfunction before ADT, and 70% reported new 
onset erectile dysfunction (DiBlasio et al., 2008).  Findings from this study confirmed 
that ADT has a multiplicity of side effects in men with prostate cancer.   
Unlike surgery and radiation, hormonal therapy may not be the first treatment of 
choice, especially if the side effects were explained to men.  Decreasing testosterone 
levels to cause castration may not be a preferred option for men.  Despite the lack of 
studies that have shown how treatment choice is made, assumptions may be made by 
understanding the importance of testosterone to men’s sexuality and masculinity.  Studies 
have documented that men undergoing ADT have decreased sexual functioning and QOL 
in additional to other symptoms such as cardiovascular side effects and osteoporosis. 
Cryotherapy 
 Cryotherapy, also referred to as cryosurgery and cryoablation, a minimally 
invasive surgical technique, uses intermittent freezing followed by thawing of the 
prostate tissue in an attempt to destroy the cancerous cells (Robinson, Saliken, Donnelly, 
Barnes, & Guyn, 1999).  The projected goal of this form of surgery is to decrease the 
invasiveness of the procedure and lower the risks of the surgical outcomes.  This 
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procedure is considered for men with early stage cancers and men who are not medically 
cleared for radical prostatectomy.  It is also effective for men who do not respond to 
radiation therapy as a result of the tumor being radioresistant.  The long term outcomes 
have yet to be studied, and side effects are not well understood (Aus, Pileblad, & 
Hugosson, 2002; Donnelly, Pileblad, & Hugosson, 2002).   
Anastasiadis and colleagues (2003) compared QOL and prostate associated 
symptoms in men after primary and salvage cryoablation for prostate cancer.  One 
hundred thirty one men who underwent cryoablation were included in the study in two 
groups.  Group 1 included men who had contraindications for or refused surgery, and 
group 2 included men after the failure of radiation therapy.  Men were treated with 
neoadjuvant ADT before cryosurgery for 3 months.  Men in the first group reported 
significantly better physical and social functioning.  However, men in the second group 
reported worse sexual and urinary symptoms.  Sexual dysfunction in both groups was 
highly prevalent, 86% and 90% in the first and second groups.  Urinary incontinence 
rates were reported to be 5.9% and 10% in group 1 and group 2, respectively.  Findings 
from this study demonstrated that cryotherapy had similar functional outcomes as the 
other conventional prostate cancer treatment options (Anastasiadis et al., 2003). 
Studies have reported impotence in 47 to 100% of men who are treated with 
cyrotherapy (Langenhuijsen, Broers, & Vergunst, 2009).  Other complications that have 
been discussed include incontinence, urethral sloughing, urinary fistula or stricture, or 
bladder neck obstruction (Shelley, Wilt, Coles, & Mason, 2007).  Due to recent 
development of this treatment option, these complications have been mainly reported 
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through case series studies.  Further examination of the complications of this procedure is 
needed through future studies. 
Watchful Waiting 
 Watchful waiting or active surveillance is also considered to be a form of 
treatment that includes vigilant monitoring of the cancer through PSA testing and prostate 
biopsy to observe the disease progression.  Men diagnosed with localized prostate cancer 
early may choose to reduce morbidity and delay treatment until disease progression is 
identified (Lu-Yao et al., 2009; Parker, 2004; Patel et al., 2004).  Watchful waiting may 
be a choice for men diagnosed at a later age or men who are asymptomatic (Chodak et 
al., 1994; Lu-Yao et al., 2009; Whitmore, 1994). 
In a longitudinal study, Waaler and Stenwig (1993) followed a small cohort of 
men with localized prostate cancer and had similar findings at 4-9 years follow up.  In 
men with localized stage C cancer, survival rates at 5 and 9 years for men who chose 
watchful waiting as a treatment were 88% and 70%, respectively (Adolfsson, Rönström, 
Löwhagen, Carstensen, & Hedlund, 1994).  These results support the decision of men 
who were diagnosed with localized prostate cancer to choose watchful waiting as a 
treatment modality.  This was especially true since the risk of dying from other causes or 
comorbidities was revealed to be around 60%, 58%, and 57% (Lu-Yao et al., 2009).  
Choosing watchful waiting as a treatment for prostate cancer did not negatively affect 
mortality and morbidity of these men. 
Watchful waiting was supported by classic cohort studies on the mortality and 
morbidity of localized prostate cancer patients that followed up patients for around 15 
years.  Johansson and colleagues (1997) described the progress of untreated early stage 
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prostate cancer and reported the long-term survival rates by stage, grade, and age at 
diagnosis.  In the prospective cohort population based study, 642 men with prostate 
cancer were recruited.  Men who died from prostate cancer and 15 year survival, 
corrected for cause of death other than prostate cancer were computed.  Findings showed 
that prostate cancer was associated for 37% of deaths in men recruited for the study.  
Around 11% of men diagnosed with localized prostate cancer died from the disease.  The 
corrected 15-year survival rate (81%) was similar in the untreated group and the group 
with initial treatment.  The corrected 15-year survival was 57% in men with locally 
advanced cancer and 6% in men with distant metastases at the time of diagnosis.  
Findings from this study suggested that men diagnosed with localized prostate cancer 
have positive outcomes when treated with watchful waiting.  Radical initial treatment did 
not show to limit the death rate.  However, for men with locally advanced or metastatic 
prostate cancer, treatment may improve outcomes and prognosis (Johansson et al., 1997).   
In a second classic study, Adolfsson, Steineck, and Hedlund (1997) studied 
outcomes in men with clinically localized prostate cancer managed conservatively.  In a 
prospective cohort study, 122 men diagnosed with localized, low-grade prostate cancer 
were followed up for 10 years.  No active treatment was provided to 48% of men at 
follow-up or before death.  The probability of being alive 5 and 10 years after diagnosis 
was 71 % and 43%, respectively.  The prostate cancer survival rate at 10 years was 90%.  
At 15 years follow up, 25% of men died from prostate cancer.  The projected prostate 
cancer survival rate was 62% at 5 years.  Findings from this study suggested that 
conservative management or watchful waiting was an appropriate option for men with a 
life expectancy of 10 years or less (Adolfsson et al., 1997).  
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Johansson and colleagues (2004) examined the long term survival of men 
diagnosed with early stage prostate cancer and chose watchful waiting as their treatment.  
In this population based cohort study, men were followed up for 21 years.  A sample of 
223 men with untreated early stage prostate cancer was followed.  Men whose cancer 
progressed were treated with hormonal therapy (i.e., orchiectomy or estrogens).  Findings 
from this study suggested that the progression of prostate cancer was rather slow during 
the first 10 to 15 years.  After 15 years, survival decreased.  At 20 years, the progression-
free survival decreased cumulatively (from 45% to 36%) in general.  The progression-
free survival also decreased in the survival without metastases group (from 76.9% to 
51.2%), and the prostate cancer–specific survival group (from 78.7% to 54.4%) groups.  
The mortality rate significantly increased from 15 per 1000 person-years (95% CI [10, 
21]) during the first 15 years to 44 per 1000 person-years after 15 years follow-up.  
Findings from this study showcase the long term progression of prostate cancer.  
Therefore, treatment with watchful waiting may not be the treatment of choice for men 
with an estimated life expectancy of more than 15 years.  Thus, the age at diagnosis may 
be a significant factor for considering watchful waiting as a treatment of choice 
(Johansson at al., 2004). 
Albertsen, Hanley, and Fine (2005) estimated the 20-year survival of men 
diagnosed with clinically localized prostate cancer and treated with watchful waiting or 
androgen withdrawal therapy alone.  In this retrospective population based cohort study, 
767 men 55 to 74 years of age were followed up for around 24 years.  The prostate cancer 
mortality and mortality from other medical conditions were computed considering men’s 
age at diagnosis and tumor grade.  Findings showed that during the first 15 years, the 
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prostate cancer mortality rate was 33 per 1000 person-years.  After 15 years follow up, 
the prostate cancer mortality rate was 18 per 1000 person-years.  There were no 
differences in the morality rates for the two follow up periods controlling for tumor 
histology.  During the first 20 years follow up, men with low grade prostate cancer were 
shown to have a low risk of dying from prostate cancer.  However, men with high grade 
prostate cancer had a high probability of dying from prostate cancer within 10 years of 
diagnosis (Albertsen et al., 2005).  Similar to findings from previous studies, Albertsen 
and colleagues supported the positive outcomes of localized prostate cancer in men with 
a life expectancy of at least 10 years who chose watchful waiting as their treatment. 
Bill-Axelson and colleagues (2008) reported the results of a randomized trial that 
compared the survival of men with prostate cancer who underwent radical prostatectomy 
(n = 347) and watchful waiting (n = 348).  A 10 year follow up with histopathologic 
review and blinded evaluation of causes of death was conducted.  A total of 137 men in 
the surgery group and 156 men in the watchful waiting group died during the follow up 
period.  Death at 10 years was associated with prostate cancer in 13.5% and 19.5% in the 
surgery and watchful waiting groups.  At 12 years, death was associated with prostate 
cancer in 12.5% and 17.9% of men in the surgery and watchful waiting groups.  Findings 
suggested that the incidence of death was stable in both groups after 10 years of follow 
up.  At 12 years, 19.3% and 26% of men in the surgery and watchful waiting groups were 
diagnosed with distant metastases.  The incidence of distal metastases did not increase 
after the 10 year follow up.  Findings from this study suggested that watchful waiting, as 
a treatment for prostate cancer, has comparable long term outcomes, prostate cancer 
mortality, and risk of metastasis (Bill-Axelson et al., 2008).  
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To examine the outcomes of localized prostate cancer treated without initial 
curative therapy, Lu-Yao and colleagues (2009) conducted a population-based cohort 
study.  Men diagnosed with stage T1/T2 prostate cancer after age 65 years from the 
Surveillance, Epidemiology, and End Results (SEER) program were followed for 
approximately 8.3 years.  The 10-year overall survival, prostate cancer survival, and 
cancer related interventions were reported.  The study identified the 10-year prostate 
cancer mortality to be 8.3%, 9.1%, and 25.6% for men with well-, moderately-, and 
poorly-differentiated tumors, respectively.  The risk of dying from causes other than 
prostate cancer was 59.8%, 57.2%, and 56.5% for men with well-, moderately-, and 
poorly-differentiated tumors.  Men between the ages of 66 and 74 years diagnosed with 
moderately differentiated prostate cancer had a 10 year disease specific mortality of 60% 
to 74%.  There was an improvement in the survival of poorly differentiated prostate 
cancer when compared to earlier published studies (Lu-Yao et al., 2009).  Findings from 
this study showed improved survival and outcomes with watchful waiting.  However, the 
advancement in technology and awareness about prostate cancer between the studies 
might play a role in the enhanced findings. 
Important psychological conditions described by men who choose to go through 
watchful waiting include anxiety, stress, and fear of unknown (Chodak & Warren, 2006).  
The choice of monitoring the disease with the assumption that it has a slow progression 
may free men from treatment side effects, especially if they are asymptomatic.  On the 
other hand, studies have reported that men who chose watchful waiting as their treatment 
of choice may also experience sexual and urinary dysfunction (Wilt et al. 2008).   
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Comparison of Treatment Options 
 There have been few randomized control trials that have compared patients who 
choose to go through one approach versus another for the treatment of prostate cancer.  
Generally, these studies have not been longitudinal in nature (Penson et al., 2008) and 
have been conducted with samples with a variety of characteristics.  Overall, the evidence 
did not yield a preference of one method over another (Penson et al., 2008).  However, 
Resnick and colleagues (2013) published a groundbreaking report that compared long-
term urinary, bowel, and sexual function after radical prostatectomy or external-beam 
radiation therapy.  Findings showed that there were no long term differences in functional 
outcomes at 15 years after treatment.  As a result, the choice of treatment is left to the 
preference of the patient and his family where the role of the healthcare provider would 
be to explain treatment side effects and guide the patient and his family in their decision 
regarding treatment option.  With the varying percentages of side effects such as sexual, 
urinary, and bladder dysfunctions, men are faced with a dilemma of which of these 
symptoms are less bothersome. 
With sexual dysfunction being a common side effect of prostate cancer, Siegel, 
Moul, Spevak, Alvord, and Costabile (2001) examined the development of erectile 
dysfunction in three groups of men undergoing radical prostatectomy, ERBT, and 
watchful waiting.  A total of 802 men had sufficient information in their medical charts 
about their erectile functioning and were included in this study and followed up for 
around 53 months.  The majority (56%) of men in this study were 70 years old or 
younger.  The sample included 190 (24%) African American men, 563 (70%) White men 
and 49 (6%) Hispanic, Asian, or men of unknown ethnicity.  Findings showed no 
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significant difference in erectile function between men treated with radical prostatectomy 
(10%) and ERBT (15%).  Men undergoing watchful waiting reported decreased risk for 
erectile dysfunction.  Potency significantly decreased in 38% of African America men 
and in 51% of White men.  Men were grouped into three groups: younger than 60 years, 
60 to 70 years, and older than 70 years.  There were no significant differences in the 
development of erectile dysfunction.  However, men younger than 60 years who chose 
watchful waiting as a treatment were less likely to develop erectile dysfunction than any 
of the other groups.  The main predictors of erectile dysfunction were clinical stage of the 
cancer and race in the watchful waiting and ERBT groups (Siegel et al., 2001).  Findings 
from this study support the evidence that has suggested that irrespective of the treatment 
option, erectile dysfunction is a major side effect of prostate cancer treatment. 
Wilt et al. (2008) presented a comparative report to evaluate the effectiveness and 
consequences of treatment for localized prostate cancer.  Two randomized control trials 
(RCTs) that compared radical prostatectomy and watchful waiting showed in one study 
that surgery significantly reduced death from prostate cancer (10% vs. 15%), while 
findings showed no statistical differences in the other study.  However, these studies had  
small sample sizes.  Findings showed common rates of sexual dysfunction among all 
treatments with impotence rates of 5-80% (including studies on nerve sparing surgical 
approach) (Wilt et al. 2008).  In an RCT in a longitudinal study in Sweden, radical 
prostatectomy and watchful waiting were compared; the overall mortality difference over 
12 years was not significant (Bill-Axelson et al., 2008).  For men younger than 65 years, 
the overall mortality favored prostatectomy (Bill-Axelson et al., 2005).  A population 
based survey in the United States comparing radiation therapy and surgery showed 
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differences in morbidity as a result of the procedure (Fowler et al., 1996).  The 
differences were in the major side effects in which radiation therapy resulted in increased 
bowel dysfunction (10% vs. 3%) and decreased urinary symptoms (7% vs. 30%) (Fowler 
et al., 1996).  In an RCT, sexual dysfunction was reported to be relieved with sildenafil 
citrate (i.e., Viagra®) (55%) as compared with the placebo group (18%) (Incrocci, Koper, 
Hop, & Slob, 2001).  In a study that compared outcomes of ERBT and radical 
prostatectomy that controlled for  specific patient characteristics, men with the former 
treatment had higher rates of acute prostatitis (18.7%) and diminished bowel functioning.  
On the other hand, men with prostatectomy complained of higher rates for 
cardiopulmonary complications (5.5%), urinary stricture (17.4%), urinary incontinence 
(9.6%), and impotence (80%) (Potosky et al., 2000). 
Recent studies have investigated the combination of treatment options.  In an 
RCT with 213 men, there were no significant improvements in outcomes between radical 
prostatectomy alone and radical prostatectomy with neoadjuvant therapy (Koltz et al., 
2003).  Another trial that examined the effect of ERBT alone and ERBT with 
brachytherapy found that the latter reduced the progression of prostate cancer (Sathya et 
al., 2005).  External beam radiation with ADT led to decreased mortality in comparison 
to ERBT alone, but this was at the expense of increased side effects that accompany 
hormonal therapy such as osteoporosis, cardiovascular disease, diabetes, and others 
(D’Amico et al., 2004; Milecki et al, 2010). 
Crook and colleagues (2011) compared urinary, sexual, and patient satisfaction 
outcomes between men who underwent surgical prostatectomy and interstitial radiation 
intervention.  Data from American College of Surgeons Oncology Group phase III 
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Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial were used to 
analyze health-related QOL outcomes on 168 men.  Patients participated in a 
multidisciplinary session that informed men about the procedures.  Men were followed 
up for a median of 5.2 years (range = 3.2 to 6.5 years).  Around 60% of men in this study 
had brachytherapy, and 39.3% had radical prostatectomy.  Study findings showed no 
differences in bowel or hormonal domains.  Men with brachytherapy had better scores in 
the urinary, sexual, and patient satisfaction domains (Crook et al., 2011). 
In a current groundbreaking study, Resnick and colleagues (2013) compared the 
long-term urinary, bowel, and sexual function after radical prostatectomy or external-
beam radiation therapy.  Functional status was assessed at baseline (i.e., diagnosis) and at 
2, 5, and 15 years after diagnosis.  Data were retrieved from the Prostate Cancer 
Outcomes Study that collected information from six Surveillance, Epidemiology, and 
End Result sites in Connecticut, Utah, New Mexico, Atlanta, Los Angeles, and Seattle.  
The data were reviewed for participants who were surveyed at 6 and or 12 months after 
the diagnosis and resulted in a sample of 3,533 men.  The sample was also limited to men 
who were diagnosed between the ages of 55 and 74 years old, underwent a follow up 
survey at 2 or 5 years, and underwent either radical prostatectomy or external beam 
radiation.  A final sample of 1,655 men was identified of whom 1.164 (70.3%) underwent 
radical prostatectomy and 491 (29.7%) underwent radiotherapy.  The results showed that 
urinary incontinence was more prevalent in patients who underwent surgery as compared 
to the radiation therapy patients at 2 and 5 years.  There were no significant differences in 
urinary functioning between both groups at 15 years.  Likewise, sexual dysfunction was 
more prevalent in patients undergoing surgery at 2 and 5 years, and there were no 
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significant differences at 15 years.  The findings from this study are radical in showing 
the long term outcomes of prostate cancer treatment (Resnick et. al., 2013) in contrast to 
the numerous studies that have highlighted the differences in functional outcomes after 
the different treatment options.  Findings from this study suggest that there are no long 
term differences in functional outcomes at 15 years after treatment.  These results will 
contribute to the change in the decision of treatments and may encourage the emphasis on 
short term functional outcomes and quality of life issues. 
In summary, there has not been evidence to support men in their choice for the 
treatment for localized prostate cancer (Penson et al., 2008; Wilt et al., 2008).  Regardless 
of treatment choice, there is evidence that has supported the high rates of side effects, 
namely sexual and urinary dysfunction, with varying percentages according to the 
treatment of choice.  The Prostate Outcomes Study reported that sexual and urinary 
dysfunction was found in 56% to 58% men up to 18 months or more after surgery 
(Stanford et al., 2000).  Other studies have documented no sexual activity in 44% to 46% 
of men up to 60 months after surgery (Penson et al., 2005).  Nerve sparing surgeries were 
introduced to decrease the sexual dysfunction side effect of surgery.  Researchers have 
suggested that nerve sparing surgeries were found to decrease the risk of sexual 
dysfunction (Penson et al., 2005).  Also, urinary incontinence was also a major problem; 
however, studies have suggested that men may achieve some levels of continence up to 2 
years after surgery (Lepor et al., 2003; Sacco et al., 2006).  Urinary incontinence was also 
reported to affect sexual performance (Palmer et al., 2003). 
Radiation therapy also leads to sexual dysfunction; bowel and bladder irritation; 
and obstruction symptoms such as frequency, urgency, incontinence, and incomplete 
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emptying of the bladder (Litwin et al., 1995; Wei et al, 2002).  In a population based 
survey of Medicare recipients, men reported requiring pads for urinary incontinence (7%) 
and increased bowel dysfunction with frequent bowel movement (10%) (Fowler et al., 
1996).  Hamilton and colleagues (2001) reported that 43% of men had impotence as a 
result of treatment 2 years after radiation therapy.  Impotence was also reported by other 
studies with rates up to 62% (Potosky et al., 2000).  Also, erectile dysfunction was 
discussed to be a major side effect (up to 80%) (Monga et al., 2005).  On another note, 
radiation was found to be carcinogenic and to lead to an increased risk for bladder and 
rectal cancer (Abdel-Wahab, Reis, Wu, & Duncan, 2009; Nieder, Porter, & Soloway, 
2008). 
Hormonal therapy has been a palliative treatment used for men diagnosed with 
advanced stages of prostate cancer due to its uncomfortable side effects: hot flashes (55-
80%), gynecomastia (13-70%), sexual dysfunction (50-100%), weight gain, osteoporosis, 
cardiovascular disease, and others (Mittan et al., 2002; Penson & Litwin, 2003; Tsai et 
al., 2007).  Watchful waiting also been considered to be a treatment modality because of 
the slow progression of the disease during the first 15 years and good survival rates 
(Adolfsson et al., 1997; Johansson et al., 1997, 2004).  Mohan and colleagues (2009) 
examined the expected survival of newly diagnosed men with treatment versus 
observation or watchful waiting.  Despite the small sample (n = 170), findings showed 
that approximately 38% of men were expected to survive more than 10 years with 
observation and therefore opted to choose watchful waiting as a treatment (Mohan et al., 
2009). 
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Research in this area is growing, and an increased number of RTCs are emerging 
that compare treatment modalities and their impact on mortality, morbidity, and health 
related QOL (Penso et al., 2008; Wilt et al., 2008).  There are also new treatment 
protocols and modalities being investigated that aim to enhance outcomes for men with 
prostate cancer such as cryotherapy (Shelley et al., 2007).  On another note, most studies 
still have not controlled for the stage of the disease, age, race/ethnicity, and other social 
variables on mortality, morbidity, and health related QOL.  Very few studies have 
examined age as a variable even though age was found to affect the sexual and urinary 
outcomes of prostate surgery (Stanford et al., 2000). 
The majority of these studies were based on large national database data or on 
data from large research oriented urology clinics.  Information about the instruments used 
to measure sexual dysfunction, urinary incontinence, and other variables were not 
provided in the majority of the study reports.  However, the majority of the studies have 
confirmed the high risk of sexual dysfunction and urinary incontinence as a result of the 
treatment of prostate cancer.  As a result, QOL in men with prostate cancer will be 
affected. 
Economic Perspective of Prostate Cancer 
The economic burden of cancer includes the direct and indirect costs.  Direct costs 
include those incurred by physician and healthcare professional fees, hospitalization, 
medications, laboratory services, and others.  Indirect costs include those acquired by the 
inability to be economically productive as a result of the inability to work or early death 
(Grover, Zowall, Coupal, & Krahn, 1999).  The national cost of cancer care in 2010 was 
estimated to be $124.57 billion with $11.85 billion used for prostate cancer.  It is worth 
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noting that the impact of these costs is enormous especially with the estimated 27% 
increase in the next 10 years (Mariotto, Yabroff, Shao, Feue, & Brown, 2010).  The 
annual productivity cost from cancer was $115.8 billion in 2000 with an estimate of 
$147.6 billion in 2020.  Men are reported to have a higher productivity cost than women 
that may be explained by the higher death rate, higher labor force participation, and 
higher wages (Bradley et al., 2008).  These different approaches in analyzing the 
financial burden of cancer show different aspects of the issues faced by patients (Ramsey, 
2008).  In an analysis of cost in terms of days lost from work, Yabroff and collegues 
(2004) found that prostate cancer has the lowest lost job productivity (21.6%), inability to 
work (12.1%), limitation of work (18.9%), days lost from work (9%) compared to breast, 
colorectal, and other cancers. 
Examinations of the costs of prostate cancer in specific reports do not clearly 
differentiate whether the disease is localized or metastasized and the consequent the 
consequent cost burden.  The majority of cost related studies have discussed treatment 
specific expenses.  Few studies have compared treatment costs including initial and long 
term financial burdens.  Wilson and colleagues (2007) showed that the initial 6 month 
costs of prostate cancer were on average $11,495 (i.e., from $2,586 for watchful waiting 
to $ 24,204 for external beam radiation).  The cost decreases after the initial 6 months to 
an average of $3,044.  The cost in the case of prostate cancer is directly related to the 
selected treatment option. 
The 5 year cost analysis showed that watchful waiting has the lowest financial 
burden of $9,130, followed by radiation ($15,589), surgery ($19,214), hormone and 
radiation combined ($25,097), and hormonal therapy ($26,896).  The initial cost on the 
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other hand was lowest for watchful waiting ($4,270), followed by surgery ($15,197), and 
hormone and radiation combined ($17,474).  The initial inpatient costs were higher for 
surgery ($8,765) and lowest for watchful waiting ($2,288).  The initial outpatient costs 
were highest for hormone and radiation combined ($16,656).  Analyzing these costs, 
there was a significant difference between initial and long term cost in addition to 
difference between inpatient and outpatient cost depending on the treatment option 
(Snyder et al, 2010).  Studies that have explored recent technological advancement also 
present a financial perspective.  Barbash and Glied (2010) showed that robotic assisted 
surgeries incur a high cost as a result of the price of the equipment, maintenance, and the 
demand of additional consumables such as single use appliances.  For example, the cost 
for radical prostatectomy without and with robotics is $2,200 versus $4,800 (Barbash & 
Glied, 2010).  As a result, Medicare and insurance companies do not reimburse for these 
surgeries in many instances.  The benefit of the robotic surgeries includes short term 
recovery as compared to the regular surgery which is the main temptation for patients.  
As a result, reports show that there is an increased number of robotic surgeries performed 
for the treatment of prostate cancer (Barbash & Glied, 2010). 
The costs of prostate cancer treatment are covered by Medicare and insurers.  The 
details of the coverage may vary between different institutions.  For example, HMOs 
cover prostate cancer treatment when it is performed by an HMO-affiliated physician 
(USMD Prostate Cancer Center, n.d.).  Radical prostatectomy (i.e., open, laparoscopic, or 
robot-assisted) is an open discussion when it comes to Medicare and insurance coverage.  
Radical prostatectomy is paid for by Medicare and insurers; however robotic-assisted 
surgery may incur additional charges that are not covered by Medicare and other insurers 
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such as CIGNA, United Health, and Blue Cross Blue Shield.  Radiation therapy is 
covered by Medicare Part A for inpatients, and Medicare Part B pays for outpatients or 
patients in freestanding clinics (Institute for Clinical & Economic Review, n.d.).  
Hormonal therapy is also covered; however, not all prescribed medications may be 
approved.  Abarelix was approved in 2005 by the Centers for Medicare and Medicaid 
Services (CMS) as a substitute for GnRH agonists with and without anti-androgens in the 
treatment of patients with advanced prostate cancer (CMS, 2005).  Cryosurgery or 
cryoablation is not covered by Medicare unless there is evidence that other treatment 
options (i.e., radiation therapy) have failed. 
On the other hand, the costs of prostate cancer treatment side effects are generally 
not covered by insurances (Victorian, 2008).  The Congress in the Department of Labor, 
Health, and Human Services and Education Appropriations Act of 2006 has banned 
Medicare and Medicaid reimbursement for ED medications.  Many private insurers have 
followed Medicare and Medicaid’s decision on decreasing or eliminating coverage of 
oral phosphodiesterase type 5 inhibitors, which are commonly considered as elective 
treatments. The American Urological Association currently supports the House 
Resolution 1903 on its goal to amend the Public Service Act and Employee Retirement 
Income Security Act of 1974.  This amendment would require insurance providers to 
include reconstructive prosthetic urology surgery if they provide coverage for prostate 
cancer treatment, especially since penile implant costs were comparative to the costs of 
breast reconstruction and the damage to body image and sexual dysfunction due to ED is 
just as important when it is caused by prostate cancer (Victorian, 2008). 
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Sexual dysfunction and urinary incontinence after the treatment of prostate 
cancer are inevitable; therefore, men opt to undergo treatments to manage these side 
effects.  However, many of the side effect options may not be paid for by Medicare and 
insurers.  For example, Medicare, United Health, Oxford, CIGNA, and others do not have 
a National Coverage Determination (NCD) for sural nerve graft to restore erectile 
function during radical prostatectomy (United Healthcare, 2012).  Also, a collagen 
implant is a procedure that is used for the treatment of stress incontinence.  Medicare 
covers the procedure when performed by men following a trauma including 
prostatectomy and/or radiation therapy.  Moreover, pads used for urinary incontinence 
incur costs that are not covered by Medicare or insurers (United Healthcare, 2011). 
Sexual impotency is considered to be a medical problem that may be caused by a 
condition and treatment.  Sexual impotency is covered by Medicare and insurers.  The 
coverage includes outpatient procedures such as external vacuum devices, pumps, or 
constriction rings (e.g., ErecAid), surgical treatment such as implantation of rigid, semi-
rigid, or inflatable penile prosthesis (e.g., FlexiRod), and penile revascularization surgery.  
Nerve graft surgeries to restore erectile function are not covered.  Medicare does not 
cover the electrical stimulation of the cavernous and associated parasympathetic nerves 
with penile plethysmography in men who underwent nerve-sparing prostatic surgery.  
Also, prescription and injectable medications for the treatment of erectile dysfunction are 
not covered (i.e., Alprostadil urethral suppository (MUSE), Testosterone patches, 
Caverject, etc.) (CMS, 2005).   
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Masculinity 
Social Construction of Masculinity 
 Gender is a main component of everyday life of people since birth.  Gender 
illustrates the ways children are raised, the way family life and sexual relationships are 
managed, and the way people present themselves (Connell, 2010).  The biological 
differences between males and females are accompanied by a series of cultural and 
societal role norms and expectations.  Since birth, boys are dressed in blue and expected 
to be rough, tough, more demanding, and vigorous.  Boys are expected to play with 
specific toys such as trucks, cars, construction tools, and other toys.  They are nurtured to 
stay away from dolls and make-up kits (Connell, 2010).  Starting in the family 
environment, gender roles are socialized.  Expectations are cultured through role 
modeling of the father and other strong male figures such as athletes and fiction heroes.  
These societal expectations encourage men to behave and perform their roles by being 
strong, dominant, and sexually active, in addition to other characteristics that constitute 
the masculinity of men (Kimmel, 2000).   
Masculinity, as a social construct, is influenced by societal and cultural beliefs.  
Discussions and writings on masculinity and the role of men in society emphasize 
theories of gender socialization (Connell, 1995).  These gender considerations are viewed 
in terms of people’s dynamic relationships and their social interaction.  Masculinity, a 
relational construct, lies at the center of the understanding of gender hierarchies (Lusher 
& Robins, 2010).  Men are taught to be dominant and competitive, men are trained to 
seek leading positions in life.  Connell’s theory of masculinity focuses on the power 
exhibited by men over their female counterparts.  This theory of masculinity highlights 
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the strength and power of men in addition to their superiority over women and other 
weaker men (i.e., those who cannot comply with the strong and powerful image).  These 
beliefs are the driving force behind most of men’s interactions in society. 
Masculinity is constructed as a social interaction in which boys are oriented to 
their social roles as they enter an organized institution (Connell, 1995).  This process is 
thought to start during childhood when boys start playing sports.  Thoughts about male 
hierarchies, competitiveness, ability to overcome injuries, and sexual contradictions of 
athletic bodies are emphasized while learning the rules of the games.  Male and female 
children are generally treated differently by their parents (Courtney, 2000).  Boys are 
indirectly socialized so that the norms of potency, superiority, and authority are 
emphasized.  These ideas are further strengthened through the expected powerful and 
strong image of men (Connell, 1995).  The expected norms and expectations grow with 
men and influence their views about many conditions including their health related 
behaviors. 
Connell (1995) discussed the hierarchies of men over women and other 
subordinate masculinities.  The dominance of men is supported by reinforcing a culture 
of patriarchy and superiority.  The term hegemonic masculinity describes the cultural 
dynamics of claiming and sustaining the leading role of men in any society (Connell, 
1995).  The inability to meet the masculine expected role constructs an image or identity 
of a subordinate man.  The subordinate masculinities include gay men, transgender men, 
or men who are underachieving (e.g., academically).  In other words, men are not only 
viewed as being superior to women but they are also at a higher rank than other men who 
do not comply with the socially expected role of being masculine.  With the emphasis on 
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sexual performance as one of the major masculine strengths (Connell, 1995; Farrell, 
1993), men with decreased ability for sexual performance may also be viewed as weak or 
subordinate men. 
Men are taught to seek independence and to be more instrumental and task-
oriented (Kimmel, 2000).  These teachings define how men manage their experiences of 
friendship, love, and intimacy.  Stemming from their practical perspective, men show that 
they rely on rational, practical sex to express their intimacy in relationships (Kimmel, 
2000).  Accordingly, sexual relationships are gendered, and sexuality has been 
masculanized. The masculinization of sex includes the emphasis on the sexual activity, 
multiple partners, the ability to satisfy the partner, and sexual experimentation (Kimmel, 
2000).  Men accentuate the importance of sexual encounter to satisfy their role 
expectation; therefore, sex is viewed as a contest in which most men feel obliged to 
dominate. 
Men are brought up and nurtured into these norms throughout their lives.  The 
inability to meet these expectations contributes to negative feedback that ranges from 
frowns to disappointments (Connell, 2010).  When the inability to meet socially 
constructed norms is due to a health condition, disease, or treatment, men feel 
disappointed and react in a manner that initially impacts their immediate environment 
such as their QOL. 
Considering the social constructionist viewpoint, masculinity is influenced by 
society, history, social class, and culture (Courtney, 2000).  Accordingly, the ramification 
of illness or disability among men may lead to reducing their gender hierarchal status that 
may contribute to a shift of power (Charmaz, 1995).  Thus, with a diagnosis of an illness, 
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men may perceive some loss of their power that challenges their perceived image as a 
man.  In the case of prostate cancer and treatment side effects (i.e., sexual dysfunction 
and urinary incontinence), there is an added concern with the decreased sexual 
performance that may challenge their perceived role expectation.  This concern arises 
from the increased emphasis on the ability of men to satisfy women sexually (Gray et al., 
2002; Khan et al, 2008). 
With the superior and strong socially constructed norms, men are cultured to 
shape their behaviors accordingly.  These traits can be seen in the communication style 
differences between men and women (Connel, 2010; Kimmel, 2000; Oliffe, 2005).  
Women exhibit more expressive communication patterns whereas men have more 
assertive, goal oriented, and dominant patterns (Connel 1995; Connel, 2010, Courtney, 
2000; Kimmel., 2000).  As such, men do not express their feelings and refrain from 
discussing issues that represent areas of weakness and subordination (i.e., prostate cancer 
diagnosis and treatment side effects) (Hoyt et al., 2013).  With these communication 
differences, it is expected that when a man is diagnosed with a illness condition, the 
communication between the couple is challenged as a result of the different styles 
utilized. 
In the majority of qualitative studies that have included men with prostate cancer, 
a main theme related to the inability to perform sexually and its effect on their ability to 
view themselves as masculine arises and results in a shift in men’s perceived status (Gray 
et al., 2002; Khan et al., 2008).  This change in status, therefore, is a major stressor for 
many men.  Men define their masculinity in terms of abiding by the historic social 
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construction of being strong, powerful, and superior to women in their environment that 
is emphasized by their ability to sexually perform and satisfy women. 
Several behaviors or activities may contribute to the concepts of stoicism and 
sexual proficiency or potency.  These concepts inform the masculinity principles and are 
viewed in terms of being successful, capable, reliable, and in control (Cheng, 2008).  
Sexuality and sexual performance are considered to be indicators that confirm the gender 
role of men and their perceived masculinity (Kimmel, 1990).  In cases in which there is 
an inability to sexually perform, men believe that they are pressured to perform their 
expected role (Oliffe, 2005).  Again, prostate cancer and treatment side effects may cause 
a threat to one of men’s expected roles.  The sexual role expectation was emphasized by 
men in qualitative findings from Gray and colleagues (2002), Khan and colleagues 
(2008), and others (Duncan & Dowseit, 2010; Hawkins et al., 2009).  Detailed 
discussions about these concepts will be elaborated in the following sections. 
Masculinity and Health Behaviors 
 Understanding the social construction of norms of gender roles is imperative in 
understanding men’s health behaviors.  People, in general, are influenced by identified 
“normal” behavior to guide their responses to what they believe their social environment 
accepts or identifies as deviant (Cialdini & Trost, 1999).  Normative behaviors are 
acquired from the cultured perception of the image of men.  Normative male figures are 
nurtured through role models in the society and introduced through the immediate 
environment and social media.  The “heroic” man is pictured to be strong, a risk taker, 
not needing medical attention, and sexually appealing and active.  The perceptions of 
men’s expected behavior are strong indicators of their responses to health issues and 
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behaviors (Addis & Mahalik, 2003; Mahalik, Burns, & Syzdeck, 2007).  The majority of 
studies on the social influences on health behaviors were conducted among young adults 
and investigated risky behaviors such as smoking (Weiss & Garbanati, 2006), alcohol 
consumption and driving (Babington, Kelley, & Patsdaughter, 2007; Linkenbach & 
Perkins, 2006), and risky sexual behaviors (Babington, Kelley, & Patsdaughter, 2009; 
Patsdaughter, Kelley, Babington, & Dyer, 2005; Peterson & Bakeman, 2006).   
Several studies have examined the impact of social norms and masculinity on 
health promotion and health seeking behaviors (Addis & Mahalik, 2003; Mahalik et al., 
2007; Pleck, Sonenstein, & Ku, 1994).  Seeking medical help is viewed by men as a form 
of weakness, and they reportedly preferred to deal with their symptoms and learn to live 
with them (Solomon, Greenberg, & Psyszczynski, 1991).  This reluctance in seeking 
medical attention is especially true when symptoms are considered to be embarrassing 
and shameful such as urinary incontinence and sexual dysfunction (Chapple & Ziebland, 
2002; Gray et al., 2002). 
O’Brien, Hunt, and Hart (2005) studied the experiences of help seeking behaviors 
and the links or relationships with practices of masculinity using 14 focus groups.  The 
study included 55 men with an age range of 15 to 72 years.  The men were from diverse 
occupational statuses, socioeconomic background, and health statuses.  Men in this study 
complained of various conditions including prostate cancer, coronary heart disease, and 
mental health problems.  Discussions during the focus groups were facilitated using 
general questions about discussing health issues with other men and seeking medical 
help.  There was minimal input about masculinity from the facilitator because the aim 
was to allow it to emerge from the men’s discussions.  During the focus groups, there 
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were differences in the responses between younger healthy men and older men with 
cardiac and mental health problems.  Participants who had not experienced a serious 
illness expressed their unwillingness to consult a physician for minor complaints.  They 
discussed that seeking medical help would be for a really serious condition or if 
something was really wrong.  Older men in this group discussed the pressure by their 
wives to seek medical help for persisting symptoms.  These men required reassurance 
that they were not making an issue about a trivial problem before they actually sought 
professional health care.  Men who had a medical treatment due to a cardiac emergency 
explained that they did not seek medical help prior to their accident.  These men 
discussed that during their cardiac emergency, they still were debating if their symptoms 
were serious enough to seek medical attention.  Men waited before they actually received 
treatment because they hoped that the symptoms would probably be resolved with time.  
Seeking help for a mental health condition was a challenge to the men’s masculinity.  
Men were hesitant to discuss mental health issues and referred to them as emotional 
disturbances or stress without elaborating or defining the problems.  Some men were 
even resistant to explore personal experiences of depression or depressed mood.  Men 
who were able to discuss issues related to depression maintained their masculine image 
and sense of control in their scripts by discussing their struggle with stress or distress and 
their inability to cope alone.  Men with prostate cancer in this study were in the advanced 
stages of the disease and were using watchful waiting as a treatment.  Their discussions 
indicated that they were proactive in seeking medical attention.  Since these men were on 
watchful waiting as a treatment, they were expected to continuously monitor changes and 
the progress of the disease.  Their health seeking behaviors only included practices to 
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monitor their cancer.  These men also recognized the "macho" aspects of not coming 
forward for medical help as exhibited by other men.  Overall findings showed the 
repetitive reluctance to seek medical help since men explained it to be challenging to 
their strong masculine image.  Men talked about enduring symptoms until tangible 
physical and visible symptoms were evident before attempting to seek help.  The 
influence of others, especially female partners, to pressure men to seek help was also 
evident in the discussions of the men (O’Brien et al., 2005).  Findings from this study 
emphasized the barriers related to the perceived masculine norms of men to seek medical 
help.  The sample included different groups of men with a wide range of experiences.  
Although there were common concepts among the groups, there were also differences in 
the manner of expressing their health seeking behaviors.  This study introduced the 
influence of the male gender in health seeking behaviors. 
Using retrospective life course methods, Oliffe (2009) described the relationship 
between health behaviors and masculinity across time among three Anglo-Australian men 
recruited from prostate cancer support groups. The author used a social constructionist 
gendered framework for the analysis of the interviews and findings. The results were 
presented in chronologic phases of life.  The early years had the theme of ill-boys in 
which being healthy was a social and self-expectation despite the presence of illnesses 
from time to time.  The three men emphasized how social expectations influenced their 
actions regarding healthcare.  The authority of the female as a primary healthcare 
provider was apparent.  The focus of healthcare was for treatment of a problem and 
definitely not for preventative care.  With the expectation to be healthy, the presence of 
an illness was initially treated with compulsive behaviors and private problem solving 
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which is reflective of being in denial.  During the middle life phase, there was an 
intersection of work, wife, and family.  In this phase, the relationship between social 
status and gender was dominant and revealed working class masculinity characteristics 
and emphasis of the breadwinner role.  Therefore, functionality and physical performance 
were imperative in addition to behaviors that men perceived to inform their masculinity 
such as smoking and drinking.  Men did not show any ownership of their health as they 
did for their family and car.  During the older age stage of life, the diagnosis of prostate 
cancer forced men to modify some of their health behaviors.  The changes in health 
behaviors included adopting some healthy behaviors, following through with their health 
conditions, and accepting to talk with other men about their health issues.  This change in 
health related behaviors was evident with age, especially when illness and dysfunctions 
disrupted men’s social expectations (Oliffe, 2009).  Findings from this study highlighted 
the influence of masculinity, age, and social influence on the health behaviors of men 
across the lifespan. 
McVittie and Willock (2006) examined the understanding of health, ill health, and 
the relationship between them and the implications for masculine identities.  Twelve 
semistructured interviews were conducted with men in Scotland ages 65 years and over.  
Findings showed that men valued being healthy which entailed the ability to do anything 
they wanted without restrictions.  The men emphasized the importance of being able to 
control their lives and their health which was reflective of the hegemonic masculinity 
traits of domination and power.  In discussion of the experience of ill health, participants 
presented illness as an external factor such as a problem or accident that was managed by 
an expert or physician.  As such, the hegemonic masculinity was maintained despite the 
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challenge of an external force.  Therefore, there was a renegotiation of their identity to 
accept a relatively subordinate position for a specific time.  The time rationalization 
allowed for the transition from a powerful masculine image to another state that included 
battling an external force which is the illness.  The transition of the masculine image also 
permitted the man to bond with the subordinate masculinity (McVittie & Willock, 2006).  
Findings from this study contribute to understanding the dynamics of negotiating 
masculinity of men when considering healthy behaviors or seeking medical attention. 
For men who seek medical guidance, it is worth examining their relationships and 
communications with their physicians and other primary care providers.  These are 
phenomena that are important to be considered since patients and their physicians are 
men most of the time.  With gender considerations regarding prostate cancer, disease 
related discussions with healthcare providers are significant.  Oliffe and Thorne (2007) 
examined qualitative transcripts from two studies that investigated patients’ experiences 
with prostate cancer and explored patient-physician communications and interactions 
with the influence of masculinity.  The sample included 29 Canadian and 33 Australian 
participants who were being treated by male urologists for prostate cancer.  The mean age 
of patients was 61.73 years old (SD = 8.59), and the majority underwent prostate cancer 
treatment for a period of around 3.03 years (SD = 5.03).  Findings included themes about 
the relationship between the disease and men’s perceptions of the communication with 
their physicians.  There was an overarching complexity inherent in prostate cancer 
communication, especially with respect to the cause or the onset of the disease.  Men 
were found to be uncertain about their disease and its trajectory.  The choice of the most 
appropriate treatment constituted a dilemma for men in the sample.  This ambiguity 
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influenced the masculine ideals that favor rationalization and problem solving 
conceptualization as it influenced the expected patient-physician communication scripts.  
The lack of definitive answers disrupted the traditional hierarchical relationship between 
the patient and his physician.  Findings showed that the dialogue about prostate cancer 
screening started with a general practitioner (GP) and then continued with a specialist or 
urologist.  This relationship was not typical to the masculine communication process 
between men.  Nevertheless, the communication process was described to follow a 
businesslike transaction (i.e., straightforward process).  With time, a trusting relationship 
was developed that conformed to the hierarchy and authoritative image of the physician.  
It was documented that anxiety was tempered by humor and sarcastic jokes.  
Communication with the GP was found to be dissatisfying in cases in which there were 
unexpected experiences or reluctance on behalf of the physician to explain treatment-
related issues (i.e., expectations, prognosis, and side effects).  Generally, the patient-
physician relationship was found to conform to masculinity traits; therefore, some men 
expressed difficulty communicating their needs with their physicians.  However, findings 
from this study showed that there were some contradictions between the masculinity 
patterns of behaviors and communication in some of the men’s discussions about the 
prostate cancer communication process (Oliffe & Thorne, 2007).  Findings from this 
study shed light on the dynamics related to the communication between men and their 
physicians. 
Mahalik and colleagues (2007) examined the contribution of masculinity and 
men’s perceptions of normative male and female health behaviors in predicting men’s 
own health behaviors.  A sample of 140 Caucasian (80.7%), married (51.4%) or in a 
74 
relationship (17.9%), and university educated men identified the influence of masculinity 
and men’s perceptions on their health behaviors.  The mean age of the men in the study 
was 42.9 years (SD = 13.7).  Health promotion behaviors including the frequency of 
engaging in health behaviors, masculinity, and perceptions of normative health behaviors 
were measured.  Health promotion behaviors were measured using Likert scale items 
about eight health behaviors: alcohol consumption, applying a seatbelt, physical fighting, 
talking to someone when dealing with a troubling issue, having an annual physical 
examination, using tobacco, exercise, and eating healthy.  Masculinity was measured 
using the Conformity to Masculinity Norms Inventory, and perceptions of normative 
health behaviors were measured the participants’ perceptions about the previously listed 
health behaviors.  Hierarchal regression showed that masculinity and men’s normative 
perceptions of health behaviors significantly contributed to explaining men’s health 
promotion behavior scores.  Men with higher masculinity scores exhibited less health 
promotion behaviors (Mahalik et al., 2007).  Perceptions of men’s normative health 
behaviors in this study represented the social constructions of how men are expected to 
deal with health issues.  Despite the limitations of the study that included online 
recruitment of a sample that was predominantly Caucasian with a wide age range from 18 
to 78 years, findings allude to a significant influence of social norms and masculinity on 
health behaviors. 
Men do not readily seek medical help and may not feel comfortable in discussing 
sensitive and embarrassing symptoms.  The majority of studies about male health seeking 
behaviors have used qualitative designs and included homogeneous samples who were 
predominantly White non-Hispanic men.  Although findings were important, they cannot 
75 
be generalized to the overall population.  It is important to ensure that the concerns of 
men are discussed and proper information is shared in an attempt to properly address 
concerns especially those that influence their QOL.  
Masculinity and Prostate Cancer 
 Chapple and Ziebland (2002) studied the manner in which prostate cancer and its 
treatment affects men’s bodies, their social roles, and senses of masculinity.  The 
majority of the sample were White (n = 48), and more than 6o years old.  The 
unstructured interviews with 52 men included discussions about the time of PSA testing, 
presence of prediagnosis symptoms, reason for seeking examination, and their 
experiences with the treatment and related side effects.  As the theme of masculinity 
emerged, men were asked to further elaborate about the impact of the side effects of 
prostate cancer on their image as men.  Findings were described according to the main 
topics discussed: men’s health behavior and treatment side effects (i.e., incontinence, lack 
of energy, impotence, and other hormonal side effects).  During the interviews, men 
expressed their reluctance to consult physicians due to the traditional norms that support 
the masculine identity.  They felt that seeking a primary care provider or specialist was a 
sign of weakness that constituted a threat to their masculinity.  Some men emphasized 
that it was embarrassing to seek help for symptoms of prostate problems.  When 
discussing treatment side effects, men talked about the importance of being able to 
control the body and to act appropriately in social settings.  Consequently, incontinence 
and other symptoms such as urinary frequency and urgency due to prostate cancer 
treatment suggested a lack of control of bodily functions and, therefore, were 
inconvenient and embarrassing.  Men who underwent hormonal treatment talked about 
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symptoms such as the lack of sexual desire that made them feel that they lost all 
masculinity.  On the other hand, men who underwent external beam radiation also talked 
about the discomfort of diarrhea, while others discussed having decreased energy that 
impeded their ability to work and maintain the role of being the household breadwinner.  
The lack of energy was a concern, although a majority of men continued working during 
treatment or returned to work soon afterward.  As a result, men in this sample were not 
able to conform to their perceived and expected social roles.  A few men talked about 
being forced to retire early and felt that they lost part of their masculine image and ability 
to work.  All except one of the men reported limited sexual functioning and discussed 
trying medications and other techniques to deal with the erectile dysfunction.  Some men 
were embarrassed to discuss their sexual dysfunction and possible treatments with their 
physicians and wife.  Their lack of ability to maintain an erection was their main issue 
and disappointment.  Alternately, some men were appreciative of being cured of prostate 
cancer and considered impotence to be a price for survival.  A grateful attitude was found 
in older men who discussed that they could handle impotence and suggested that it would 
be a bigger problem for younger men.  Findings from this study highlighted the 
importance of the ability to perform sexually on masculine identity of men despite the 
fact that some men considered it as a small price to pay (Chapple & Ziebland, 2002).  
Chapple and Ziebland (2002) discussed the concerns of some men regarding their 
sexuality as being the result of awareness about medical regimens and other treatment 
options. 
In a study that explored the experiences of men living with sexual dysfunction as 
a consequence of having been treated for prostate cancer, 18 men (i.e., 14 heterosexual 
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and 4 homosexual) were interviewed in a series of four to five sessions each.  The 
majority of the men were White and recruited from a prostate cancer support group.  The 
participants were 57 to 75 years old and lived with prostate cancer diagnosis for 1 to 8.5 
years.  The majority of men in this study (n = 13) reported minimal to no erectile function 
after their treatment.  Semistructured interviews were conducted.  Interviews discussed 
the experiences with prostate cancer in addition to dialogues about the men’s childhood, 
important relationships, family life, their values and beliefs about the meaning of being a 
man, and the impact of prostate cancer on these values.  Findings documented that loss of 
sexual functioning was a major challenge to men’s masculinity.  Men considered that the 
focus of their adjustment included treatment or prevention of sexual dysfunction.  
Accordingly, the investigators identified "preservation of manhood" as an important 
overarching theme that described participants’ experience with prostate cancer.  Findings 
identified five themes: enhancing the odds, disrupting a core performance, bearing an 
invisible stigma, effortful mechanical sex, and working around the loss.  The majority of 
men in the study considered prostate cancer treatment as a tradeoff for life, although the 
sexual sacrifice was not as simple as they anticipated.  Men in this study varied in their 
knowledge and confidence in the availability of options to predict or prevent decline from 
their previous sexual functioning levels.  Sexual performance was an integral expression 
of manhood, and men felt pressured to maintain the social expectations of being able to 
sexually perform.  Some men talked about the ability of having sex in terms of virility 
and vitality.  Irrespective of the sexual orientation of the men, erectile function was 
considered to be a conquest and competition in which a dysfunction meant that the man 
lost the ability to relate to other men.  Men with erectile dysfunction were reluctant to 
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discuss their concerns because they considered that sexual impairment constituted a 
threat to who they were.  They perceived that they could not participate in being vocal 
about their sexual accomplishments.  In a culture and environment that supported sexual 
competition, these men perceived that they had to hide their dark secret as an invisible 
stigma.  As long as they did not come out or disclose their problem, they felt secure and 
safe from socially constructed shame and embarrassment.  The majority of men in the 
study discussed reliance on mechanical devices such as vacuum pumps, intracavernosal 
injections, or other mechanisms to restore their sexual functioning.  These devices were 
found to disrupt the natural flow of sexual intercourse and, therefore, added a strain and 
lack of spontaneity associated with sexual performance.  Some men described their 
sexuality as a switch that was turned off by the treatment of prostate cancer.  In an 
attempt to regain their sexuality and manhood, some men tried to find ways to work 
around the loss.  Findings from this study were presented from a theoretical framework 
that showed the experience of older men whose sexual dysfunction was principally due to 
prostate cancer treatment (Fergus et al., 2002). 
In a qualitative study, Gray and colleagues (2002) explored the relationship 
between masculinity and prostate cancer.  A narrative approach was used that focused on 
stories about the lives of men with prostate cancer.  In a sample of 18 men from the larger 
Toronto area, four interviews (i.e., introductory meeting, prostate cancer experience, life 
prior to prostate cancer, and the link between precancer and postcancer lives) were 
conducted with the participants.  The sample included four gay men and four Afro-
Canadian men.  The investigators intentionally included men with different social 
experiences to allow the study to explore the differential construction of masculinity with 
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different sexual orientation and ethnicity.  Findings from a streamlined approach to 
narrative display shed light on the different perspectives of hegemonic masculinity and 
prostate cancer.  The experiences of the men shared core elements: work experiences, 
relationships with women, sexuality issues, relationships with other men, prostate cancer 
self-help groups, health, illness and the body, age, and renegotiating masculinity.  Work 
experience shaped the manner in how men approached the disease and the decision on 
treatment.  Men in this study identified their wives as their source of social support, but 
some of them did not go to their wife for expressing emotions and feelings about their 
sexual dysfunction and urinary incontinence.  Relationship with the wife differed 
between the different men in this study, and there were various approaches to how they 
interacted with and allowed the wife to support them.  For example, some men allowed 
their wives to go with them to their appointments and be involved in discussions about 
sexual dysfunction.  All of the men expressed that their sexuality was their primary 
concern, and some of them talked about preferring a more serious disease with which 
they could deal better with its consequences.  Men also discussed that prostate cancer 
interfered with their masculinity and ability to have multiple partners.  Sexual activity 
was a major indicator of their ability to express being a man.  Some of the men thought 
that the importance of being sexually active is to be able to meet the needs of their wives 
and live up to their perceived sense of masculinity.  The report of findings from the study 
did not include the experiences of gay men.  One of the men narrated that after the 
diagnosis of prostate cancer, he started flirting with more women to feel appealing and be 
acknowledged.  Interestingly, all of the men stressed that they did not want other men to 
know about their prostate cancer diagnosis and sexual issues.  They were ready to discuss 
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their concerns with female colleagues but did not want to show other men their struggles 
because they perceived confession as losing a sense of control.  Unlike findings from 
other studies, men in this study were ready to go to support groups and were involved in 
health promotion activities.  Age and aging of the body were not discussed by the men, 
and this omission may have been because men in the sample were generally younger than 
the average age of men with prostate cancer.  Hegemonic masculinity was evident in the 
transcripts of men in the precancer and postcancer discussions.  However, they 
renegotiated some of their behaviors and changed some of their perceptions in an attempt 
to maintain their perceived masculine performance.  Most of the changes involved 
modifications in their relationships with their wives which included refraining from 
extramarital affairs or viewing wives as administrative assistants helping them with the 
consequences of the disease.  There was a shift in the social relations described by these 
men which was accompanied by a shift in the meanings of masculinity toward a new 
social environment territory.  The men’s experiences during the precancer phase 
influenced their behaviors in the postcancer phase (Gray et al., 2002).  Findings from this 
study highlight the importance of exploring the change in the meanings of masculinity 
and its influence on men’s behaviors.  The inclusion of men with different sexual 
orientations and ethnicities gave an overview of the experience of different men, but it 
might have also concealed the details of the experiences of these men within their culture.  
However, the experiences of men with different sexual orientations were not discussed 
and expanded by the authors.  Also, the authors did not discuss the differences in 
narratives between men of different ethnicities.  The article focused on the narratives of 
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three White heterosexual men.  The other men interviewed were not demographically 
identified by the authors. 
Studies of men with prostate cancer that have addressed masculinity revolved 
around the masculine social role expectations and challenged sexual functioning.  In a 
qualitative study using an ethnographic approach with 15 men who underwent 
prostatectomy, Oliffe (2005) found main concerns to be shortened penis, loss of potency, 
and reactions to impotence that revolve around treatment for the erectile dysfunction.  
The age of the men ranged from 46 to 74 (M  = 57.06, SD = 6.68).  All of the men were 
in a partnered relationship for an average of 27.6 years (SD = 12.99).  Findings 
documented three major themes:  anticipation of impotence, acute recovery, and reactions 
to impotence.  Upon diagnosis of prostate cancer, men were prepared to trade their 
potency for the potentially life threatening illness, functionality, and longetivity of 
relationships.  Prior to the surgery, survivorship was the main concern of these men and 
their wives.  Some men needed reassurance from their wives about their sexuality to 
satisfy their hegemonic masculinity and to make sure that they would not be viewed as “a 
lesser man.”  Older men who experienced challenges with their libido and sexual 
prowness expressed their acceptance of the possibility of impotence following the 
surgery.  The discussions of men referred to the social construction of asexual older men 
and the “filthiness” of being sexually active.  Men displayed a hierarchy with the 
expectation of younger men to express their sexuality openly, while older men were 
expected to place less weight on sexuality.  During the recovery phase, men discussed 
shortening of the penis.  This consequence was a major issue since penis size informed 
the masculine hierarchy between men and differentiated between men and women.  Loss 
82 
of potency was also a concern since it led to emotional challenges and added to the 
decrease in sexual performance.  During the interviews, men referred to media that 
mocked male impotence.  They also talked about the external and internal pressures to 
sexually perform according the normative ways (i.e., penetrative sex).  As a reaction to 
impotence, many men tried to treat their erectile dysfunction with medications and other 
procedures.  However, men reported that with time they stopped using these treatments 
because they were artificial, ineffective, and lacked spontaneity in achieving and 
maintaining erection.  The concept of redefined masculinity included discussions about 
the preference of treatment to restore their potency.  Findings from this study highlighted 
the redefined sexuality and masculinity experienced by men following prostatectomy 
(Oliffe, 2005).  Findings supported the socially constructed concepts of hegemonic 
masculinity.  This study was conducted with Canadian men and did not include ethnically 
diverse populations. 
Kelly (2009) examined masculine embodiment in the context of prostate cancer.  
Using an ethnographic approach, interviews with 14 men and observations at significant 
events such as diagnostic consultations and radiotherapy were conducted over a period of 
18 months.  Five professionals working with these men were also interviewed.  Themes 
that emerged represented the trajectory of the cancer experience: “physical change and 
living with a new body”, “diagnosis”, “restoring the masculine self”, “working with 
changed men”, “survival of the fittest”, “a new male identity”, and “seeing other men in 
the world”.  After the diagnosis of prostate cancer, the body was viewed as being 
different.  Some men talked about being confused that they survived the cancer despite 
being left impotent.  Other men perceived that their bodies were less valuable in a social 
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and personal sense because they could not conform to the conventional standards of 
masculinity.  Sexual dysfunction and urinary incontinence were considered to be the 
major concerns of these men.  The diagnosis of prostate cancer was perceived to be 
unpleasant and embarrassing due to the respective diagnostic procedures such as digital 
rectal examination and prostate biopsy.  During confirmation of the diagnosis, men 
observed the cancer to be an alien entity in their body that was resented because of the 
physical, social, and emotional dilemmas that went along with it.  During the interviews, 
men emphasized previous masculine identities as coping strategies.  The professionals 
acknowledged the changes in men’s bodies and the resultant consequences such as losing 
their social status in addition to their health.  Men viewed their battle with cancer in terms 
of “losing the game of life” but recognized that they were at an advantage in comparison 
to others who lost their lives to cancer.  Consequently, they perceived that they had a new 
male identity with a new body with limitations that was not able to function as it used to.  
The changed male ideology resulted from the perceived shift in the masculine role 
experienced as a result of their inability to engage in sexual activity.  Due to their 
inability to engage in sexual activity, men felt that they needed to renegotiate their 
masculinity (Kelly, 2009).  The study was conducted in Pakistan and yielded findings 
that are specific to a specific culture and area; nevertheless, the discussions are in 
concordance with studies conducted in other cultures (Oliffe, 2005).  Men who could not 
live up to expected masculine roles in society renegotiated their masculinity to be able to 
come up with modified norms that would maintain their sense of being a man.  
In a study with 95 elder U.S. veterans, Stansburry, Mathew-Chapman, and Grant 
(2003) studied the concepts of manhood and compared men diagnosed with prostate 
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cancer with other military veterans at a Veterans Affairs medical center.  An unmatched 
case-control design with purposeful sampling was used.  Men diagnosed with prostate 
cancer who underwent either surgery or radiation therapy were recruited.  The control 
group included patients at the urology clinic who complained of conditions other than 
cancer.  The majority of the sample was White non-Hispanic (n = 80, 84.2%) and married 
(n = 66, 69.5%), with an average age of 68.4 years (SD = 11.6).  Demographic data were 
collected using a survey.  Additional data were collected using techniques adapted from 
cognitive anthropology (i.e., freelists, single pilesorts, and a three-point scale for 
assessing different attributes of masculinity).  The men in the study highlighted the 
elements of masculine schema to include civic roles and masculine roles (i.e., boss, 
breadwinner, mentor, protector, citizen, head of house, provider).  The term sexual was 
found to be closer to the main cluster of roles and values than to the physical attributes.  
Sexuality was perceived as an individual characteristic that is related to the moral roles 
and ideals in addition to the masculine identity.  Findings showed that men perceived 
masculinity in terms of moral terms (i.e., integrity, responsibility, trust, helpfulness, 
dependability, and honor).  Although sexuality was not central to the structure of 
masculinity in this sample, sexual identity and performance seemed to retain centrality in 
the veteran’s roles.  Findings documented that men with prostate cancer had a strong 
moral discourse about the meanings of being a man.  Despite addressing a population 
with stronger sense of masculinity and powerful beliefs, the results allude to the 
importance of sexual potency for the masculine image of these men (Stansburry et al., 
2003). 
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In a qualitative study, Grunfed, Drudge-Coates, Rixon, Eaton, and Cooper (2013) 
explored the meaning of work among prostate cancer survivors and described the 
linkages between masculinity and work following prostate cancer treatment.  Fifty 
participants who were between the ages of 18 and 65 years old, had a paid job prior to the 
diagnosis of prostate cancer, had no evidence of metastatic disease, and spoke English 
were recruited for the study from outpatient cancer departments in the United Kingdom.  
The participants were recruited to participate in the study within 4 weeks of treatment 
completion.  Forty one participants were contacted again at 12 months after the 
completion of the treatment.  The participants were 59 years (SD = 5.81), White (n = 38, 
76%), and underwent different types of treatment such as surgery (n = 33,66%), 
brachytherapy (n = 14, 28%), and radiotherapy (n = 3, 6%).  Semistructured interviews 
were conducted with the consenting participants.  Data were analyzed using a framework 
analysis approach.  The majority of men returned to work by 12 months after treatment. 
Most of the participants returned to the same company (n = 35, 85%, with no change in 
duties (n = 32, 78%, and worked the same number of hours as prediagnosis (n = 31, 
76%).  The findings suggested four themes: work and self identity, work related 
implications of treatment side effects, disclosure of cancer, and future as cancer survivor.  
Most of the participants’ reported urinary incontinence to be a prevailing concern that 
hindered their experience of going back to work (e.g., frequent bathroom breaks, fear of 
leak, embarrassment).  There was an expressed anxiety about the practical issues related 
to dealing with incontinence while maintaining their normal work routines within a 
disclosed social context.  The concepts of masculinity were identified throughout the 
transcripts of the interviews through the emphasis on the importance of work and the 
86 
significance of the social interaction within the work environment.  Men tried to hide 
physical hindrances to appear strong and capable.  These findings show that after the 
treatment of prostate cancer, men may feel challenged by their social and work-related 
roles.  This study highlights an important aspect of men’s life after the treatment of 
prostate cancer.  It focuses on the practicality of going back to work and its social and 
work implications on men.  Additional research is needed to explore the experiences of 
men in different cultures with variety of labor laws and systems in addition to cultural 
norms emphasizing the breadwinner role of men (Grunfed et al., 2013). 
In a study that linked masculinity to health outcomes, Burns and Mahalik (2006) 
examined the moderating effects of physical health and scripts for masculinity (i.e., self 
reliance and emotional control) on the relationship between powerful other people health 
locus of control (i.e., the power and influence of other people on the progression of their 
disease) and mental health in men treated for prostate cancer.  Two hundred thirty men 
were recruited for the study.  The Powerful Other People Health Locus of Control scale 
measured the men’s perceptions that family, friends, and peers are important in 
controlling the progression of prostate cancer.  The Physical Health Quality of Life 
Summary scale (i.e., physical functioning, role limitations, general health perception), 
mental health subscale of the SF-36 Quality of Life survey, and Conformity to Masculine 
Norms Inventory (self reliance and emotional control scales) were also used for data 
collection.  Results suggested that men with poor physical health had poor mental health 
when having higher self reliance (i.e., masculine norm) and believed powerful others 
were important in fighting prostate cancer.  The beliefs of men with poor physical health 
and strong powerful showed enhanced mental health outcomes when they had lower self 
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reliance.  Poor physical health contributed to poor mental health in men with strong 
emotional control (i.e., masculine norm) and strong belief in powerful other people.  Men 
with poor physical health and strong powerful other people  had positive mental health 
outcomes with strong emotional control.  Findings from this study documented that 
physical health and masculine scripts (i.e., self reliance and emotional control) served as 
moderating variables in the relationship between powerful other people locus of control 
and mental health (Burns & Mahalik, 2006). 
In a study that examined the moderating role of sexual functioning on the 
relationship between men’s enactment of traditional norms of masculinity and their 
social, role, and mental health after the treatment of prostate cancer, 234 men comprised 
the sample.  The SF-36 Quality of Life Questionnaire was used to measure the men’s 
social, role, and mental health functioning.  The Expanded Prostate Cancer Index 
Composite (EPIC) was used to measure sexual and urinary functioning.  The Conformity 
to Masculine Norms Inventory was used to measure masculine norms.  Results showed 
that poor sexual functioning contributed to poor social functioning in men who endorsed 
traditional masculine norms.  Men also reported that that with poor sexual functioning, 
they had poor role functioning when they conformed to traditional masculine norms.  
Poor sexual functioning led to poor mental health in men with strong masculine norms.  
Results from this study documented the mediating role that sexual functioning plays in 
the relationship between masculine norms and men’s social, role, and mental health 
functioning (Burns & Mahalik, 2008). 
Hoyt, Stain, Irwin, and Thomas (2013) conducted a longitudinal study and used a 
cancer specific assessment to determine whether or not cancer related threat to 
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masculinity predicts prostate related (i.e., urinary, bowel, sexual) functioning over time 
and whether or not cancer related emotional coping processes explain these relationships.  
Participants who had undergone radical prostatectomy or radiation therapy 2 years prior 
to the initiation of the study were recruited and interviewed at time of participation (T1), 
and after 2 (T2), and 4 (T3) months.  Sixty six men with a mean age of 65.76 years (SD = 
9.04), White (86%, n = 66) and married or partnered (n = 66, 89.4%) participated in the 
study.  Data were collected using a cancer-related masculine threat instrument that was 
developed by the researchers, UCLA Prostate Index to measure prostate-specific 
functioning, Emotional Approach Coping, Emotional Self Efficacy Scale-Cancer, and 
Emotional Suppression Scale of the Emotion Regulation Questionnaire.  Path analysis 
was used to assess whether or not emotional approach coping processes explained the 
contributions of cancer-related threat to masculinity in changing prostate-specific 
functioning.  Controlling for baseline functioning and age, cancer-related masculine 
threat explained decline in (T1 to T3) urinary, bowel, and sexual function.  Cancer-
related masculine threat also explained decreased emotional processing (T1 to T2) but did 
not explain emotional expression.  Decreased emotional processing explained the effect 
of cancer-related masculine threat on bowel and sexual function.  It also predicted the 
decreased prostate-specific functioning.  The findings from this study show that 
masculinity plays an integral role in prostate cancer functioning.  When men believe that 
their cancer is inconsistent with their masculinity, they are at risk of decreased prostate-
specific functioning after treatment.  Cancer-related masculine threat significantly 
contributes to the coping responses of men and is negatively related to efficacy of 
emotion-directed coping.  These findings suggest that having unthreatened masculine 
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identity enhances the functioning after the treatment of prostate cancer (Hoyt et al., 
2013).  This study emphasized the importance of masculine roles and beliefs of gender 
roles on functioning after undergoing treatment of prostate cancer. 
In summary, having a profound social and cultural influence, masculinity is also 
influenced by several sociocultural constructs.  Boys have been socialized into 
emphasizing the concepts of sexual potency, superiority, and authority (Connell, 1995; 
Kimmel, 2000).  Most of these constructs in the case of prostate cancer lead to the 
notions of the loss of authority and/or power which may influence the hegemonic 
masculinity of men (Connell, 1995).  Wall and Kristjanson (2005) emphasized the 
psychosocial impact of prostate cancer in light of the concepts of hegemonic 
masculinities.  Men were found to feel subordinated and less manly as a result of sexual 
dysfunction (Gray et al., 2002; Hawkins et al., 2009).  Studies that have attempted to 
reframe the common masculinity norms to be able to embrace some conditions such as 
prostate cancer have highlighted several themes including health seeking behaviors, 
relationship issues, and sexual issues (Wall & Kristjanson, 2005).   
As a result of gendered societies, men enduring prostate cancer treatment side 
effects tend to rely on themselves and, therefore, will not ask for help or seek medical 
guidance (Burns & Mahalik, 2007).  Men’s self reliance in health issues was observed to 
be a theme among all men, especially those diagnosed with prostate cancer.  Men seeking 
medical attention were found to be perceived as less masculine or “macho”. Accordingly, 
medical attention was sought in advanced cases (O’Brien et al., 2005).  Decreased 
medical attention was also heightened by the fact that most urologists are men who are 
caring for men with prostate cancer; therefore, many psychosocial concerns may not have 
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been discussed since the emphasis is based on the biophysiological symptoms and 
outcomes of the treatment (Oliffe & Thorne, 2007).  Men also try to exhibit self control 
and strong emotions as a result of their masculine expected behavior.  Feelings of 
desperation, humiliation, and despair are reported by men who cannot initiate sex and 
thus feel less masculine (Oliffe & Thorne, 2007).  These feelings are important 
considerations for nurses and healthcare providers to be able to appropriately support and 
care for men with prostate cancer. 
Men emphasized their role and image in society.  Qualitative studies with men 
diagnosed with prostate cancer have discussed the importance of being able to control 
bodily functions in social settings (Chapple & Ziebland, 2002).  As a result, sexual 
dysfunction and urinary incontinence were a source of embarrassment, shame, and stigma 
(Chapple & Ziebland, 2002).  The decreased sexual ability was a major concern for men 
after diagnosis of prostate cancer due to the perceived importance of sexuality for the 
socially constructed masculine norms (Burns & Mahalik, 2006; Chapple & Ziebland, 
2002; Fergus et al., 2002).  Also, social norms of sexuality were affected by the age 
group of men and how they expressed the impact of sexual dysfunction on their lives 
(Oliffe, 2005).  Younger men expressed their concerns about sexuality more openly than 
older men (Oliffe, 2005).  The consequences of sexual dysfunction and urinary 
incontinence in light of the socially constructed masculine norms were found to result om 
decreased mental health functioning of men with prostate cancer, especially in those who 
emphasized strong and rigid masculine norms (Burns & Mahalik, 2006). 
 Other sources that accentuate the importance of sexual performance and strength 
include the advertisement of products and media.  The media continuously advertises the 
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easy availability and accessibility of male enhancement gadgets and regimens.  These 
messages emphasize the social expectation of men to be able to sexually perform, 
especially since the lead faces of these campaigns are athletes or socially prominent 
figures.  Male sexual enhancement products that improve the sexual performance of men 
are elaborated in a manner that promotes charisma, charm, muscle, and satisfactoriness 
(Clarke, 1999; Stibbe, 2004).  Therefore, the media supports the masculine image as 
described by Connell (1995).  Masculinity has also been highlighted by the emerging 
studies that emphasize the importance of testosterone ("T"), the sex hormone, on levels 
on sexual activity (Loizides, Swierzewski, O’Neill, Griesser, & Smith, 2004; Mazur & 
Booth, 1998).  
Irritable male syndrome and low T are concepts that are being recently discussed 
as concerns facing men during their later adult years.  Consequently, these advertisements 
are providing a medical reason or cause for men who do not meet masculine concepts at 
older ages when testosterone levels tend to decrease (Loizides et al., 2004; Mazur & 
Booth, 1998).  Accordingly, men may perceive themselves as less masculine and, 
therefore, seek medical advice such as sexual male enhancements.  This is especially true 
because most men in their older adult years still feel sexual (DeLamater & Moorman, 
2007) despite their diminished sexual abilities due to comorbidities such as decreased 
testosterone levels or prostate cancer.  These factors may explain men’s hesitancy to 
discuss their prostate cancer side effects (Fergus et al., 2002) as an attempt to save their 
masculine image.  The medicalization of decreased sexual abilities may also provide the 
grounds to revert to prescriptions that would decrease their challenged sexual 
functioning. 
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In summary, the diagnosis and treatment of prostate cancer results om challenges 
to men’s masculinity.  With socially expected sexually potent men, prostate cancer 
treatment side effects contribute to a perceived sense of embarrassment and shame.  
Men’s decreased help seeking attitudes inhibit them from seeking appropriate help to 
manage better their sexuality.  As a result, the QOL in these men is affected.  However, 
the majority of studies that have examined the impact of prostate cancer on QOL have 
used qualitative designs with small samples of men that is difficult to generalize and only 
results of one quantitative study was published in two manuscripts.  There remains to be a 
gap in the literature regarding the contributions of masculinity on QOL in men with 
prostate cancer using quantitative research designs.  
Relationship with Partner 
Sexual dysfunction as a result of prostate cancer treatment leads to emotional 
distress resulting in a series of responses including emotional distance between couples.  
Other reports on psychological effects on men with prostate cancer include isolation, 
anxiety, and depression (Hawkins et al., 2009).  Studies that have included partners of 
men with prostate cancer have described their experiences in terms of decreased 
intimacy, emotional burden similar to that of caregivers, and a change of role. Women 
reported that they were no longer the lovers in the relationship, and romance was 
replaced by the resultant stress from the sexual issues (Badr & Carmack Taylor, 2009; 
Giarelli et al., 2003).  Additionally, resultant psychological and physical distress were 
reported to be major burdens on intimate relationships (Gilbert, Ussher, & Hawkins, 
2009). 
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Erectile dysfunction was found to be significantly correlated with lower sexual 
and relationship satisfaction.  McCabe and Matic (2008) found that in couples facing 
sexual dysfunction issues, there was increased conflict as well as decreased 
communication and sexual activity.  Approximately 86% of men and 52% of women 
reported that sex was very or extremely important in a relationship.  Contrary to men, 
female partners reported that erection problems were not imperative compared to other 
issues in their life (t = -4.25, p < .001).  Age was not included as a variable in this study 
to help understand if findings are applicable to all age groups.  Also, decreased levels of 
intimacy predicted a decline in the overall relationship satisfaction (McCabe & Matic, 
2008).  Badr and Carmack Taylor (2009) reported that erectile function and intercourse 
were positively correlated with marital adjustment and negatively associated with partner 
distress.  In other words, despite controversy, it can be concluded that sexuality is an 
important contributor to relationship satisfaction and wellbeing; thus, sexual dysfunction 
as a result of prostate cancer may have a negative effect on partner relationship.  
Couples with prostate cancer reported stressful relationships and distress that were 
affected by avoidant coping behaviors (Lavery & Clarke, 1999; Wootten et al., 2007).  
Intimacy and communication were the major signs of relationship disruption.  Promoting 
communication and education about intimacy issues were found to be essential to 
enhancing QOL in these couples (Galbraith & Crighton, 2008).  Men and women 
reported a major change in their roles whereby women assumed the role of caregivers and 
became less feminine and sexual.  On the other hand, men felt that they could carry on 
the tasks they used to perform (Sanders et al., 2006).  As a result, theses change created 
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increased levels of stress that resulted in challenges in the relationship between the 
couples. 
In a qualitative study that examined sexuality and intimacy of couples after the 
diagnosis of cancer, Hawkins and colleagues (2009) interviewed 156 partners and 20 
patients with cancer.  Approximately 76% of partners of patients with nonreproductive 
cancers and 84% of partners of patients with reproductive cancer reported an impact on 
their sexual relationship.  More than half of the women (59%) and more than three 
fourths of the men (79%) reported decreased frequency of sex and intimacy.  
Renegotiation of sexual intimacy was a significant finding discussed by 19% of the 
women and 14% of the men.  Findings from this study suggested two main themes:  
decreased frequency of sex and renegotiation of sex or intimacy.  These themes were 
discussed in terms of dysfunction in which alternative intimacy behaviors were 
considered at first but then faded with time.  Redefining of the role of partners as 
caregivers affected the sexual attractiveness between the couple and ultimately eliminated 
the image of the “lover”.  As a consequence of the cancer diagnosis, sexual experiences 
were altered resulting in intimacy and relationship issues.  The changes in sexuality were 
linked to reports of self blame, rejection, sadness, and decreased sexual fulfillness 
(Hawkins at al., 2009).  Findings from this study supported the premise that the 
acknowledgement of the changes in sexual relationships of couples with cancer is an 
important area to promote relationship satisfaction. 
Galbraith and colleagues (2008) described health related outcomes of couples 
experiencing prostate cancer before treatment and at 6, 12, and 18 months.  Men and their 
female partners (n = 216 couples) were enrolled in the study.  Men and their female 
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partners were provided with separate questionnaire packages and instructed to fill the 
questionnaires separately.  Men in this study were on average 67.8 years (SD not 
reported) and married for an average of 34.8 years (SD not reported).  The partners had a 
mean age of 64 years (SD not reported).  The majority of the sample (i.e., men and their 
partners) was Caucasian (86%).  Men were treated by watchful waiting (n = 2), surgery 
(n = 39), conventional radiation (n = 8), mixed beam radiation (n = 48), and proton beam 
radiation (n = 109).  Before the initiation of treatment, men scored significantly higher 
than their partners on relationship satisfaction, physical role function, emotional role 
function, mental health, and pain.  Female partners had significantly better health than 
men at most of the time points.  At 6 months after initiation of treatment, partners had 
better health-related QOL than men; on the other hand, men had better mental health 
functioning and general health.  At 12 months, men continued to have better mental 
health, and the partners scored higher on health-related QOL and general health.  Similar 
findings were reported at 18 months.  Upon analysis of the overall summary of the 
scores, there was a significant difference in mental health scores during the pretreatment 
phase between men and their partners.  Before treatment, men’s scores significantly 
predicted partners' scores on relationship satisfaction, emotional role function, energy, 
mental health, and social function.  At 6 months, men’s scores predicted their partners' 
scores on health-related QOL, physical role function, emotional role function, mental 
health, and general health.  At 12 months, a similar pattern was found in addition to 
partner’s energy levels and social functioning scores.  At 18 months, all variables were 
significantly different (i.e., relationship satisfaction, physical role function, emotional 
role function, and mental health) with the exception of bodily pain and general health 
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between men and their partner.  The partner relationship scores of men and their partners, 
measured by the Dyadic Assessment Scale (DAS), were significantly positively 
correlated at all the time points.  Cross-lag analyses were conducted and showed that 
couples’ scores had a reciprocal pattern of influence between the dyads at all time points.  
The men and their partners' mental health component scores were correlated before 
treatment.  The partners' mental health component scores at 6 months predicted the man’s 
scores at 12 and 18 months.  The men’s mental health scores at 12 months predicted the 
partners' scores at 18 months.  Men’s physical component scores before treatment 
predicted their partners' scores at baseline and 6 months.  Similarly, partners' physical 
component scores at baseline predicted the men’s scores at baseline and at 6 months.  
Men’s scores at 6 months predicted their partner’s scores at 12 months, a relationship 
mirrored by the partner’s scores.  Findings from this study suggested that the diagnosis 
and treatment of prostate cancer affect men and their partnerz (Galbraith et al., 2008).  
This study highlighted the effect of prostate cancer and treatment side effects on couples.  
However, a study limitation was that the sample was predominantly Caucasian, and men 
underwent different treatments.  Also, the attrition rate was 26%, and there was no 
description provided about the couples that dropped out.   
Boehmer and Clark (2001) explored men’s and their wives’ perceptions upon 
prostate cancer diagnosis and their role in treatment decision making.  In a sample of men 
diagnosed with metastatic prostate cancer and their wives (n = 7 couples), separate focus 
group interviews were conducted.  Men in this sample were 61 to 75 years old.  Five 
couples were White and two were African American.  The couples were separately asked 
about the prostate cancer experience.  Men discussed issues and problems faced prior to 
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the diagnosis of prostate cancer (i.e., urinary and erection problems).  The discussions 
included details of the symptoms and the process of seeking help. In the men’s focus 
groups, few mentioned their wife.  Men did not talk about discussing their problems or 
symptoms with their wives.  Most of the men delayed seeking medical attention until the 
symptoms became severe or when they were admitted to a hospital for another disease 
and subsequently diagnosed with the cancer.  During the focus groups with the wives, the 
interviewer posed the same questions.  Women talked about how they knew about their 
husband’s diagnosis.  The difference in the first section of the focus groups was about the 
focus of the discussions.  Men focused on their prediagnosis symptom,s and the wives 
stressed on the process of being informed about the diagnosis of prostate cancer.  When 
discussing the treatment decision making phase, men and women talked about how the 
treatment was selected.  Some men made the decision with their physician and totally 
excluded the wife.  The wives of these men talked about not being informed about the 
diagnosis, treatment, and prognosis.  Two of the men included the wife in every step of 
the decision making.  This inclusion of the wife was suggested and emphasized by the 
physician and not the men themselves.  However, this was not a concept discussed by the 
majority of men in this study. Men in this study did not make an effort to discuss their 
diagnosis with their wives.  The inclusion of the wife was solely planned and carried by 
the physician.  Two couples talked about a spousal partnership.  They discussed the 
details of the diagnosis and treatment in which the physician was a third party.  Findings 
from this study showed the different scenarios or roles that the partners of men with 
prostate cancer experience (Boehmer & Clark, 2001). 
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Gray and colleagues (2000) explored the issues of support and coping in couples 
diagnosed with prostate cancer.  In a longitudinal qualitative study, the authors 
investigated the experiences of couples with the diagnosis and surgical treatment of 
prostate cancer.  Thirty four men and their partners were interviewed before the surgery, 
8 to 10 weeks post surgery, and 1 year post surgery.  The interviews were conducted with 
men alone, women alone, and men and women together.  Men were 50 to 68 years old, 
and the partners were 42 to 72 years old.  A grounded theory approach was used to 
collect and analyze the data.  Managing the impact of illness was the core category of the 
couples’ experience.  Five domains were identified: dealing with practicalities, stopping 
illness from interfering with everyday life, keeping relationships working, managing 
feelings, and making sense of it all.  The couples in this study talked about being actively 
involved in every step from the diagnosis to treatment.  These couples discussed several 
challenges but exhibited means to manage the impact of the cancer on their lives.  The 
challenges started from the moment of diagnosis, but with time the couples became more 
informed about the disease and treatment.  Proper communication and information about 
the disease helped couples deal with the illness.  It was evident that the couples in this 
sample focused on continuing their lives rather than focusing on the presence of cancer 
and corresponding losses.  Men and their partners tried to minimize the impact of prostate 
cancer during the discussions and focused on strategies to deal with the crisis.  Men 
expressed less distress than their partners.  Few men disclosed emotional struggles.  On 
the other hand, men talked about relying on their partners for help, encouragement, and 
companionship.  Nevertheless, the couples discussed challenges in the relationship.  
Many times, men would distance themselves from the partner while trying to act tough 
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and in control in an attempt to meet their perceived manly expectations.  The wives 
perceived their reactions as being hard on themselves while focusing on recovery.  
Women voiced their preference to have more communication with their husbands.  
However, men did not feel comfortable in exhibiting a need for their partner, while at the 
same time the women were reported to be their source of social support.  In response, 
women were providing support without appearing to do so, and they were reassuring their 
husbands about their decreased potency.  The requirements from women denied them the 
opportunity to use their own coping strategies and therefore they were more distressed 
than men (Gray et al., 2000).  Findings from this study shed light on the experiences of 
couples diagnosed and treated for prostate cancer.  However, the struggle of these 
couples cannot be generalized due to the qualitative nature of the study and the 
homogeneity of ethnicity of the sample.  These findings, contrary to the previously 
discussed study (Boehmer & Clark, 2001), suggested that the wives played a vital role by 
being a source of social support for men with prostate cancer.  Men in this study also 
included their female partners in the discussions about their illness and tried to include 
them when finding ways to deal with the crisis. 
In a similar study, Harden and colleagues (2002) explored the experience of 
couples living with prostate cancer, the impact if the illness on their QOL, and their 
ability to manage symptoms.  Six focus groups were conducted: two with men only (n = 
14), two with partner-caregiver only (n = 12), and two with dyads (n = 8 couples).  The 
majority of men were Caucasian (64%) and married (86%).  The focus groups yielded 
four themes: enduring uncertainty, living with treatment effects, coping with changes, 
and needing help.  With the diagnosis of prostate cancer, men struggled with treatment 
100 
options and were disturbed with the emerging interruption of their lives and roles.  There 
were changes in the men’s social lives and household responsibilities.  After the 
treatment, men discussed losing urinary control, sexual difficulties, hormonal alterations, 
and overwhelming fatigue.  As a result, they had to modify their lives to manage these 
challenges.  Men discussed planning their schedules around the availability of restrooms.  
Many men grieved the loss of their sexual functioning and the challenges of that faced 
their marriage.  Women acknowledged the distress with sexual dysfunction but were 
willing to work with it because they did not want to lose their husbands.  Men treated 
with hormonal therapy experienced mood swings, hot flashes, and weight gain.  The 
couples were not prepared for these symptoms and therefore were in deep distress.  The 
challenge of the masculine image of the man was discussed by the group undergoing 
hormonal treatment.  The changes experienced by couples contributed to a new family 
lives.  Some couples talked about being together more often and not being able to engage 
in outside social events.  Couples also had some shifting roles in which the men and their 
female partners could not accomplish some of the tasks they used to perform.  However, 
the couples still mentioned that they tried to manage the situation but needed help in 
dealing with their situations.  Help was sought from professional resources and 
individualized information that would work in their cases.  Findings from this study 
indicate that couples go through turmoil of emotions and challenges.  The need for 
support and more information was highlighted throughout the study (Harden et al., 2002). 
Fergus and colleagues (2002) explored the patient-provided support for spouse 
caregivers within the context of prostate cancer.  Thirty four couples were interviewed 
before surgery, 2 months after surgery, and 1 year following surgery.  Men who 
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participated in this study were 50 to 68 years old and married between 12 to 41 years.  
The women were 42 to 72 years old.  The semistructured interviews included questions 
about supportive interactions between partners.  Findings yielded four domains of 
patient-provided support for their spouse caregivers: easing spousal burden, keeping us 
up, considering spouse, and maintaining connection.  Men were conscious about the 
burden that their disease and their side effects have on their partners.  Men tried to 
decrease the burden by taking care of themselves and doing things on their own.  Some 
men thought that keeping their wives away would alleviate the burden on them.  Men 
also took a positive standpoint concerning the cancer so as not to distress their partners.  
They tried to control their mood and disappointments.  Wives discussed trying to get 
closer to their husbands to spend more time with them and provide support.  As a result, 
the couples were spending more time together.  Men encouraged their partners to be more 
independent and take care of themselves.  Wives perceived the new relationship to be 
more caring, although men focused on the distress of erectile dysfunction.  Men talked 
about prostate cancer to be a disease of the whole family that led them to spend more 
time together, share experience, and express affection.  Findings from this study shed 
light on the role of men diagnosed with prostate cancer and how they tried to take control 
of their partner’s social and emotional wellbeing (Fergus et al., 2002). 
Giarelli and colleagues (2003) described wives’ self reports of preparedness to 
care for their husbands' physical and emotional needs during the first 6 months after 
prostatectomy.  The mixed methods clinical trial had two groups: the intervention (n = 
57) and control groups (n = 53).  The intervention group received standardized nursing 
intervention protocol that included information provided by an advanced practice nurse 
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about symptom management, restoration of urinary incontinence, and promotion of 
marital communication and sexual intimacy.  The participants were 32 to 73 years old 
and predominantly Caucasian.  Data were collected using the Preparedness for 
Caregiving Scale (PCGS) and an open ended question at baseline and 3 and 6 months 
following prostatectomy.  Results were presented in two sections: quantitative and 
qualitative findings.  The PCGS showed no difference between the intervention and 
control groups in reporting preparedness to take care of their husbands' physical and 
emotional needs.  Preparedness scores were found to increase over time in both the 
intervention and control groups.  However, at 3 months, preparedness scores of the wives 
in the control group slightly decreased.  During the same time, the wives in the 
intervention group scored higher in preparedness.  The increased preparedness of wives 
was thought to be the effect of the advanced practice nursing intervention.  Qualitative 
findings showed three main themes: prepared with practical information, prepared for 
emotional responses, and prepared with resources for problem solving.  Wives described 
their emotional turmoil with the care of their husbands and requested practical 
information to deal with physical and emotional needs.  Emotional needs were not only 
for the men but also for the wives who reported to have similar distress levels.  At 3 
months, the practical information was needed to deal with side effects such as 
incontinence.  There was a need in both groups for information about sexual dysfunction 
and ways to deal with the emotional needs and maintenance of effective communication.  
At 6 months, women in the intervention group did not require practical information; 
however, men in the control group still asked for explanations about physical needs.  
Feelings of fear, apprehension, impatience, distress, and unwillingness to care were 
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experienced by both wives and husbands.  Wives wanted to be prepared for their new role 
as a caregiver with the loss of support of their husband and the emotional distress.  At 3 
months, both groups still reported emotional distress.  However, the control group still 
needed to be prepared for emotional needs and distress.  The intervention group needed 
ways to deal with depression, discouragement, exhaustion, and distress associated with 
the role changes and the memories or better times.  At 6 months, there was a difference in 
the preparedness between the groups.  Wives in the intervention group discussed the need 
to deal with husbands' anxiety and depression.  On the other hand, wives in the control 
group discussed feelings of uncertainty that were transformed into frustration and more 
distress.  Preparedness for problem solving included being able to identify resources for 
social support, spirituality, time management, and identifying personal strengths and 
weaknesses.  At 3 months, the resources for problem solving included social support, self 
awareness, and marital relationship.  Nurses were identified as being important sources of 
social support by both groups.  Similar findings were reported at 6 months.  Findings 
from this study documented the importance of including families, especially wives, in the 
treatment path of men with prostate cancer.  Wives are the source of social support, and 
they are equally affected by the diagnosis (Giarelli et al., 2003). 
Harden and colleagues (2006) examined the experiences of men with prostate 
cancer and their partners according to their life cycle cohort: 50 to 64 years (i.e., late 
middle age), 65 to 74 (i.e., young old), and 75 to 84 (i.e., old old).  This qualitative study 
aimed to compare the age-related differences in couples with a man who was diagnosed 
and treated for prostate cancer.  Five couples per group were recruited using purposeful 
sampling.  The majority were Caucasian (n = 14 couples), and all partners were women.  
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Analysis of the semistructured interviews extracted three themes: couples’ daily lives, 
their dyadic and family relationships, and developmental issues.  The majority of men in 
the late middle age group talked about being distressed and stressed about not being able 
to fulfill their perceived role in the family.  These men reported being depressed or being 
treated for depression.  One wife talked about having to retire early to be able to be the 
caregiver of her husband, and one man talked about being forced to take early retirement 
to be able to deal with disease side effects.  The daily lives of couples was summarized 
by feelings of fatigue, changing priorities, and financial concerns.  When talking about 
dyadic and family relationships, intimacy issues and talks about being “in it together” 
emerged.  Couples in the middle aged group compared themselves to friends who had 
other chronic and fatal diseases.  Couples with prostate cancer reported they were 
struggling with cancer and sexual issues.  They preferred that the diagnosis of prostate 
cancer was given to them at a later stage in life.  The young old group of couples had a 
more positive perspective.  Their lives were not as disrupted by the cancer.  Intimacy 
issues were related to impotence as a result of prostate cancer treatment.  The wives 
discussed the change in sexual patterns in their relationship as affecting their overall 
lifestyles.  Couples in this group also compared themselves to others their age and, 
therefore, accepted the positive prognosis of their disease.  They accepted the timing of 
the diagnosis.  The oldest group reported that the diagnosis of prostate cancer interrupted 
their plans and daily lives.  Dyadic and family relationships revolved around intimacy 
issues and togetherness.  Men felt uncomfortable with not being able to continue with 
their sex lives, which was a source of distress.  The discussions of the couples reflected 
the togetherness of the relationship.  They seemed to do many things together.  When 
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comparing themselves with others in their age group, the diagnosis of prostate cancer did 
not seem to be as bad as they thought due to its positive prognosis.  However, the men 
talked about having limited treatment options as a result of their age and other 
comorbidities.  Findings from this study suggested that the lives of couples are affected 
by the diagnosis and treatment of prostate cancer irrespective of age.  However, priorities 
and the manner that the disease affected the couples and the degree of positivism were 
different between the age groups.  Couples were interviewed together, and there may be a 
possibility that men and women may not have had the courage or opportunity to openly 
express themselves.  
Sanders et al. (2006) conducted a qualitative study to investigate the concern of 
couples who were surviving prostate cancer and treatment.  Three 30-minute segment 
focus groups were conducted with 10 couples to discuss their experiences as a couple, as 
individual men and women, and regarding intimacy issues and relationship needs.  Men 
and women in the first focus group were together; then they were separated in the second, 
and they were brought back together in the third.  Men were 45 to 81 years old, and the 
women were 38 to 75 years old.  Findings suggested that the men's and women’s 
experiences with the diagnosis of prostate cancer were different.  Women saw that their 
role evolved from being the wife and lover that was being transformed into being the 
caregiver.  Sexual relationships were significantly different and led wives to feel 
unattractive and less as a woman.  Sexual dysfunction led to a decrease in romance and 
intimacy which were reported by women to be a source of frustration.  Men, on the other 
hand, felt castrated as a result of erectile dysfunction and urinary incontinence.  There 
was a feeling of fatigue that prohibited men from sharing in chores and duties around the 
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house.  Men talked about major communication issues with their wives.  When grouped 
together, the couples agreed that they needed more information and guidance to manage 
as a couple.  The preferred mode of information was different between men and women.  
Women wanted to participate in support groups to be able to talk to other couples who 
were going through the same experience.  Men, on the other hand, preferred receiving 
brochures and written material.  The couples agreed that regardless of the source, 
information received needs to be individualized (Sanders et al., 2006).  Findings from this 
study showed the experiences of couples with prostate cancer that changed the romantic 
role of the women to a caregiver image.  The relationship in couples was affected by the 
diagnosis and treatment side effects as reported by the participants in the study.  The 
study also showed that the couples needed more information about the course of the 
disease and what to expect.  However, husbands and their wives had different preferences 
regarding the delivery of desired information. 
Hawes and colleagues (2006) described the problems chosen as the focus of 
problem-solving therapy by spouses and men with prostate cancer.  This study was part 
of a randomized control trial that tested the therapeutic value of problem solving skills 
training for couples coping with prostate cancer.  In a descriptive, cross-sectional study, 
66 spouses and partners answered a survey that included the Problem-Solving-Inventory-
Revised (SPSI-R) and the Profile of Mood States (POMS).  The majority of the couples 
was married (85%) or cohabitating (15%).  Most of the sample was White (82%) and age 
65 years or older (37%).  The first two problems identified by couples were categorized 
to determine the major problems encountered.  Four problem categories were identified: 
treatment and side effect issues, patient issues, family issues, and spouse issues.  Couples 
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wanted more information about the cancer, new treatment trends, and medications.  
Urinary incontinence and impotence were sources of frustration for the patient.  Men 
were viewed as being sloppy and not taking care of themselves, and they engaged at 
times in risky behaviors (i.e., smoking, no nutritional eating habits).  Men were also 
viewed as having a bad temper and at times were verbally abusive.  Scheduling dinner 
and other social events was an issue.  Relationship with the spouse and children living at 
home were also jeopardized.  The spouses considered their emotional wellness to be a 
major concern.  They did not perceive that they had time for themselves anymore which 
increased their anxiety levels, decreased their self esteem, unbalanced their temper, and 
caused complaints of a declined physical health conditions.  Findings from this study 
highlighted major spousal issues (i.e., women’s emotional wellness, balancing their 
medical concerns with their husbands' conditions) and patient issues (i.e., men’s lack of 
communication, depression) (Hawes et al., 2006).  Identifying the key concerns and 
problems of couples struggling with prostate cancer will help in recognizing the best 
suitable ways to plan appropriate healthcare plans. 
Kershaw and colleagues (2008) sought to determine if baseline antecedent 
variables and intermediary appraisal variables predicted coping strategies and QOL 
outcomes.  The majority of the sample in this study (n = 121, 67%) was newly diagnosed 
with prostate cancer for an average of 8 months.  Most of the sample was White (86%) 
and married for an average of 31.8 years (SD = 14).  Results of this study suggested that 
men with prostate cancer and their spouses scored higher on mental QOL and lower on 
physical QOL compared to the general population norms.  Findings presented a 
longitudinal analysis of factors associated with QOL in prostate cancer patients and their 
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spouses.  Baseline variables (i.e., self efficacy, current concerns, age, socioeconomic 
status [SES], social support, communication, general symptoms, phase of the disease) 
were found to have effects on couples’ appraisal at 4 months and on their coping and 
QOL outcomes at 8 months after the initiation of the study.  Using the stress-coping 
model as a conceptual framework, the model accounted for 40% of the variance in 
patients' mental functioning and 34% of the physical QOL outcomes at 8 months.  Men 
who had more active coping, lower avoidant coping, less hopelessness at 4 months, and 
fewer symptoms at baseline had improved mental health functioning at 8 months.  
Physical QOL was associated with less negative appraisal of illness at 4 months, fewer 
baseline symptoms, and new onset of the disease.  The model accounted for 43% of the 
variance in spouses' mental functioning and 24% of the physical QOL outcomes at 8 
months.  Better mental health at 8 months was predicted by less active avoidant coping 
and less negative appraisal at 4 months and less current concerns at baseline.  Spousal 
physical QOL was enhanced at 8 months if they were younger and had fewer baseline 
symptoms.  The model accounted for 19% of the variance in the patients' active coping 
and 16% in avoidant coping at 8 months and was influenced by baseline social support 
and negative appraisal of illness at 4 months.  The model accounted for 10% of the 
variance in spouses' active coping and 27% of avoidant coping at 8 months and was 
influenced by baseline patient symptoms, spouses' negative appraisal of illness, and 
patients' uncertainty at 4 months.  Findings from this study supported the stress-coping 
theory and suggested how antecedent personal, resource, and illness variables at baseline 
influenced appraisal variables at 4 months.  Also, strategies when utilized influenced 
QOL outcomes (Kershaw et al., 2008).  Findings need to be considered with caution 
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because structural equation modeling was used for analysis despite the small sample size.  
Also, the study was conducted without controlling for race/ethnicity or treatment 
modality which may have effects on QOL outcomes and course of coping and adjustment 
of couples.   
Badr and Carmack Taylor (2009) examined the sexual functioning of prostate 
cancer patients and their partners and investigated the relationship between sexual 
dysfunction and psychosocial adjustment in relation to spousal communication patterns.  
One hundred sixteen couples answered surveys that included the International Index of 
Erectile Function (i.e., patient’s sexual function), Female Sexual Function Index (i.e., 
partner’s sexual function), DAS (i.e., marital adjustment), Centers for Epidemiological 
Studies Depression Scale (i.e., psychological distress), and Communication Patterns 
Questionnaire (i.e., spousal communication patterns).  The majority of the sample was 
White (83.7%), retired (54.5%), and married (99.2%).  The average age of men in the 
sample was 67.4 (SD = 7.94).  More than half of men (52%) were undergoing treatment 
during the time of the study.  Partners were also predominantly White (82.9%), retired or 
unemployed (66.9%), and had a mean age of 62.7 years (SD = 8.32).  Findings from the 
study showed that patients and partners had high rates of sexual dysfunction.  There was 
a strong positive association between the couples’ sexual functioning and spousal 
communication patterns.  Partners of patients with poor erectile function were likely to 
report decreased open spousal discussions which was associated with partners' marital 
distress ratings.  Regardless of sexual functioning, couples with increased mutual 
constructive communication had better marital adjustment.  Greater sexual dysfunction 
was associated with lower mutual constructive communication and poor marital 
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adjustment in patients and their partners.  Findings from this study suggest that healthy 
communication and sexual rehabilitation may enhance marital adjustment in couples 
struggling with prostate cancer (Badr & Carmack Taylor, 2009). 
Wu, Mohamed, Winkel, and Diefenbach (2013) explored whether spouses’ illness 
beliefs about the timeline of illness mediated relations between spouses’ illness beliefs 
about treatment control and patient’s QOL 6 months after participation in the study.  Fifty 
three men undergoing treatment for localized prostate cancer and their spouses 
participated in this study.  Men were 64 years old (SD = 9.0) and their spouses were 60.6 
years old (SD = 9.5).  The majority of participants were Caucasian (92.5%, n = 49), and 
underwent radiation therapy (52.8%, n = 28), and surgery (26.4%, n = 14).  Data for 
treatment control and timeline beliefs were collected from the patient and spouse using 
the treatment control and the timeline subscales of the revised Illness Perception 
Questionnaire.  Data on patients’ general QOL was collected using the Functional 
Assessment of Cancer Therapy-General instrument.  Data on patients’ urinary and sexual 
function were obtained using the American Urological Association symptom index and 
sexual adjustment questionnaire, respectively.  The results suggested that spouses’ 
timeline beliefs mediated the relationship between spouse treatment control beliefs and 
patient QOL.  A similar relationship was not found when patients’ beliefs were 
considered.  These findings emphasize the importance of including spouses in discussions 
about the treatment and outcomes of prostate cancer.  Spouses’ beliefs about the positive 
treatment outcomes enhanced the QOL of patients (Wu et al., 2013).   
In summary, the diagnosis and treatment of prostate cancer affects couples faced 
with the disease.  These couples’ relationships are influenced by the responses of men to 
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their sexual dysfunction.  Sexual dysfunction as a result of prostate cancer was reported 
to influence the psychological status of couples and generate feelings of social isolation, 
emotional distress, anxiety, and depression (Hawkins et al., 2009).  Research has shown 
that there is a relationship between couples’ sexual functioning, open communication, 
and relationship satisfaction (Badr & Carmack Taylor, 2009).  As a result, the 
relationships of couples had suffered from decreased intimacy and emotional burden 
(Badr and Carmack Taylor, 2009; Giarelli et al., 2003).  The decreased intimacy levels 
led to a decline in the overall relationship satisfaction (McCabe & Matic, 2008).  Couples 
discussed the modifications in the image of the woman from the romantic partner to the 
female caregiver (Gilbert et al., 2009; Hawkins et al., 2009).  As a result, the couples 
described their relationships as stressful and accompanied by avoidant behaviors 
(Wootten et al., 2007).   
Intimacy issues were directly related to the satisfaction with the relationship 
(Galbraith & Crighton, 2008; Hawkins et al., 2009).  The diagnosis of prostate cancer did 
not affect men alone; it also affected female partners (Galbraith et al., 2008).  However, 
male and female partners were found in one study to respond differently to the illness 
(Boehmer & Clark, 2001).  In this study, some men were found to alienate their wives 
from discussions about the disease, others included their wives because the physician 
insisted, and two couples formed a spousal coalition with the physician acting as a third 
party (Boehmer & Clark, 2001).  However, other studies have shown that female partners 
play a significant role in being the major source of social support (Gray et al., 2000).  The 
focus of these couples was to manage the illness as a couple and find ways to maintain 
the relationship status (Gray et al., 2000).  Fergus and colleagues (2002) suggested that 
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men were trying to control their disappointments and mood changes to decrease the 
burden on their wives.  Communication and adequate information about the course of the 
disease were identified to be key factors that helped couples deal with prostate cancer and 
its treatment side effects (Giarelli et al., 2003; Gray et al., 2000; Harden et al., 2002). 
Other challenges that faced couples included the change in the men’s social life 
(Harden et al., 2006).  Harden and colleagues (2002) showed that men had to modify 
their priorities, household responsibilities, schedules, and other issues to accommodate 
the urinary incontinence and sexual dysfunction that accompanied the treatment of 
prostate cancer.  These challenges were reported to bring couples together since they 
were spending more time together and less social engagement time (Fergus et al., 2002; 
Harden et al., 2002, 2006).  Few studies examined the contribution of men’s perceived 
relationships with their partners on men’s QOL.  Also, other variables such as age, 
race/ethnicity, and masculinity have not been examined in relation to the relationship 
with partner to understand their independent and combined contribution to QOL in men 
with prostate cancer. 
Age 
Sexuality and sexual functioning of adults (i.e., adults in their 40s, 50s and 60s) 
are controversial issues.  People 65 years old and older are considered to be older adults.  
There were few studies that showcased the importance of sexual functioning of older 
men.  The hesitancy of this discussion may be influenced by the stereotypes that older 
men engage less than younger men in sexual activities.  The value of sexual functioning 
for men 50 years and older is important to explore in an attempt to understand the 
influence of sexual dysfunction in men diagnosed with prostate cancer.   
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The National Social Life, Health, and Aging Project was conducted to report the 
prevalence of sexual activity, behaviors, and problems in a national probability sample of 
3,005 U.S. adults (i.e., 1,550 women and 1,455 men) 57 to 85 years of age.  Findings 
suggested that the majority of older adults (i.e., adults in their 60s and older) had a 
partner and were involved in an intimate relationship.  Sexuality was considered to be an 
essential part of their lives.  However, the prevalence of sexual activity decreased with 
age (i.e., 73% in adults 57 to 64 years, 53% in adults 65 to 74 years, and 26% in adults 75 
to 85 years).  Men were more likely to engage in sexual activities despite 37% of men 
reporting erectile difficulties.  Interestingly, both men and women with decreased sexual 
activity rated their health as being poor (Lindau et al., 2007). 
Araujo, Mohr, and McKinlay (2004) described the individual changes in sexual 
function (i.e., sexual intercourse, erection frequency, sexual desire, ejaculation with 
masturbation, satisfaction with sex, and difficulty with orgasm) over 9 years in a 
population based cohort study.  A sample of 1,085 men participated in the study.  
Findings showed that there were significant changes in all of the sexual function domains 
with the exception of the frequency of ejaculation with masturbation.  The changes in 
individual sexual function over time were strongly associated with age.  With increasing 
age, there was a significant decline in sexual function.  The frequency of sexual activity 
decreased less than once per month, less than two times per month, and less than three 
times per month in men in their 40s, 50s, and 60s, respectively.  Similarly, the number of 
erections decreased by 3, 9, and 13 in men in their 40s, 50s, and 60s, respectively.  
Findings from this study showcase the developmental decline in sexual activity with age 
(Arauju et al., 2004).  The reason for sexual decline was not explained by the researchers, 
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but it may be due to the emergence of diseases that are common at the identified age 
cohort.  However, the sexual desire and interest in sexual activity was not shown to be 
affected by age (Laumann, Glasser, Moreira, & GSSAB [Global Study of Sexual 
Attitudes and Behaviors] Investigators' Group, 2009).   
Age was found to be a significant predictor of prostate cancer.  After the age of 
40, the prostate cells tend to multiply causing hypertrophy of the gland.  However, this 
increases the risk of developing cancerous cells (PCF, 2011).  Trends have shown that 
there was a significant increase in prostate cancer diagnosis with increased age (ACS, 
2011; PCF, 2011).  The majority of men (97%) diagnosed with prostate cancer were 50 
years and older (ACS, 2011), and 65% of men were 65 years and older (PCF, 2011).  
With the positive life expectancy associated with prostate cancer, these men were 
anticipated to live longer with the outcomes of their disease.   
Studying the prognosis of prostate cancer, there were no significant differences by 
age at diagnosis.  Examining the long term outcomes and 10 years life expectancy 
suggested that age was not a predictor of prostate cancer survival (Bill-Axelson et al., 
2005; Wong et al., 2006).  Bill-Axelson and colleagues (2005) reported the 10 years 
outcomes of two groups of men undergoing radical prostatectomy (n = 83) and watchful 
waiting (n = 106) as a treatment for prostate cancer.  The percentage of death due to 
prostate cancer increased from 2% after 5 years to 5.3% after 10 years.  There was a 
significant difference in deaths from prostate cancer between the two groups with more 
deaths in the surgery group.  Findings suggest that surgery had better functional outcomes 
(i.e., sexual and urinary functioning) for men 65 years old and younger (Bill-Axelson et 
al., 2005).  Similar findings were reported by Wong and colleagues (2006).  Active 
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treatment (e.g., surgery or radiation) in low and intermediate risk prostate cancer in men 
ages 65 to 80 years was found to have better 5 and 10 years survival rates (Wong et al., 
2006).  
Age was hypothesized to be associated with the outcomes of treatment (i.e., 
sexual dysfunction and urinary incontinence).  Stanford and colleagues (2000) suggested 
that age was a significant contributor to sexual and urinary functioning after 
prostatectomy.  Results were replicated in a sample of men undergoing nerve sparing 
prostatectomy (Penson et al., 2005).  It was found that age contributed to urinary 
incontinence (Sacco et al., 2006) and sexual functioning (Rondorf-Klym & Colling, 
2003; Sanda et al., 2008).  Harden and colleagues (2006) examined the experiences of 
men and their partners according to their life cycle.  Findings suggested that all age 
groups had issues with their relationships, intimacy, changing priorities, distress, and 
other issues (Harden et al., 2006).  Nevertheless, younger couples had more positive 
perspectives of their relationships, intimacy, changing priorities, and other issues (Harden 
at al., 2006).  In a qualitative study, Oliffe (2005) suggested that older men were expected 
to place less emphasis on sexuality.  As a result, they were hesitant to expand the 
discussion about the influence of decreased sexuality on their perceived masculinity.  On 
the other hand, younger men were able to elaborate on the importance of their sexuality 
more openly (Oliffe, 2005). 
In summary, age is an important variable to consider when studying men with 
prostate cancer.  Age was reported to be a risk factor for the development of the disease 
(ACS, 2011; PCF, 2011).  Men after the age of 50 years are at a higher risk for being 
diagnosed with prostate cancer (ACS, 2011; PCF, 2011).  Research examining the 
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outcomes and survival rates of prostate cancer has indicated that the 5- and 10-year 
survival rates were 100% and 97% respectively (Bill-Axelson et al., 2005).  However, 
age was a factor in determining the functional outcomes of treatments (i.e., surgery, 
radiation, watchful waiting) (Bill-Axelson et al., 2005).  Irrespective of age and 
treatment, men diagnosed with prostate cancer were at a high risk of developing sexual 
dysfunction (Rondorf-Klym & Colling, 2003; Sanda et al., 2008) and urinary 
incontinence (Sacco et al., 2006).   
On the other hand, the majority of adults in their 50s, 60s, and older had a partner 
and were involved in an intimate relationship.  Sexuality and sexual activity were 
important to them despite the reported decreased rates with age.  Men after the age of 50 
are at a higher risk of developing erectile difficulties; however, they were found to be 
more likely to be interested in engaging in sexual activities.  Sexual activity was an 
indicator of good health for men and women after the age of 50 years (Lindau et al., 
2007).  Age was also associated with decreased sexual activity, although sexual desire 
did not change (Laumann et al., 2009).  Findings may be related to the emergence of 
medical conditions that may hinder sexual activities at later ages.  As a result, men in 
their 50s and older who are at higher risk for developing prostate cancer (ACS, 2011) are 
subject to sexual dysfunction and may be disappointed when their sexuality is 
jeopardized.  Consequently, due to the sexual dysfunction, men may face intimacy 
challenges with their wives and therefore their relationship satisfaction may be 
compromised (Harden et al., 2006).  Problems related to sexual dysfunction are not often 
reported due to the social understanding that sexual activity is expected to decrease and 
be less emphasized with age (Oliffe, 2005).  With sexuality being important for all age 
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groups, sexual dysfunction is anticipated to affect men of all ages and consequently may 
influence their QOL. 
Ethnicity 
Ethnicity refers to people from a shared heritage and identity such as a common 
language, culture, or ideology.  It can also be referenced as a shared belonging to a 
common geographic area (i.e., Hispanic) (Isajiw, 1974; Nagel, 1994).  In research, race 
and ethnicity have been used as variables but not consistently defined by researchers 
(Drevdahl, Taylor, & Phillips, 2001; Sheldon & Parker, 1992).  The majority of studies 
have used race/ethnicity as a single category and have included African American, 
Hispanic, and others in a single item.  Ethnicity, in this proposal, will be able to capture 
the self-identified cultural affiliation (Bradby, 2003) in addition to the U.S. Census 2010 
categorization.  Additional categorization in the Hispanic group will be added to include 
the Hispanic descendants in the sample to be able to represent the uniqueness of the 
population in Miami, Florida (e.g., Cuban, Nicaraguan, Dominican, Colombian, and 
Venezuelan). 
Studies identified racial disparities in the prevalence of prostate cancer.  As 
previously discussed, it was reported that African American men have the highest 
incidence of prostate cancer followed by Hispanic men (Edwards et al., 2010). 
Nonetheless, few studies have examined the differences in outcomes (i.e., sexual 
dysfunction, urinary incontinence, masculinity, partner relationship, QOL) among men 
from different racial/ethnic backgrounds.  Stanford et al. (2000) identified a difference in 
sexual functioning among ethnicities in which African American and Hispanic men 
reported better erection functioning compared to Caucasian men 18 months after radical 
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prostatectomy.  The details of the study were previously explained.  The majority of 
studies among men diagnosed with prostate cancer were conducted among samples that 
self identified as non-Hispanic Whites or Caucasians.  Some studies had 12 to 14% of 
their sample from different ethnic groups; however, they did not compare or report 
separate findings from these ethnicities. 
Miami is a multiethnic and multiracial metropolitan area that is predominantly 
Hispanic.  There is evidence that has suggested that cultural and ethnic constructions 
influence health behaviors of men (Addis & Mahalik, 2003; Courtney, 2000).  In a 
Hispanic community that emphasizes the concepts of machismo and caballerismo, the 
masculinity of men who experience sexual dysfunction may be challenged.  Machismo is 
a socially constructed phenomenon that emphasizes the Hispanic male gender 
expectations and the meanings of being a Latino man (Arciniega et al., 2008).  The 
traditional role of a Hispanic man has been identified in terms of being strong, a family 
protector, provider, and sexual prowness (Arciniega et al., 2008).  The concept of 
machismo is closely related to the concepts of hypermasculinity and traditional masculine 
roles discussed by Connell (1995).  The machismo beliefs are interrelated with strong and 
rigid traditional masculine gender roles (Abreu, Goodyear, Campos, & Newcomb, 2000).  
Latino and Hispanic men who endorse their ethnicity and ethnic belonging were found to 
have greater adherence to traditional masculine ideologies and hypermasculine attitudes 
(Abreu et al., 2000).  Men’s genital organs are considered to be a sense of pride as well as 
symbols of their masculinity and being a man (Lugo, 1990).  Consequently, any man who 
does not conform to this normal or expected understanding may be considered less of a 
man and may not be considered macho (Lugo, 1990).  As a result, belief in machista may 
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have an influence on health behaviors and health outcomes (Rivera-Ramoz & Buki, 
2011).  
Maliski, Rivera, Connor, Lopez, and Litwin (2008) explored how African 
American and Latino men maintained masculine identity with prostate cancer treatment 
side effects.  A total of 60 Latino and 35 African American men were interviewed using a 
semistructured guide.  Transcripts were analyzed using a grounded theory technique and 
generated a descriptive model.  Findings suggested that men’s constructions of their 
masculinity were influenced by their experiences in their early lives.   Prostate cancer 
treatment side effects and sexual dysfunction challenged their masculine identity.  As a 
result, these men renegotiated their masculine identity to maintain their image and manly 
role in society (Maliski et al., 2008).  The Latino men in this study were generally of 
Mexican origin; therefore, these findings may not be similar in a Miami sample that is 
predominantly Cuban and other Caribbean as well as Central and South American 
ethnicities.  
Research with men with prostate cancer has generally not represented the 
experiences of men from minority ethnic groups.  R. A. Jones and colleagues (2011) 
explored cancer support and financial issues related to prostate cancer in a sample of 23 
rural and urban 65 years old and older African-American men.  Using a descriptive 
qualitative design, five focus groups were conducted.  Men were recruited from 
community-based centers (e.g., churches, barbershops, diners, and primary care clinics).  
The analysis of the focus groups yielded two main themes: family and physician support 
are important, and insurance is a necessity for appropriate health care.  Female partners of 
African American men with prostate cancer were the main source of social support.  
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These themes represented the main concerns of African American men with prostate 
cancer.  There was a difference between rural and urban men.  African American men 
living in rural areas expressed the importance of spirituality in helping them deal with the 
diagnosis and treatment of prostate.  Insurance and financial issues related to healthcare 
treatment were also important to decreased QOL in both rural and urban men with 
prostate cancer (R. A. Jones et al., 2011). 
In a sample of 17 African American men using a phenomenological approach, 
Jones, Steves, and Williams (2010) explored how and when they decided to go for 
prostate cancer screening.  The majority of men discussed their limited education about 
prostate cancer and that they were not aware of the increased risk of African American 
men.  Men emphasized the importance of having a family member involved in the 
decision to go for prostate cancer screening.  The involvement of a family member was 
needed because they were accustomed to seeking health advice from informal sources 
such as family members (e.g., wife, daughter, sister).  Men in this sample placed great 
emphasis on their trust in physicians.  They discussed the importance of having their 
physicians insist that they perform prostate cancer screening.  However, this trust was 
related to having a long standing relationship with the physician.  Men who do not have a 
long standing relationship with a physician or healthcare provider did not agree with this 
concept (Jones et al., 2010).  Findings from this study may suggest that family and health 
provider trust are important for African American men with prostate cancer.  Therefore, 
their availability may contribute to QOL in African American men with prostate cancer. 
Research studies that have used samples of Hispanic men with prostate cancer are 
scarce.  In a randomized control trial, the short-term effects of a community-based 
121 
intervention were conducted with Hispanic men aiming to encourage informed decision 
about prostate cancer screening with PSA.  Senior social and housing centers were 
randomized into the intervention.  The intervention group attended a Spanish language 
educational program facilitated by promotores (i.e., 12 centers; 161 men).  The control 
group promotores attended diabetes awareness video and discussions (i.e., 13 centers; 
160 men).  Findings showed that 44% of participants had previous PSA testing at 
baseline.  After the intervention, the intervention group reported knowledge gains, 
demonstrated increased awareness about PSA testing, and showed more involvement in 
decision making roles regarding testing.  Men in the intervention group believed that it 
was important to consider the advantages and disadvantages of screening and anticipated 
that the decision to go for prostate cancer screening was going to be easier.  The control 
group did not exhibit any changes in their intentions or beliefs about choosing whether or 
not to be screened for prostate cancer (Chan et al., 2011).  Findings from this study 
support the importance of community based programs that increase awareness of prostate 
cancer screening using culturally and linguistically appropriate methods.  Findings from 
this study also suggest that culturally appropriate awareness about the course of prostate 
cancer treatment may be beneficial for Hispanic men. 
In summary, racial and ethnic backgrounds of men may contribute to the risk for 
developing prostate cancer (Edwards et al., 2010).  African American men have the 
highest incidence of prostate cancer followed by Hispanic men (Edwards et al., 2010).  
Stanford and colleagues (2000) identified differences in sexual functioning among ethnic 
groups in which African American and Hispanic men reported better erection functioning 
compared to Caucasian men 18 months after radical prostatectomy.  However, prostate 
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cancer side effects (i.e., sexual dysfunction and urinary incontinence) and their influence 
on QOL in African American and Hispanic men have not been well reported in the 
literature. 
With prostate cancer resulting in sexual dysfunction and urinary incontinence, 
concepts of masculinity and the impact of these side effects on QOL is in question.  The 
Hispanic community’s strong and rigid masculine constructions of machismo may 
influence these men’s reactions to the disease.  Research on the machista beliefs of 
Hispanic men and their influence on health behaviors and perceptions health outcomes 
suggest that Hispanic men may be distressed as a result of prostate cancer treatment side 
effects (Rivera-Ramoz, & Buki, 2011).  It can be anticipated that Hispanic men 
diagnosed with prostate cancer will have similar experiences to findings reported from 
studies with White males with strong and rigid conformity to masculine norms (Addis & 
Mahalik, 2003; Courtney, 2000; Maliski et al., 2008).  Similarly, it can be anticipated that 
as a result of prostate cancer treatment side effects, men’s relationships with their female 
partners may be influenced.  Consequently, men’s QOL will be challenged. 
The impact of sexual dysfunction on masculinity and impressions of African 
American men with prostate cancer has not been extensively examined in the literature.  
However, research with African American men has addressed prostate cancer screening 
attitudes and beliefs.  Research may have focused on this area due to the increased risk of 
developing prostate cancer in African American men and the importance of early 
screening (Edwards et al., 2010).  Studies that have examined the attitudes and beliefs 
about prostate cancer of African American men highlight the importance of social 
support of the wife and family in addition to the influence of healthcare providers in 
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creating awareness (Jones et al., 2010).  The increased reluctance of African American 
men toward prostate cancer screening may be due to a relationship with sexual stigma 
that is modified with the awareness and educational programs (Jones et al., 2010; R. A. 
Jones et al., 2011).  In the case of men with prostate cancer and consequent side effects, it 
can be anticipated that they will experience challenges to their QOL.  Hence, despite the 
scarcity of research representing the experiences of men with prostate cancer from 
different racial/ethnic backgrounds, it can be anticipated that they may experience similar 
QOL challenges.  For this reason, a study examining QOL in men with prostate cancer in 
a multiethnic region like Miami, Florida will help understand these men’s responses to 
the disease. 
Quality of Life 
Quality of life (QOL) is a major area of research that has emerged in the last 
couple of decades that is related to prostate cancer.  Consequently, several definitions and 
conceptualizations have been studied with different diseases and chronic conditions and 
in various age groups and ethnicities.  QOL was considered to be an outcome of a chronic 
illness or disease progression.  The World Health Organization (WHO, 1947) introduced 
QOL when they defined health in terms of physical, mental, and social wellbeing.  In the 
late 1970s, psychosocial care and QOL were identified as a patient’s right in healthcare.  
This was also emphasized by the FDA when they favored QOL and enhanced survival as 
acceptable and preferred outcomes when considering the approval of drugs (Johnson & 
Temple, 1985).  This emphasis led to the emergence of research on the effects of 
psychological, social, environmental, and other factors on QOL in healthcare.   
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QOL has been defined by many sources.  It has been agreed that QOL is a 
multidimensional concept with a subjective nature (Cella, 1994; U.S. Department of 
Health and Human Services, 1990; Zhan, 1992).  WHO (1993) defined QOL in terms of 
the individuals' perceptions of their lives accounting for cultural, social, and 
environmental circumstances.  The nursing literature has emphasized the importance of 
defining and studying QOL.  Accordingly, several definitions and models have been 
tested in a variety of populations along with several variables including disease specific, 
race/ethnicity, and other variables.  Ferrans and colleagues’s (2005) definition of QOL as 
the normal functioning, social usefulness, general well-being, ability to fulfill life’s goals 
and happiness, and life satisfaction guides the conceptualization of this proposal (Ferrans 
et al., 2005).  Initiated by Padilla and Grant’s (1985) model of the relationship between 
the nursing process and the dimensions of QOL, the importance of embarking on 
studying men with prostate cancer emerged.  The role of nursing research in contributing 
to the understanding of different dimensions of QOL is essential to enhance life 
satisfaction.  In the case of men with prostate cancer, the disease and treatment impose 
side effects that impact the physical, psychological, and social wellbeing of men.   
Weber and colleagues (2007) investigated the relationships between post radical 
prostatectomy urinary, sexual, and bowel dysfunction and the resultant bother to men.  A 
sample of 72 men was recruited and surveyed 3 to 6 months after surgery.  Self efficacy, 
social support, uncertainty, and physical function, and bother were measured.  The 
majority of the sample (83%) were White and married (73.6%) with an average age of 
59.8 (SD = 6.8) years.  Sexual functioning scored lowest followed by urinary and bowel 
functioning.  Upon examination of symptom bother scores, urinary symptoms scored the 
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highest followed by sexual and bowel symptoms, respectively.  There was no significant 
correlation between sexual function and bother.  Conversely, there was a positive 
relationship between urinary function and bother (r = .74, p < .001).  Similarly, there was 
a positive relationship between bowel function and bother (r = .05, p < .001).  Men in this 
study reported having low self efficacy regarding treatment side effects.  The majority of 
men (57%) had low to moderate social support despite most of them being married.  Most 
men (75%) had moderate to high uncertainty about their disease, diagnosis, and 
treatment.  Findings from this study showcased the physical functioning and resultant 
bother after undergoing radical prostatectomy (Weber et al., 2007).  Findings from this 
study also made a unique contribution to the knowledge of the experience of men with 
prostate cancer.  Nevertheless, findings cannot be generalized to the population because 
the sample size. 
The physical and psychosocial factors that affect QOL in men 12 to 24 months 
after radical prostatectomy were examined (Rondorf-Klym & Colling, 2003).  The 
investigators hypothesized that the principle bodily functions affected by radical 
prostatectomy treatment were sexual and urinary functions.  These functions were 
thought to contribute to changes in urinary and sexual appraisal which in turn affected 
men’s psychosocial responses.  With a sample of 88 Caucasian men diagnosed with 
prostate cancer, path analysis was conducted to test the hypotheses.  Findings showed 
that sexual and urinary functioning predicted sexual appraisal.  Similarly, urinary 
function predicted urinary appraisal.  Urinary appraisal predicted health locus of control.  
Self esteem, perceived social support, and health locus of control were mediating 
variables and predicated QOL.  Age predicted sexual function.  There were no 
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relationships between sexual and urinary appraisal and self esteem, anger suppression, 
perceived social support, and depression.  There was also no relationship between sexual 
appraisal and health locus of control (Rondorf-Klym & Colling, 2003).   
Sexual and urinary dysfunctions have been documented to be primary concerns 
following prostatectomy.  Gralnek, Wessells, Cui, and Dalkin (2000) studied the impact 
of nerve sparing techniques on QOL after radical retropubic prostatectomy for prostate 
cancer.  Data were collected from 129 men at least 1 year after radical retropubic 
prostatectomy.  The majority of the sample (n = 83) underwent nonnerve sparing surgery, 
and the rest (n = 46) were treated with unilateral nerve sparing prostatectomy.  Men in the 
nerve sparing group scored significantly higher on the sexual function, sexual bother, 
physical function, and physical limitation domains of the RAND/UCLA Prostate Cancer 
Index.  The nerve sparing procedure did not have a significant effect on urinary 
functioning, bowel functioning, and disease outcomes (Gralnek et al., 2000).  Findings 
from this study are important to consider despite the rather small sample size.  Findings 
suggested that despite the enhanced sexual functioning outcomes, the nerve sparing 
surgery was not found to decrease the other side effects of the surgery.  As a result, men 
after nerve sparing prostatectomy still suffer from urinary functioning, bowel functioning, 
and disease outcomes.  Therefore, this surgical technique may not enhance QOL 
outcomes in men with prostate cancer. 
Brandeis, Litwin, Burnison, and Reiter (2000) compared general and disease 
specific health related QOL in men undergoing either brachytherapy or radical 
prostatectomy.  In a sample of 48 men treated with brachytherapy and 74 men treated 
with surgery, health related QOL data were collected 3 to 17 months after treatment.  The 
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brachytherapy and prostatectomy groups were matched with a healthy control group from 
the literature.  Findings showed that the general health outcomes did not differ between 
the three groups.  The brachytherapy patients reported bowel function and urinary 
symptoms that were worse than the control group but better than the prostatectomy 
group.  Sexual functioning and bother were much worse in both treatment groups when 
compared with the healthy control group.  Patients who underwent brachytherapy 
reported improvement in physical function, bodily pain, urinary function, and bother with 
time (i.e., after the first year of treatment) (Bradeis et al., 2000). 
Monga et al. (2005) evaluated QOL in men diagnosed with prostate cancer who 
underwent ERBT.  The study also investigated the relationships between QOL, 
depression, sleep disturbance, and fatigue.  The sample consisted of 40 men whose ages 
ranged from 55 to 78 years and were predominantly married (70%).  The participants 
underwent ERBT over a period of 7 to 8 weeks.  Data were collected at five time points: 
pretreatment, midtreatment, completion of treatment, 4 to 8 weeks follow-up, and long 
term (i.e., 12 months or more).  Findings showed that 45% of men developed mild to 
moderate proctitis (i.e., infection of the prostate) during ERBT.  There were no 
significant changes in functional status, social wellbeing, functional wellbeing, and 
relationship with physician.  There was a significant decline in physical wellbeing at 
midtreatment, completion of treatment, and long term.  Physical wellbeing scores 
increased at 4 to 8 weeks without reaching baseline levels.  Similar findings were 
demonstrated on the Piper Fatigue Scale.  There was a significant inverse relationship 
between physical wellbeing and fatigue.  Overall, there was a long term improvement in 
QOL in men undergoing ERBT without reaching baseline status (Monga at al., 2005). 
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Potosky and colleagues (2002) examined QOL outcomes in men who underwent 
ADT or no therapy.  A sample of 661 men (i.e., 245 receiving ADT and 416 receiving no 
therapy) were recruited from the Prostate Cancer Outcomes Study.  A cross-sectional 
analysis to compare men receiving ADT and no therapy was conducted analyzing health 
outcomes 12 months after the diagnosis of prostate cancer.  The majority of the ADT 
group received LHRH agonists.  Findings at baseline showed that men who received 
ADT were less likely to have an erection firm enough for intercourse, lower libidos, and 
less frequent sexual activity compared with the no therapy group.  The analysis was 
conducted between changes in sexual function in the ADT group and no therapy group 
and examined men who reported good sexual function at baseline.  A total of 444 (ADT 
group = 149, no therapy group = 295) men reported some interest in sexual activity at 
baseline.  One year later, 79 (54%) men in ADT group and 35 (13%) of men in the no 
therapy group reported no interest in sexual activity.  A total of 311 (ADT group = 88, no 
therapy group = 223) men were potent at baseline.  The majority of men in the ADT (n = 
68, 80%) and no therapy (n = 60, 30%) groups was impotent at 12 months.  Men in the 
ADT group reported significantly more breast swelling (20%) and hot flashes (58%).  
Physical discomfort, physical limitations, and overall bother were significantly higher in 
men in the ADT group.  Men in the ADT group reported significantly decreased physical 
role functioning and vitality 12 months after the treatment (Potosky et al., 2002).  
Findings from this study suggested that ADT, similar to surgery and radiation therapy, 
has a negative effect on sexual functioning and QOL outcomes in men with prostate 
cancer. 
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The percentage of men who underwent primary or adjuvant radiation therapy with 
changes in sexual function from the beginning to end of therapy was described by 
Howlett and colleagues (2010).  Seventy men who underwent primary or adjuvant 
radiation therapy were recruited to participate in the descriptive longitudinal study.  
Depression, anxiety, and QOL measures were administered.  Based on a question about 
the illness impacting their sexuality, patients were categorized into four groups: no 
problem (i.e., score less than 5) at beginning and end of radiation, no problem at 
beginning and problem at end of radiation, problem at beginning and end of radiation, 
and problem at beginning and no problem at end of radiation therapy.  A cutoff point of 5 
on a scale of 0 to 10 scale on the sexuality question was used to identify the categories.  
The majority of the sample was Caucasian (79%) and married or partnered (74%) with a 
mean age of 67.1 years (SD = 7.8).  The sexuality question showed that 39% of men had 
no problem at beginning and end, 10% had no problem at beginning and problem at end, 
44% had a problem at beginning and end, and 7% had a problem at beginning and no 
problem at end.  There was a significant difference in the sexuality item between baseline 
and end of radiation in the no problem at beginning and end of radiation, no problem at 
beginning and with problem at end of radiation, and problem at beginning and no 
problem at end or radiation therapy groups.  Findings showed that there was a significant 
change in depression scores from baseline to end of radiation therapy depending on the 
sexuality group.  There was a significant effect of anxiety in the sexuality group but time 
did not have an effect.  Men without sexual problems at the beginning and end of 
treatment had lower anxiety and depression scores in addition to higher QOL scores than 
did men in other groups.  Although men did not score high on the depression scale, there 
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was a significant difference in their scores over time depending on their sexuality group, 
especially in the groups in which men sustained sexual problems at the end of therapy.  
Changes in sexual function affected physical, psychosocial, and social wellbeing of men 
on the QOL scale.  Men with decreased sexual functioning scored lower on the 
psychological and social wellbeing subscales (Howlett et al., 2010). 
 Sanda and colleagues (2008) examined the determinants of health-related QOL 
after primary treatment of prostate cancer and measured the effects of these determinants 
on satisfaction with the outcome of treatment in patients and their spouses or partners.  
Data were collected from 1,201 men and 625 spouses or partners before and after radical 
prostatectomy, brachytherapy, or ERBT.  Findings showed that patients who underwent 
brachytherapy complained of long-lasting urinary irritation as well as bowel and sexual 
symptoms.  Prostatectomy patients reported urinary incontinence.  These symptoms were 
exacerbated by obesity, large prostate, high PSA, and older age.  African American men 
had lower satisfaction with overall treatment outcomes.  Sexual QOL was affected in all 
treatment groups.  In the radical prostatectomy group, men who underwent nerve sparing 
procedures had better sexual functioning when compared to the nonnerve sparing group.  
In the ERBT group, improvement in sexual functioning was better in men who received 
radiotherapy alone when compared with men who received radiation and ADT.  Large 
prostate size, high baseline PSA, and older age were associated with worse sexual 
functioning.  QOL scores were significantly associated with the degree of outcome 
satisfaction among men and their spouses or partners.  Spouses or partners reported 
distress related to erectile dysfunction in 44% of the prostatectomy group, 22% of the 
radiation group, and 13% of the brachytherapy group.  Men in the brachytherapy and 
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radiotherapy group reported having lower QOL related to bowel function up to 1 year 
after treatment.  Bowel dysfunction was associated with distress reported by 5% of 
spouses or partners in the radiotherapy group and 4% in the brachytherapy group.  Men’s 
QOL was associated with the satisfaction with the spouse or partner (Sanda et al., 2008). 
 In a 2 year follow up study on men treated with prostate cancer, Penson and 
colleagues (2003) examined the relationships between primary treatment, urinary 
dysfunction, sexual dysfunction, and general health related QOL.  Participants were 
selected from the Surveillance, Epidemiology, and End Results (SEER) registries.  
Baseline surveys were completed within 6 to 12 months of diagnosis.  Men were 
followed for up to 2 years after the diagnosis, and health related QOL data were 
collected.  Findings showed that primary treatment was not associated with 2-year 
general health related QOL outcomes.  A total of 2,306 cases met the inclusion criteria of 
the study.  Men in this sample were mostly White (78%), 60 years or older (86%), and 
married or had a sexual partner (83%).  At 24 months, men reported having a moderate or 
big problem with their sexual function (39.2%) with no erection firm enough for sexual 
intercourse (65%), especially in men undergoing radical prostatectomy.  Urinary function 
was also described to be in the form of frequent leakage or total loss of control (90.9%), 
especially for men who had hormone ablation therapy and radiation therapy.  Urinary 
bother and sexual dysfunction significantly affected health related QOL.  Urinary 
function was not to have a significant effect on health related QOL.  Sexual dysfunction 
and bother contributed to a decline in the six domains of health related QOL.  There was 
no significant primary treatment effect on health related QOL 2 years after the diagnosis 
of prostate cancer.  Findings from this study suggested that irrespective of the treatment 
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choice, long term QOL in men treated for prostate cancer is very similar (Penson et al., 
2003). 
 Potosky and colleagues (2004) investigated 5 year QOL outcomes in men who 
underwent radical prostatectomy or radiotherapy for treatment of prostate cancer.  Men 
ages 55 to 74 years (n = 1,187) diagnosed with localized prostate cancer and treated with 
radical prostatectomy or ERBT were included in the study.  Data on clinical outcomes 
and QOL at baseline (i.e., upon diagnosis) as well as 2 and 5 years following treatment 
were collected.  Five years after the diagnosis, sexual functioning declined (41-62%) in 
both groups, especially in the domains of interest, frequency of any sexual activity, or the 
extent of bother due to sexual dysfunction.  Men who underwent radical prostatectomy 
had a greater prevalence of erectile dysfunction (79.3% vs. 63.5%).  Two years after the 
diagnosis of prostate cancer, men reported impotence after radical prostatectomy (82.1%) 
and after ERBT (50.3%).  At 5 years, these percentages were 79.3% versus 63.5%, 
respectively.  Upon comparison of sexual functioning between 2 and 5 years, men who 
received ERBT had a significantly larger decline in their sexual function, whereas men 
undergoing surgery experienced a smaller decline.  Men who underwent surgery were 
more likely to be incontinent at 5 years (15.3% vs. 4.1%).  Urinary incontinence had 
similar percentages at 2 years.  It is worth noting that men who had ERBT reported a 
higher prevalence of pretreatment incontinence.  Bowel dysfunction (e.g., bowel urgency, 
incontinent hemorrhoids) was common among men undergoing ERBT (Potosky et al., 
2004). 
Steineck and colleagues (2002) compared the QOL between men treated with 
radical prostatectomy and watchful waiting.  Data on QOL in men with localized prostate 
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cancer who participated in a large population based cohort study were analyzed.  Three 
hundred and twenty six men were included in the study.  Findings suggested that erectile 
dysfunction was reported by men treated with radical prostatectomy (80%) and men who 
were following watchful waiting (45%).  Urinary leakage (49% and 21%) and urinary 
obstruction (28% and 44%) were also reported, respectively.  There were no differences 
in bowel function, anxiety, depression, well-being, and QOL between the two groups.  
Findings from this study suggested that there may be a difference in the treatment side 
effects between watchful waiting and surgery.  However, there were no differences in 
wellbeing or QOL as shown in the 4 year follow up of the study (Steinek et al., 2002). 
In a comparison of the effects of radical prostatectomy (n = 1,156) and ERBT (n 
= 435) on urinary, bowel, and sexual functions on QOL, Potosky and colleagues (2000) 
conducted a 2-year follow-up study.  Men ages 55 to 74 years old and newly diagnosed 
with prostate cancer who underwent one of the two treatments were recruited to 
participate in the study.  Men who had radical prostatectomy were more likely to be 
incontinent (9.6% vs. 3.5%, p < .001) and be impotent (79.6% vs. 61.5%, p <.001).  
There was a significant decline in sexual functioning in both groups from before to after 
the procedure.  However, men who underwent radiation therapy reported having a 
significant decline in bowel function.  There was no significant difference in the health 
related QOL outcomes between the two groups (Potosky et al., 2000).   
Chen, Clark, and Talcott (2009) reported QOL outcomes of 409 patients 36 
months after radical prostatectomy, external beam radiation, and brachytherapy.  
Findings showed that the greatest increases in erectile dysfunction were found in men 
with normal baseline function.  Men with poor baseline urinary obstruction or irritation 
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reported an improvement in their symptoms after treatment, especially surgery.  Findings 
from this study compared patient outcomes to baseline functional status.  This 
comparison helps explain the impact of prostate treatment according to the specificity of 
each man’s condition.  Results highlight the importance of baseline functioning on 
patient outcomes up to 36 months after treatment (Chen et al., 2009). 
 To explore the uncertainty, anxiety, and the health related QOL and affective 
QOL in men who underwent watchful waiting, a descriptive study was conducted with 21 
men diagnosed with prostate cancer.  The age range of men in this study was 65 to 85 
years (M = 76, SD = 6.71) who were diagnosed with prostate cancer for an average of 4.5 
years (SD = 33.89 months).  Correlational analyses between anxiety, uncertainty, and 
danger appraisal as independent variables and health related QOL were not significant.  
Hierarchal regression analysis showed that uncertainty explained 36% of the variance in 
affective QOL.  Adding anxiety and uncertainty to the model explained 60% of the 
variance.  Danger appraisal played a mediating effect between uncertainty and affective 
health function of QOL (affective health function is one of the domains measured in 
health-related QOL).  Affective health function was the only QOL domain significantly 
related to the independent variables.  Findings from this study suggest that men engaging 
in watchful waiting as a treatment for prostate cancer were uncertain.  Uncertainty 
contributes to their perception of danger and influences affective QOL.  Despite the small 
sample, findings support the uncertainty experienced by men with watchful waiting as a 
treatment (Wallace, 2003).  Generalization of these findings cannot be made, but the 
effect of uncertainty on QOL in men with prostate cancer is suggested. 
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 A qualitative study to explore the influence of erectile dysfunction on men who 
had undergone definitive treatment for early nonmetastatic prostate cancer was conducted 
using seven focus groups.  A total of 48 men treated for early prostate cancer for 12 to 24 
months were included in the study.  Men’s experiences and QOL concerns related to 
prostate cancer and its treatment were discussed in the semistructured interviews.  The 
extracted themes identified the impact of sexual dysfunction on the QOL in these men.  
Four themes were identified:  the qualities of sexual intimacy; everyday interactions with 
women; sexual imagining and fantasy life; and men's perceptions of their masculinity.  
Discussions suggested that sexual dysfunction had an effect on the men’s intimate 
relationships and the way they perceived themselves as sexual beings (Bokhour, Clark, 
Inui, Silliman, & Talcott, 2001). 
Korfage and colleagues (2006) explored the discrepancy between levels of 
erectile, urinary, or bowel dysfunctions and generic QOL scores.  In a qualitative study to 
explore men’s perceptions of the side effects of prostate cancer treatment, 33 men were 
interviewed using a semistructured guide.  Eighteen interviews were conducted asking 
men about their health and how it was affected by prostate cancer.  The aim of the study 
was to further explore findings from a quantitative study that suggested high QOL scores 
despite the high prevalence of side effects (i.e., sexual, urinary, and bowel dysfunctions).  
The participants were randomly assigned to two groups.  The first group was interviewed 
to determine if the shift in responses was the result of their adaptation of health change.  
The second group explored the possibility of generic measures being insensitive to 
changes in health status after the treatment of prostate cancer.  Findings from this study 
suggested that age of men in the sample influenced the degree of considering the side 
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effects to be a major issue affecting their health.  Men in their 70s accepted their sexual 
dysfunction and considered being alive a priority for them.  Urinary incontinence was 
considered more of an issue since it made them dependent on others.  Older age of men 
contributed to their acceptance of sexual dysfunction as a side effect of prostate cancer.  
The rationalization of old age and aging process was used by men to help accept their 
condition.  Men talked about getting used to their problems.  They explained side effects 
in terms of a consequence or inconvenience that resulted from a life saving procedure.  
However, when they compared themselves to other men in their 70s age category, they 
were thankful to be rather healthy.  Trying to adapt to their situation and the 
corresponding changes in their life was their main focus.  Since they perceived these side 
effects would accompany them for a long time, men were trying to accept their new 
condition.  As a result, they did not consider impotence and urinary leakage as health 
problems and therefore scored higher on the health related QOL measure (Korfage et al., 
2006).  Findings from this study showed that men with prostate cancer symptoms may 
reach acceptance of their conditions.  However, the study was conducted in the 
Netherlands, and findings may not be applicable in different cultures and settings.   
In summary, the diagnosis of prostate cancer has inevitable side have side effects 
of sexual dysfunction and urinary incontinence (Penson et al., 2008; Potosky et al., 2000; 
Stanford et al., 2000; Wilt et al., 2008).  These side effects affect men’s sexuality and 
QOL (Penson et al., 2003).  Research that has used data from the Surveillance, 
Epidemiology, and End Results (SEER) registries has shown that sexual dysfunction 
contributed to a decline in QOL irrespective of the treatment choice (Penson et al., 2003).  
Other studies have highlighted the impact of different prostate cancer treatments on 
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sexual and urinary function and the consequent effect on QOL.  For example, Howlett et 
al. (2010) indicated that here was a significant change in depression and QOL scores 
between before and after radiation therapy in men without sexual problems.  Changes in 
sexual function affected physical, psychosocial, and social wellbeing of men on the QOL 
scale (Howlett et al., 2010).  Sanda and colleagues (2008) also reported that men who 
underwent brachytherapy and radiotherapy reported having low QOL.  Men’s QOL was 
found to be associated with satisfaction with the spouse or partner (Sanda et al., 2008).  
In this study, African American men had lower satisfaction with the overall treatment 
outcomes.  Also, older age was associated with worse sexual functioning (Sanda et al., 
2008).  Men who opted to undergo watchful waiting for prostate cancer progression were 
found to be uncertain due to perceptions of danger that may affect their health; therefore, 
their QOL was affected (Wallace et al., 2003). 
As a result of side effects, men’s sexuality is compromised due to the decreased 
sexual abilities.  Thus, men feel distressed and try to maintain their perceived socially 
constructed and expected role (Chapple & Ziebland, 2002; Gray et al., 2002; Hawkins et 
al., 2009).  Men strive to save their personal image as a man and try to maintain their 
image in front of their partner (Wall & Kristjanson, 2005).  Consequently, their 
masculinity and partner relationships are challenged and their QOL may be affected 
(Burns & Mahalik, 2006; Chapple & Ziebland, 2002; Fergus et al., 2002).   
Studies have not examined the contributions of age, ethnicity, treatment side 
effects (i.e., sexual dysfunction and urinary incontinence), masculinity, and men’s 
perception of their partner relationship together for their independent and combined 
contribution to QOL in men with prostate cancer.  Studies have examined the 
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contributions of these variables independently (Burns & Mahalik, 2006; Chapple & 
Ziebland, 2002; Fergus et al., 2002; Penson et al., 2008; Potosky et al., 2000).  Also, 
masculinity has mostly been studied using qualitative research designs (Hawkins et al., 
2009; Gray et al., 2002; Oliffe, 2005).  Likewise, the majority of studies have been 
conducted with samples that were predominantly Caucasian or nonHispanic White men.  
With Miami, Florida hosting a large Hispanic and Latin American community that 
emphasizes the values of machismo, examining QOL in men with prostate cancer society 
will contribute to the literature and to the quality of healthcare.   
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CHAPTER III 
RESEACH DESIGN AND METHODS 
Design 
This study used a cross-sectional design to examine the contributions of age, 
ethnicity, sexual dysfunction, urinary incontinence, masculinity, and perception of 
relationship with the partner on QOL in men diagnosed with prostate cancer.  The cross-
sectional design is used to capture data about men with prostate cancer at one period of 
time.  This method is appropriate for studies whose purpose is to describe the status of a 
phenomena or relationships between concepts at one point in time (Polit & Beck, 2012).  
In this study, the purpose was to examine relative contributions of age, ethnicity, sexual 
dysfunction, urinary incontinence, masculinity, and perception of the relationship with 
the partner on the quality of life in men diagnosed with prostate cancer.  Thus, a cross-
sectional design was appropriate for the purpose of the study.  Men with prostate cancer 
were recruited by the principal investigator (PI) who has had clinical experience working 
with oncology patients. 
Setting 
 Men diagnosed with prostate cancer were recruited from four urology clinics in 
Miami and Broward counties in FL.  Potential participants were identified by staff at the 
clinics and support groups.   
Clinic 1 is a urology clinic that provides excellent urologic care to residents of 
south Florida and the surrounding region.  The clinic physicians treat patients with a 
variety of urologic disorders such as kidney stones, benign prostatic hyperplasia (BPH), 
prostate cancer, bladder cancer, urinary incontinence, sexual dysfunction, and recurring 
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urinary infections.  Clinic physicians diagnose and treat around 300 men with prostate 
cancer annually using surgery, hormonal therapy, and watchful waiting.  Clinic 2 is a 
clinic that delivers quality and innovative urologic care since 1968.  The clinic physicians 
care for patients with infections, urinary incontinence, male sexual dysfunction (i.e., 
impotence), male infertility and minimally invasive surgery (MIS) of the urinary tract.   
More than 250 men with prostate cancer are annually cared for at the clinic. 
Clinic 3 is known for their latest innovative urologic procedures and diagnostic 
Studies include robotic and laparoscopic surgery, laser prostate surgery, flexible 
uretersoscopy, minimally invasive incontinence correction surgery, and nerve-sparing 
prostatectomy.  The physicians at the clinic attend to a diverse population with urinary 
symptoms, prostate cancer, kidney stones, urinary incontinence, erectile dysfunction, 
bladder cancer, kidney cancer, testicular cancer, urinary tract infections, infertility, and 
vasectomy.  The clinic serves more than 200 men with prostate cancer yearly.  Clinic 4 is 
a clinic that provides care for patients with a multitude of urologic symptoms and 
diseases.  The clinic also has a new procedure, Evolve Laser of the Prostate.  Around 200 
men with prostate cancer are estimated to be cared for by this clinic each year.  These 
clinics are considered to be major centers in South Florida, and they both serve a 
multicultural patient population that mirrors the population of Miami and includes 
Hispanics (e.g., Cuban, Columbian, Venezuelan, Chilean, Peruvian), African Americans, 
Caribbean, Haitians, Caucasians, and men from other ethnicities. 
Sample 
Men diagnosed with prostate cancer who self-identified as being heterosexual and 
partnered were recruited for participation in the study.  Men self who identified 
141 
themselves as men who have sex with men were excluded for the purpose of this study.  
Gay men have been identified to have a different experience with decreased sexual 
functioning and relationships with partners (Blank, 2005).  Men in the sample were 
required to be English or Spanish speaking and able to communicate with the researcher 
and research assistants as well as read and respond to the study instruments.  Study 
instruments and the consent form were available in English and Spanish according to the 
preference of the participant.  The duration since the diagnosis or treatment and the 
length of the relationship with the partner was not specified in the inclusion criteria in 
order to not limit the number of men eligible for participation in the study.  Men with 
erectile dysfunction, urinary incontinence, or bowel dysfunction due to reasons other than 
prostate cancer were excluded from the study.  
Power Analysis 
 Power analysis was conducted for study analyses used G*Power 3.1 (Faul, 
Erdfelder, Lang, & Buchner, 2007).  G*Power is a statistical program used for a priori 
and post hoc analysis (Faul et al., 2007; Faul, Erdfelder, Buchner, & Lang, 2009).  A 
priori sample size estimation is essential to determine an adequate sample size for a 
specific statistical analysis (i.e., correlational analysis, regression analysis) (Cohen, 1988; 
Cohen, Cohen, West, & Aiken, 2003).  For this study, power analysis based on regression 
analysis to answer research question two was conducted with effect size of .15 (i.e., 
medium effect), power of .80, and five predictors (Cohen, 1988).  Pearson r correlation 
and Chi Square analysis were conducted to answer research question one.  A priori 
analysis to determine the adequate sample size needed to conduct correlation analysis 
using t test family with five variables was computed.  Effect size was identified to be .3 
142 
(i.e., medium effect) with a desired power of .80 and significance level set at .05.  A 
sample size of 64 men was identified to be adequate for the analysis.  This was also 
similar to conducting Chi Square analysis with two variables.  A sample of 92 men was 
identified to be adequate to conduct regression analysis.  Significance level (i.e., alpha) 
was set at .05.  Moderate effect sizes were selected since the instruments used to measure 
the variables are valid, reliable, and have been widely used.  Therefore, it is anticipated 
that these instruments will be able to measure each of the identified concepts 
appropriately (Mertler & Vannatta, 2013).  Due to the sensitivity of the subject, it was 
projected that 25% of the surveys may not be completed or returned.  As a result, a total 
sample of 123 men meeting the inclusion criteria of the study was recruited.  A total of 
107 men completed the study questionnaires, hence rendering the response rate to be 
87%. 
At the end of the study, post hoc analysis was conducted to determine the actual 
power attained.  Post hoc analysis to conduct correlation analysis using t test family with 
five variables was computed and a sample of 107 men living with prostate cancer; effect 
size was identified to be .3 (i.e., medium effect), and significance level set at .05.  The 
power was 0.94.  This was also similar to conducting Chi Square analysis with two 
variables.  A power of 0.87 was identified in the post hoc analysis for regression analysis 
with significance level set at .05 and five predictors.   
Pilot  
The study instruments were available in English and Spanish according to the 
preferences of the participants.  The English and Spanish versions of the instruments have 
been used and validated.  The psychometric properties of the instruments have been 
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published.  The validity and reliability of the instruments will be discussed in a later 
section.  The majority of the Spanish versions of the instruments were validated in 
Hispanic populations in the South West and North East of the United States where the 
Hispanic community is predominantly Mexican or Puerto Rican.  However, the Hispanic 
population in Miami is predominantly Cuban, Columbian, and other Caribbean and Latin 
American ethnicities.  In order to ensure the comprehension and legibility of instrument 
items during the study, a pilot study including five men who resided in the community 
and who met the eligibility criteria was conducted.  Also, the pilot provided information 
about the estimated amount of time needed to complete the instruments. 
The pilot study participants were asked to read the demographic form and study 
instruments and identify understandability, clarity, and cultural appropriateness of the 
items.  These participants were required to identify items that may not be understood.  
The results of the pilot were reviewed by the principle investigator (PI) as well as 
dissertation chair and committee.  Based on findings from the pilot study, modifications 
were made.  The purpose of the pilot study was to ensure the cultural and linguistic 
appropriateness of the Spanish version of the study questionnaire. 
Sampling and Recruitment   
Writings about the recruitment of men in research studies has discussed the 
experiences of researchers and addressed issues to be considered when designing a men’s 
health study.  Yancy, Ortega, and Kumanyika (2006) discussed recruitment strategies that 
include mass mailing to African American men especially men of middle to higher 
socioeconomic status.  The authors did not support population based sampling since it 
was reported to produce insufficient samples from required ethnic minorities.  
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Community involvement survey responses were found to be effective when followed 
with telephone follow up with African American men.  Cultural adaptation of the 
recruitment strategies was the utmost important consideration that encouraged men to 
participate in studies (Yancy et al., 2006).  Cultural adaptation of recruitment strategies 
and cultural sensitivity were also discussed by Woods, Montgomery, and Herring (2004).  
The authors emphasized the importance of understanding the acceptable language, 
terminologies, and approach to the concepts being studied.  For example, for this study, 
sexual dysfunction and prostate cancer are considered to be sensitive topics to men in 
general and Hispanic men in specific.  Therefore, recruitment strategies refrained from 
referring to participants as having sexual or prostate problems in order to encourage men 
to participate in the study without being identified as having a condition that would affect 
their masculine image.  S. G. Jones and colleagues (2011), on the other hand, emphasized 
the importance of conducting focus groups and discussions with men who met eligibility 
criteria to share the appropriate recruitment strategies.  Their discussion was generally 
focused on the recruitment of Hispanic men in a sexual behavior study.  Recruitment 
from urology or specialized clinics and clinicians was also advised.  The length of the 
survey and the appropriate incentives were important considerations (S. G. Jones et al., 
2011).  Word of mouth was also considered to be a successful strategy in the recruitment 
of African American men (Jones, Richard, & Ishan, 2009). 
As a result, the strategies for the recruitment of men for this study included 
primarily collaborating with urology clinics, support groups, physicians, and clinicians to 
identify potential participants.  The support of the main physicians at the urology clinics 
and support groups encouraged men to participate in the study.  The support of the 
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physicians, nurses, nurse practitioners, physician assistants, and clinic staff, figures of 
authority was thought to provide trust and confidence to men and therefore increased the 
likelihood of their participation in the study.  The recruitment material referred to the 
study as the “Men’s Health Study” (S. G. Jones et al., 2011).  Meetings and 
communication with the PI, dissertation chair, and committee members included 
discussions of the effectiveness of strategies for recruitment of study participants.  
Accordingly, strategies were maintained and modified to reach the recommended sample 
size within the allotted time frame. 
Meetings were conducted at the clinics and support group meeting places to 
explain the objectives and procedure of the study to the physicians and staff.  The 
purpose of these meetings was to familiarize the physicians and staff with the study to 
support the PI by referring potential participants.  Potential participants were referred to 
the PI from the pool of men attending these clinics and support groups.  These 
participants were diagnosed and treated for prostate cancer prior to participating in the 
study.  The PI then contacted the potential participants to recruit them for the study and 
secure their informed consent.  After the informed consent was obtained, data were 
collected from men using paper and pencil questionnaires with the study instruments.  To 
ensure confidentiality of participants, a private room/office was provided at each of the 
clinics for men to be able to conveniently and privately complete the study instruments.  
Data regarding disease stage and treatment were collected using a demographic data form 
that was provided to the participants with the study instruments. 
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Procedure 
Institutional Review Board (IRB) approval for the study was obtained from 
Florida International University (FIU) to ensure ethical standards were met.  Letters of 
support were obtained from the clinics and support groups.  Informed consents included 
information about the study objectives and contact information for the researcher in 
addition to potential risks and benefits of the study based on the FIU IRB policies and 
procedures.  The PI and dissertation chair completed the required human subjects’ 
research training.  Research assistants were also required to complete the required human 
subjects’ research training (i.e., CITI). 
Men with prostate cancer were referred to the PI as potential study participants by 
staff at the urology clinics and support groups.  The clinic staff distributed study flyers 
with the name of the study, the PI, and contact information in case the potential 
participants wanted to contact the PI.  The PI met potential participants at the urology 
clinics and support group meeting sites and introduced the “Men’s Health Study” as well 
as explained the study objective, procedure, and potential risks and benefits.  The PI 
screened the men for eligibility and asked them about their interest in participating in the 
study.  Men who elected not to participate in the study were thanked and ensured that 
their decision would not affect the course of their treatment at the clinic.  No further 
contact with these men was made.  Men who choose to participate in the study and who 
met the eligibility criteria met with the PI in a private room.  Men at the clinic who 
learned about the study from flyers and clinic staff were also approached by the PI.  The 
PI screened the men for eligibility and explained the study objective, procedure, and 
potential risks and benefits.  The same procedure was followed thereafter. 
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The clinic staff was informed about enrollment of potential participants to 
facilitate the arrangement of a room for the identified appointments.  At the clinic, a quite 
room was provided for the PI and the participant to ensure privacy and confidentiality.  
The study objectives, purpose, procedure, benefits, and potential risks were reviewed 
with the potential participant.  The informed consent was read to the potential participant.  
After reading and explaining the informed consent to the potential clients, the PI assessed 
the client’s understanding of the purpose of the study.  The client was asked to describe 
or answer specific questions about the risks, anticipated benefits, research purpose, and/ 
or voluntariness issues.  This was thought to assess the client’s ability to give informed 
consent.  If the PI suspected that the potential participant had problems understanding 
consent-related issues, the participant was not enrolled in the study for a potential 
impaired ability to consent.  Ensuring the participant’s ability to demonstrate an adequate 
level of understanding of the consent is paramount to comply with research ethics 
standards (U.S. Department of Health and Human Services, 2009). 
The study questionnaire was provided to participants after the informed consent 
form was signed.  The study questionnaire included a demographic data form, the  
University of California Los Angeles Prostate Cancer Index (UCLA PCI), Conformity to 
Masculine Norms Inventory (CMNI), Dyadic Adjustment Scale (DAS), and Quality of 
Life (Short Form Health Survey version 2.0 [SF36v2]) instruments.  Men were asked to 
return the completed questionnaire to a sealed box.  If men needed assistance reading the 
questionnaire items, the PI read the items and wrote participants' answers to the items.  
Participants were asked not to include their names or any identifiers on the study 
questionnaire.  Questionnaires and informed consent were available in English and 
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Spanish depending on the language of preference of participants.  Data about the disease 
(i.e., stage of the tumor, PSA levels, Gleeson score, treatment option, and presence of co-
morbidities) were collected as part of the demographic data form.  
It was estimated that the data collection process required 20 to 30 minutes to be 
completed.  Participating men were allowed time for breaks during data collection to 
ensure comfort and completion of the process.  Data collection in the urology clinic 
before and during the waiting time of the appointment facilitated the process for 
participating men.  Men recruited from the support groups completed the questionnaires 
after the completion of the meeting.  The clinic and support groups were considered to be 
safe and comfortable environments that would help men be at ease when completing 
sensitive questions about sexual dysfunction, urinary incontinence, masculinity, partner 
relationship, and QOL.  The presence of the PI during data collection allowed 
participants to ask questions and clarify items of the questionnaire.  Upon completion, the 
participants returned the questionnaires to a sealed box that was emptied weekly by the 
PI.  This was thought to promote comfort and maximize confidentiality. 
Participation in the study posed a minimal risk for men.  A potential risk was the 
psychological distress that may be experienced by men as a result of sensitivity of the 
concepts included in the questionnaires.  Men were provided with a list of resources for 
psychological assistance and counseling in the Miami and Broward metropolitan areas.  
The questionnaires were self administered and therefore could be completed by men 
without the presence of the PI.  Therefore, the list of resources was included as part of the 
package that included the consent form and questionnaires.  During the recruitment 
process, the PI discussed the resource list in case psychological assistance was needed.  
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Also, the PI is an experienced nurse in the caring for oncology patients and cancer 
survivors who has undergone training regarding working with this population. 
 Due to the nature and scope of the study, there were no anticipated physical, 
social, or legal risks.  Breech in confidentiality was also prevented through the anonymity 
of the research packages, and data were kept in secure and locked files.  The informed 
consent was separated from the study questionnaires so as to preserve confidentiality.  
Protection against breach of confidentiality was ensured through use of identification 
numbers for each participant.  No names or information that would identify the 
participants were included in the return packages.  There was no list of participants or 
names of participants provided to the PI so as to ensure privacy and confidentiality.  The 
handling of the questionnaires and the data was solely by the PI and dissertation 
committee chair and members who have completed the CITI human subject training.  
Data entry and coding included identification numbers, and data were handled by the PI.  
Dissemination of the study findings included aggregate data and did not include any 
information that will reveal the identity of the participants.  Demographic data were 
presented in terms of frequencies and percentages for nominal level variables and 
descriptive statistics for ordinal and interval level variables. 
 The potential benefit of participating in the study was to broaden knowledge 
about the experience of men with prostate cancer from minority racial/ethnic groups.  
While answering the questionnaires, men may think about the issues related to their 
prostate cancer treatment, masculine norms, and relationships with their partners, and 
QOL.  These thoughts may encourage them to use the provided psychological resources 
to seek help or support.  The resources provided may also provide men with a venue to 
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enhance their QOL.  There was no projected harm that was anticipated from participation 
in the study. 
Measures 
 The study included five independent variables and one dependent variable.  The 
variables were measured using valid and reliable instruments.   
Independent Variables 
 The independent variables were age, ethnicity, sexual dysfunction, urinary 
incontinence, masculinity, and relationship with the partner.   
Demographic and Background Variables.  Demographic and background data 
were collected by items on participant age, race/ethnicity, SES, sexual history, time since 
diagnosis, relationship status (e.g., married, cohabitating), and relationship duration.  
Data were also gathered on education, employment status, and number of children, if 
applicable.  Data on the stage of the tumor, PSA levels, Gleeson score, treatment option, 
and presence of co-morbidities were collected as part of the demographic data form and 
were used to describe the sample.  Participants were also asked about sexual 
enhancement regimens with an item on the survey.   
Data on the presence of co-morbidities were collected, and the relationship 
between presence of co-morbidities and QOL was analyzed.  In case of the presence of a 
strong relationship, controlling for the presence of co-morbidities was considered.  
Patient-centered care provision was assessed using three questions in the demographic 
that asked about coming to the decision of treatment, degree of inclusion of patient 
preferences, and whether patient concerns were taken into consideration prior to making 
the treatment decision.  These data were used to further describe the sample.  
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Prostate cancer treatment side effects.  Prostate cancer treatment side effects 
(i.e., sexual dysfunction and urinary incontinence) were measured using the University of 
California Los Angeles Prostate Cancer Index (UCLA PCI) (Litwin et al., 1998). The 
majority of instruments used to assess prostate cancer treatment side effects also measure 
quality of life.  The European Organization for Research and Treatment of Cancer 
Quality of Life Questionnaire- Prostate Cancer (EROTC PR-25), Functional Assessment 
of Cancer Therapies- Prostate (FACT-P), Expanded Prostate Cancer Index Composite 
(EPIC), International Prostate Symptom Score (IPSS), and International Index of Erectile 
Function (IIEF) have been used to assess sexual dysfunction and urinary incontinence in 
men with prostate cancer.  EROTC PR-25 is a 25-item instrument that assesses erectile, 
bowel, and urinary function, however it has not been widely used.  FACT-P is a 34-item 
questionnaire that assesses weight loss, role, erectile, and lower urinary tract symptoms 
after prostate cancer; however, the measure may not be sensitive to early prostate cancer 
symptoms.  EPIC is a 50-item instrument that measures prostate cancer treatment side 
effects and is considered to be an expanded version of the UCLA PCI.  IPSS and IIEF 
measure erectile function and lower urinary tract symptoms (i.e., storage, voiding, post 
micturition) without assessing the relationship with the quality of life of men.  UCLA 
PCI is one of the most widely used instrument that has been translated and validated in 
Spanish. 
UCLA PCI is composed of 15-items that assess outcomes of men with prostate 
cancer in three domains: urinary function, bowel habits, and sexual function.  The items 
are rated on 3 or 5-point Likert scales (i.e., there are different ratings for each question).  
The overall score ranges from 0 to 100, and the higher the score, the better the identified 
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health status.  The test-retest reliability estimates of the urinary and sexual functioning 
subscales over a 2 week period were reported to be .93 and .92, respectively.  The 
internal consistency estimates of the subscales were .87 and .93, respectively (Litwin & 
McGuigan, 1999).  Construct validity was also supported for the English version of the 
scale by correlating the results with other well established quality of life scales (Litwin & 
McGuigan, 1999).  The instrument was also successfully tested for its responsiveness to 
changes in QOL in men with prostate cancer (Bergman, Saigal, Kwan, & Litwin, 2010).  
Studies have used the UCLA PCI to measure the extent of symptom bother (Weber et al., 
2007) and health related QOL (Anger et al., 2007) of men with prostate cancer.  The 
UCLA PCI was translated into Spanish and validated on a sample of men (n = 100) 
recruited from Hialeah, Florida.  The majority of men were born in Puerto Rico or Cuba 
in addition to other Latin American countries and Spain.  Reliability estimates 
documented that kappa was at least .81 for all items.  The items related to health and 
social interactions showed poorer reliability estimates.  The authors explained the poor 
reliability of these items to be related to the fact that men participating in the study were 
in good health and socially active (Krongrad et al., 1997).  Findings from study indicated 
favorable reliability estimates for the English and Spanish versions.  The authors 
suggested that the sample included a variety of Spanish dialects and therefore the 
instrument may be used with Spanish speaking men from a variety of Latin American 
countries (Krongrad et al., 1997).   
Masculinity.  The Conformity to Masculine Norms Inventory (CMNI) was used 
to measure masculinity.  Other instruments that have been used to measure masculinity in 
other studies are Bem Sex Role Inventory, Macho Scale, Gender Role Conflict Scale, 
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Eisler’s Gender Role Stres Scale, Brannon Masculinity Scale, Male Role Norms Scale, 
Male Role Norms Inventory.  The Bem Sex Role Inventory and the Macho scale assess 
masculinity in a unidimensional manner without focusing on the complex and 
multidimensional nature of the concept.  The other instruments measure conflicts with 
masculinity and did not focus on the perception and adherence to masculine norms.  
CMNI was devised by Mahalik and colleagues (2003) to measure the socially 
constructed norms and the conformity of men to masculine behaviors.  The original 
multidimensional tool consisted of 94 items and 11 subscales (i.e., winning, emotional 
control, risk-taking, violence, dominance, playboy, self reliance, primacy of work, power 
over women, disdain for homosexuals, and pursuit of status) that measure conformity to 
masculine norms.  The items scales are answered on a 4-point Likert scale ranging from 0 
(strongly disagree) to 3 (strongly agree).  Scores on the inventory range from 0 to 282 
with higher scores indicating higher conformity to norms of masculinity.  Internal 
consistency estimates for the original tool were .72 to .91 for the subscales and .94 for the 
total scale.  Test-retest reliability estimates over a 2 to 3 weeks period ranged from .75 to 
.95 for the subscales and .96 for the total inventory.  Validity was also examined using 
exploratory factor analysis (Mahalik et al, 2003).   
Permission for the use of this tool was secured from the author.  This author also 
has a short version of the CMNI that includes 22 items which was used in this study.  The 
CMNI was used to examine the conformity of masculine norms and health related 
behaviors with men with spinal cord injury (Schopp, Good, Mazurek, Barker, & Stucky, 
2007), traumatic brain injury (Schopp, Good, Barker, Mazurek, & Hathaway, 2006) and 
perceived normative health behaviors (Mahalik, Burns, & Syzdek, 2007).  This tool was 
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used to measure masculinity in adult men with prostate cancer.  The details of the studies 
have been previously discussed in the literature review.  The CMNI was translated to 
Spanish; however, the psychometric estimates for the Spanish version have not been 
published. 
Relationship with partner.  Relationship with partner was measured using the 
Dyadic Adjustment Scale (DAS), a 32-item self report instrument (Spanier, 1976).  Other 
instruments that measure relationship with the partner considered include the 
Multidimensional Relationship Questionnaire (MRQ) and Measure for Marital 
Satisfaction (MMS).  However, the decision to use the DAS was based on the fact that 
the majority of cancer studies have used this instrument for assessing the relationship 
with the partner. 
The DAS has been used with married and cohabitating couples; thus, it is 
appropriate for this study of partnered men irrespective of their marital status.  It 
measures the relationship satisfaction using four subscales: satisfaction, cohesion, 
consensus, and affectional expression.  The items are scored on a 6-point Likert scales 
ranging from 0 to 5 with variable anchors.  Total scores range from 9 to 151 where a total 
score below 100 indicates marital distress and higher score reveal better relationship 
functioning (Spanier, 1976).  Cronbach’s alpha internal consistency for the total scale 
was reported to be .92, and internal consistency estimates for the subscales ranged from 
.73 to .94 (Spanier, 1976).  The DAS has been used to measure the quality of a dyadic 
relationships in many populations including patients with prostate cancer (Badr & 
Carmack Taylor, 2009; Banthia, Malcarne, Varni, Ko, Sadler, & Greenbergs, 2003; 
Wootten et al., 2007).  The DAS was translated to Spanish and validated on a sample of 
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Hispanic Americans in Miami (n = 78).  The internal consistencies were reported to rage 
from .67 to .93, and test retest estimates after 2 weeks ranged from .79 to .87.  Also, there 
were  high correlations between the English and Spanish versions (.91 to .99) 
(Youngblut, Brooten, & Menzies, 2006).   
Dependent Variable 
 The dependent variable was quality of life of men with prostate cancer.   QOL in 
men with prostate cancer was measured using the 36-item Short Form Health Survey 
version 2.0 (SF-36v2) that measures the overall health status, functional status, and health 
related QOL (Ware, Kosinski, & Dewey, 2000; Ware, Kosinski, & Gandek, 2000).  The 
Expanded Prostate Cancer Index Composite (EPIC), EROTC-PC, FACT-P, Prostate 
Cancer-specific Quality of Life Instrument (PROSQOLI), Prostate Cancer Treatment 
Outcomes-Questionnaire (PCTO-Q), Patient Oriented Prostate Utility Scales (PORPUS), 
Prostate Cancer Related Quality of Life, and Prostate Cancer- Quality of Life (PC-QOL) 
are other instruments that were used to measure QOL in men with prostate cancer.  The 
SF 36v2 is a widely used instrument that measures QOL providing information about the 
physical and mental health functioning of men with prostate cancer. 
SF-36v2 includes eight subscales: physical functioning, role physical, bodily pain, 
general health perceptions, vitality, social functioning, role emotional, and mental health 
(Ware, Kosinski, & Dewey, 2000; Ware, Kosinski, & Gandek, 2000).  These subscales 
include physical and mental health component summary measures.  The SF-36 was 
developed using concepts from the Medical Outcomes Study that represent the major 
concepts used in health surveys and affected by disease and treatment (Stewart & Ware, 
1992; Ware, 1995). 
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The SF-36 version 2.0 is an enhanced version of the survey that was documented 
to be simplified with shortened items.  The instrument was shown to have greater 
comparability between the translated versions and demonstrated good cultural 
adaptations (Ware et al., 2000).  The SF-36 is available in standard (i.e., 4-week) and 
acute (i.e., 1 week) recall (Ware et al., 2000).  The standard version was used for this 
study.  The SF-36v2 consists of 36 items that are scored on a 5-point Likert scale with the 
exception of the physical functioning subscale that is scored on a 3-point Likert scale 
(Ware et al., 2000).  The overall score ranges from 0 to 100 in which higher scores 
indicate better health status and QOL (Ware et al., 2000).   Factor analysis confirmed the 
two components of physical and mental health accounting for 80% to 85% of the 
reliability variance in the eight subscales (Ware, Kosinski, & Keller, 1994).  The physical 
functioning, role physical, and bodily pain subscales were found to be highly correlated 
with the physical component, thus contributing mostly to the physical component score 
(Ware, Kosinski, & Keller, 1994).  The mental health, role emotional, and social 
functioning subscales were highly correlated with the mental health component measure.  
The vitality, general health perceptions, and social functioning were correlated with both 
components.  Thus, the physical functioning, role physical, bodily pain, and general 
health subscales compose the physical health summary component.  The vitality, social 
functioning, role emotional, and mental health subscales compose the mental health 
summary component.  Reliability estimates for the physical and mental health 
components were .80 (Ware et al., 1993) and .90 (Ware, Kosinski, & Keller, 1994), 
respectively.  Reliability estimates for the subscales were also reported to be at least .80 
for all the subscales except for the social functioning subscale that showed to have a 
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reliability of .76 (Ware et al., 1993).  Test- retest estimates over a 2 week period showed 
correlation coefficients at least .80 on all dimensions (Ware et al., 2000).  The SF-36v2 
has been used to measure QOL in men with prostate cancer (Hegarty, Wallace, & 
Comber, 2008; Mikhail et al., 2006; Shikanov et al., 2008).  The Spanish SF-36 was 
validated with ay group of elderly Mexican Americans (n= 65).  Internal consistency 
reliability estimates were .80 or above on all scales except social functioning (r = .69) 
(Bennett & Riegal, 2003).    
Table 1 
Major Study Variables 
 
Core Measure 
 
Brief Description 
 
Author 
 
Demographics 
 
Demographic and background data. 
 
Ballout, S. (2013) 
 
Prostate cancer 
treatment side 
effects 
University of California Los Angeles 
Prostate Cancer Index (UCLA PCI) 
measures prostate cancer treatment side 
effects: sexual, urinary, and bowel 
functioning and bother. 
 
Litwin et al., 1998 
Masculinity Conformity to Masculine Norms Inventory 
(CMNI) measures the socially constructed 
norms and the conformity of men to 
masculine behaviors. 
Mahalik et al., 2003 
Relationship with 
partner 
Dyadic Adjustment Scale (DAS) measures 
relationship satisfaction.   
Spanier, 1976 
Quality of life Short Form Health Survey version 2.0 (SF-
36v2) measures the overall health status, 
functional status, and health related QOL. 
 
Ware, Kosinski, & 
Dewey, 2000 
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Data Management 
Study packets were prepared by the PI to include an informed consent, 
questionnaires (i.e., demographic data form, UCLA PCI, CMNI, DAS, and SF36v2 
instruments), and list of resources.  The questionnaires were labeled with the participant’s 
identification number on each page.  The packets were prepared before data collection 
sessions with potential participants; however, the PI ensured completeness of the 
questionnaire and packet at each session. 
A code book identifying codes for responses and missing values was created by 
the PI to facilitate the coding of the information obtained.  The code book was completed 
prior to initiating of data entry.  Data were entered into SPSS 18.  Data were reviewed by 
the PI continuously to minimize data entry errors.  Examination of frequencies, 
histograms, and descriptive statistics were used to identify data entry errors, missing data, 
and outliers for demographic data and all study instruments.  Discrepancies were 
managed by referring to the questionnaires.  Prior to initiation of data analysis, specific 
items were recoded as indicated by the instrument tutorial or as appropriate to conduct 
the proposed statistical analyses.  Missing data were kept, and their corresponding cases 
were not deleted.  Missing values were coded as ‘9’ or ‘99’ in SPSS.  During analysis, 
listwise deletion was used for missing data (Mertler & Vannatta, 2013).  Outliers were 
identified and cases may be deleted in order not to skew the results.  Outliers were 
identified in urinary functioning and were deleted.  Details about the management will be 
detailed in next chapter. 
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Data Analysis 
 Data analysis was conducted using SPSS 18.0.  Each interval level variable was 
assessed for normality using graphical and statistical analyses (Mertler & Vannatta, 
2013).  Linearity was also assessed as appropriate.  Assuming normality and linearity are 
basic assumptions for the conduct of multivariate analysis (Mertler & Vannatta, 2013).     
Sample description.  Frequency distributions, measures of central tendency (i.e., 
mean, median, mode), measures of variability (i.e., range, standard deviation), and 
inferential statistics were used to examine the demographic characteristics and major 
study variables. 
Reliability of instruments.  Internal consistency of the instruments (i.e., UCLA-
PCI, CMNI, DAS, SF36v2) were computed using Cronbach’s alpha (r) for the English 
and Spanish versions.  Internal consistencies were compared with the published values of 
the original tools. 
Research Question 1.  Is there a relationship among age, ethnicity, sexual 
dysfunction, urinary incontinence, masculinity, and perception of the relationship with 
the partner, and quality of life in self identified heterosexual and married/partnered men 
diagnosed with prostate cancer? 
Hypothesis 1.  There is a relationship between age, ethnicity, sexual dysfunction, 
urinary incontinence, masculinity, and perception of the relationship with the partner, and 
quality of life in self identified heterosexual and married/partnered men diagnosed with 
prostate cancer. 
Pearson Product Moment correlations (r) were used to examine the relationships 
between age, urinary incontinence, sexual dysfunction masculinity, perceived 
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relationship with partner, and quality of life.  These variables are continuous measures, 
and therefore Pearson r was the appropriate statistical test to identify relationships.  Chi 
square analysis was conducted to examine the relationship between ethnicity and quality 
of life since ethnicity is a nominal level variable. 
Research Question 2.  What are the relative contributions of age, ethnicity, sexual 
dysfunction, urinary incontinence, masculinity, and perception of the relationship with 
the partner on men’s quality of life in self identified heterosexual and married/partnered 
men diagnosed with prostate cancer? 
Hypothesis 2.  Age, ethnicity, sexual dysfunction, urinary incontinence, 
masculinity, and perception of the relationship with the partner will make independent 
and combined contributions to the quality of life of men diagnosed with prostate cancer. 
 Regression analyses was used to examine research question two to specify the 
independent and relative contributions of age, ethnicity, sexual dysfunction, urinary 
incontinence, masculinity, and perception of the relationship with the partner on QOL.  
Ethnicity was dummy coded (i.e., Hispanic and non-Hispanic) before being entered into 
the regression equation.  This decision was made since the sample mirrored the 
population in Miami and therefore was predominantly Hispanic.  Regression analysis is 
appropriate to explain the contribution of the five independent variables on the dependent 
variable (Mertler & Vannatta, 2013).  The correlational analyses used to answer the first 
research question provided information about multicollinearity and the degree of the 
relationships among the independent variables.   The F test was used to determine the 
strength of the relationships between the independent variables and the dependent 
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variable.  The regression coefficients (β) were used to identify the contribution of the 
independent variables to explain the dependent variable (Mertler & Vannatta, 2013). 
	    
162 
CHAPTER IV 
RESULTS 
The purpose of this study was to examine relative contributions of age, ethnicity, 
sexual dysfunction, urinary incontinence, masculinity, and perception of the relationship 
with the partner on the quality of life in men diagnosed with prostate cancer.  English or 
Spanish speaking heterosexual and partnered men diagnosed with prostate cancer were 
recruited from four urology clinics and two support groups in Miami and Broward 
counties in Florida.  Recruitment of participants was accomplished through close 
collaboration with the urology clinics and support groups.  A total of 117 men completed 
the self administered study questionnaire that included a demographic data form, the  
University of California Los Angeles Prostate Cancer Index (UCLA PCI), Conformity to 
Masculine Norms Inventory (CMNI), Dyadic Adjustment Scale (DAS), and Quality of 
Life (Short Form Health Survey version 2.0 [SF36v2]) instruments.   
Pilot 
English and Spanish versions of the study instruments and informed consent were 
available for participants to choose their preferred language.  The Conformity of 
Masculine Norms Inventory (CMNI) was not available in Spanish.  Hence, it was 
translated by two independent Spanish speaking nursing students who were born in Cuba 
and Colombia, respectively, and lived in Miami for more than five years.  Both translated 
versions were compared and a final Spanish CMNI version was agreed upon by an 
independent Spanish speaking experienced Cuban Nurse Practitioner.  A third graduate 
nursing student back translated the Spanish CMNI to English.  The back translation was 
compared to the original CMNI English version (Polit & Beck, 2012).  There were no 
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major differences in original and back translated English versions of the CMNI.  
Accordingly, the Spanish version of the CMNI was administered as part of the study 
questionnaire.  The informed consent was also translated from English to Spanish 
following the same procedure. 
A pilot test was conducted to validate the comprehension and legibility of the 
Spanish versions of the instruments.  The Hispanic population in Miami is predominantly 
Cuban, Venezuelan, Columbian, and other Caribbean and Latin American ethnicities; 
thus, it was deemed necessary to ensure understanding of the items of the questionnaires 
that have been validated with Hispanic populations who were primarily from Mexican or 
Puerto Rican origins.  Another purpose of the pilot was to identify the duration of time 
needed to complete the study instruments.   
A total of 10 Spanish speaking men (i.e., from Cuba, Columbia, Venezuela, and 
Dominican Republic) who met the inclusion criteria were recruited from the community.  
The pilot study participants read and answered the demographic form and study 
instruments.  The pilot participants suggested adding “Black Caribbean” as one of the 
ethnicity options.  The other demographic questions and study instruments were deemed 
understandable, clear, and culturally appropriate.  There were no items or questions that 
were considered to be offensive or written in a manner that was thought to be culturally 
inappropriate.  The 10 pilot participants took 20 to 35 minutes to complete the 
questionnaire.  After completing the pilot, the suggestion of the pilot participants was 
considered and “Black Caribbean” was added as one of the ethnicity answer options in 
the English and Spanish versions of the questionnaire.  Also, the average time needed to 
complete the questionnaire was added to the study material (i.e., flyer and cover letter) 
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and informed consent.  The average time needed to complete the questionnaire and the 
successful completion of the pilot phase was discussed during recruitment of research 
sites and study participants. 
Data Screening 
Prior to conducting the analysis, the data were screened for missing values and 
outliers, and tests were conducted to assess normality, linearity, and homoscedasticity.  
Data screening and exploratory data analysis aimed at ensuring the validity of the 
multivariate analyses to be conducted.  Frequency distributions and descriptive statistics 
for all variables were conducted to make sure that values did not lie outside the range of 
possible values in the case of continuous variables or coded values in the case of 
categorical variables.  The scores that fell outside the range of legitimate values were 
identified as missing values (Van den Broeck, Cunningham, Eeckels, & Herbst, 2005).  
Missing data were kept, and their corresponding values were coded as “9” or “99”, as 
appropriate.  During analysis, listwise deletion was used (Howell, 2009).  The data were 
assessed for presence of outliers.  There were no major outliers that required deletion of  
cases.   
Dummy coding was used for ethnicity; data were recoded into 0 (nonHispanic) 
and 1 (Hispanic) to conduct analyses to answer the research questions of the study.  
White/Caucasian, African American, and Black Caribbean ethnicities were considered to 
be nonHispanic.  White Hispanic and Black Hispanic were considered to be Hispanic. 
Using the scoring manuals of the instruments, variables were recoded and total values of 
the urinary functioning, sexual functioning, CMNI, DAS, and QOL were computed. 
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The assumptions of normality, linearity and homoscedasticity of the major study 
variables (i.e., age, dummy coded ethnicity, urinary functioning, sexual functioning, 
CMNI, DAS, and QOL) were assessed (Mertler & Vannatta, 2013).  Normality was 
explored by examination of the histogram of each variable.  Skewness and kurtosis 
coefficients for the major study variables (i.e., age, ethnicity, sexual function, urinary 
function, masculinity, relationship with partner, and QOL) were also examined.  Age, 
ethnicity, CMNI, DAS, and QOL showed negative skewness and kurtosis.  Skewness of 
all interval level major study variables lied within -1 and +1; where values ranged 
between -.37  for the CMNI and +.90 for urinary functioning.  Kurtosis for age, CMNI, 
DAS, DAS, and QOL lied with -1 and +1.  However, kurtosis values for urinary 
functioning and sexual functioning were 1.90 and 1.96, respectively.  Examination of the 
means and standard deviations (SD) of urinary functioning and sexual functioning scores 
showed that the SD was relatively high (urinary functioning M = 31.57, SD = 14.46; 
sexual functioning M = 32.95, SD= 12.38).  Scores for urinary functioning (n = 116) 
ranged between 5 and 82; 7 cases had scores below 10, and 4 cases had scores above 6.  
Scores for sexual functioning (n = 117) ranged between 0 and 69, and 6 cases were above 
60.  Examination of the Q-Q Plots of the variables confirmed the results of kurtosis.  
Therefore, the cases with extreme values were excluded and counted as missing values.  
The recoded variables were identified as urinary functioning 2 and sexual functioning 2.  
Urinary functioning 2 (n = 105, M = 31.58, SD = 10.61) had a positive kurtosis of .17 in 
addition to slight positive skewness.  Sexual functioning 2 (n = 111, M = 31.04, SD = 
9.48) had kurtosis of .64 and maintained slight negative skewness.  Urinary functioning 2 
and sexual functioning 2 were used for the analysis of the data from this point forward 
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and was referenced as urinary functioning and sexual functioning.  Normal Q-Q plots 
were observed for the other variables. 
Linearity was assessed by observing the scatterplots of the independent and 
dependent variables.  Scatterplots of age, ethnicity, urinary functioning, sexual 
functioning, CMNI, DAS, and QOL were inspected (Mertler & Vannatta, 2013).  The 
scatterplots showed nonelliptical shapes for all variable combinations.  To further 
investigate linearity, the standardized residuals were compared with the predicted values 
of the dependent variable (i.e., QOL).  The scatterplot of the standardized predicted 
values by standardized residuals and the normal P-P Plot was examined.  Hence, the 
assumptions of normality and linearity were met.  Homoscedasticity or homogeneity of 
variances were tested using Levene’s Test as part of the statistical analyses discussed 
below. 
Description of the Sample 
The sample ranged in age from 52 to 85 years with a mean age of 67.47 (SD = 
8.42) years (see Table 2).  More than half the sample identified themselves to be of 
Hispanic origin (n = 63, 54.3%).  The ethnic distribution mirrored that of South Florida 
where the most men identified themselves as White Hispanic (n = 39, 33.6 %), Black 
Hispanic (n = 24, 20.7 %), and Black Caribbean (n = 19, 16.4%).  The majority of men in 
the sample were born in the United States (n = 34, 29.8 %), Cuba (n = 23, 20.2%), or 
Haiti (n = 12, 10.5%).  However, the majority identified that their family was originally 
from Cuba (n = 24, 25%), Haiti (n = 12, 12.5%), or the United States (n = 11, 11.5%). 
The inclusion criteria of the study required men to be partnered (i.e., married or 
cohabitating).  More than half the sample were married (n = 61, 52.1%) or living with 
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their partner (n = 45, 38.5%).  The majority of the men were involved in the current 
relationship for more than one year (n = 92, 79.3 %).  Few couples chose not to live 
together (n = 11, 9.4%).  Most men had three (n = 43, 37.1%) or two children (n = 36, 
31%).   
Table 2   
Demographic Characteristics of the Sample (N = 117)  
Variables Total Sample 
N (%) 
Hispanic 
n= 63 
n (%) 
NonHispanic  
n= 53 
n (%) 
 
Statistic p 
value 
Age [M (SD)] 67.57 (8.42) 66.60 (8.56) 
 
68.55 (8.20) t = 1.24 .22 
Ethnicity      
White/ Caucasian 17 (14.7%)     
White Hispanic 39 (33.6%)     
African American 17 (14.7%)     
Black Hispanic 24 (20.7%)     
Black Caribbean 19 (16.4%)     
 
Country of Birth  
     
United States 34 (29.8%)     
Cuba 23 (20.2%)     
Haiti 12 (10.5%)     
Columbia 10 (  8.8%)     
Venezuela  9 (  7.9%)     
Others 26 (22.9%)     
 
Relationship Status 
     
Living with partner 45 (38.5%) 28 (44.4%) 17 (32.1 %) 
χ2 = 
2.73 .26 
Married  61 (52.1%) 31 (49.2%) 29 (54.7%) 
Not living with 
spouse or partner 
1  (  9.4 %) 4 (6.3%)  7 (13.2%) 
 
Number of children 
     
1 7  ( 6.0%) 3 (4.8%) 4 (7.5%) 
χ2 = 
3.10 .54 
2 36 (31.0%) 16 (25.8%) 20 (37.7%) 
3 43 (37.1%) 25 (40.3%) 17 (32.1%) 
4  23 (19.8%) 13 (21.0%) 10 (18.9%) 
5 or more 7 (6.0%) 5 (8.1%) 2 (3.8%) 
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Table 2 (Continued) 
Variables Total Sample 
N (%) 
Hispanic 
n= 63 
n (%) 
NonHispanic  
n= 53 
n (%) 
 
Statistic p 
value 
Length of relationship      
Less than 6 
months 
1 (.9 %) 1 (1.6 %)	   0	  
χ2 = 
6.79 .08 
More than 6 
months and less 
than 1 year 
23 (19.8 %) 13 (20.6%)	   10 (19.2 %)	  
More than 1 year 
and less than 2 
years 
45 (38.8%) 30  
(47.6%)	  
15 (28.8%)	  
More than 2 years 47 (40.5%) 19 (30.2%)	   27 (51.9%) 
	  
Educational level      
Some high 
school or 
technical school 
10 (8.5%)	   4 (6.3%)	   6 
(11.3%)	  
χ2 = 9.15 .06 
High school or 
technical school 
21 (17.9%)	   8 (12.7%)	   13 (24.5%)	  
Some college 28 (23.9 %)	   18 (28.6%)	   10 (18.9 %)	  
College graduate 32 (27.4 %)	   22 (34.9%)	   9 (17%)	  
Graduate or 
professional 
school after 
college 
 
26 (22.2 %)	   11 (17.5%)	   15 (28.3%)	  
Employment status 	       
Full time 28 (23.9%)	   15 (23.8%)	   13 (24.5%)	  
χ2 = 1.81 .87 
Part time 21 (17.9%)	   10 (15.9%)	   10 (18.9%)	  
Looking for a job 12 (10.3%)	   6 (9.5%)	   6 (11.3%)	  
Unemployed 16 (13.7%)	   8 (15.1%)	   8 (12.7%)	  
Retired  35 (29.9%)	   20 (31.7%)	   15 (28.3%)	  
Disabled 5 (4.3%)	   4 (6.3%)	   1 (1.9%) 
	  
Changes in employment 
status (Yes) 
 
44 (40.0%)	   23 (38.3%)	   21 (42.9 %)	   χ2 = .23 .70 
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Table 2 (Continued) 
Variables Total Sample 
N (%)	  
Hispanic 
n= 63 
n (%) 
NonHispanic  
n= 53 
n (%) 
 
Statistic p 
value 
Annual income 	       
None 14 (12.1%)	   10 (15.9%)	   4 (7.7%)	  
χ2 = 6.37 .27 
$15,000 or less 21 (18.1%)	   14 (22.2%)	   7 (13.5%)	  
$ 15,001 to 
$25,000 
11 ( 9.5%)	   7 (11.1%)	   4 (7.7%)	  
$25,001 to 
$50,000 
27 (23.3%)	   14 (22.2%)	   12 (23.1%)	  
$50,001 to 
$80,000 
24 (20.7%)	   11 (17.5%)	   13 (25%)	  
$80,001 to 
$100,000 
 
19 (16.4%)	   7 (11.1%)	   12 (23.1%)	  
 
Men in this sample were generally educated and around half the sample reported 
being at least a college graduate (n = 58, 49.6%).  Only 41.8% (n = 49) of participants 
reported to be employed either part time or full time.  The majority were retired (n = 35, 
29.9%), unemployed (n = 16, 13.7%), or looking for a job (n = 12, 10.3%).  Around 60% 
(n = 70) of the participants reported their annual income to be more than $25,000 but less 
than $100,000.  After the diagnosis of prostate cancer only 40% (n = 44) had to change or 
leave their job. 
Data were collected from four urology clinics.  Participants from the four research 
sites were compared on demographics such as age, ethnicity, relationship status, and 
presence of comorbidities.  Analysis of variance (ANOVA) showed that there were no 
differences in age among the six clinic sites.  Chi-square analysis showed that there were 
no differences among the clinics in ethnicity, relationship status, and presence of 
comorbidities. 
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Prostate cancer disease status and presence of comorbidities was investigated (see 
Table 3).  Most men in this sample complained of asthma, emphesyma, or breathing 
problems (n = 15, 15.3%) and circulation problems in the lower extremities (n = 15, 
15.3%).  Many men were smokers or had current or past smoking related problems (n = 
14, 14.3%).  Others endured other conditions such as stroke (n = 11, 11.2%), amputation 
(n = 10, 10.2%), diabetes (n = 8, 8.2%), kidney disease (n = 6, 5.1%), heart problems (n = 
6, 5.1%), or others.  The majority of men participating in this study were diagnosed with 
prostate cancer more than one year (n = 70, 59.9%) ago.  The PSA levels ranged between 
0.12 and 11.20 (M = 3.260, SD = 2.01).  Men in this study were mostly diagnosed with 
stages II (n = 44, 38.3%) and III (n = 46, 40%).  They were treated with different options 
such as radiation therapy (n = 29, 25.4%), hormonal therapy (n = 21, 17.9%), watchful 
waiting (n = 21, 17.9%), and surgery (n = 16, 13.7%).  Some men also had more than one 
form of treatment (n = 22, 18.8%).   
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Table 3  
Disease Status (N = 117) 
 
Variables 
 
Total 
Sample 
N (%) 
 
Hispanic 
n = 63 
n (%) 
 
NonHispanic  
n = 53 
n (%) 
 
Statistic 
 
p 
value 
Comorbidities      
Asthma, 
emphesyma, 
breathing 
problems 
 
15 (15.3%)	   13  
(23.2%)	  
2 (4.9%)	  
χ2 = 14.0 .23 
Circulation 
problems in legs 
or feet 
 
15 (15.3%)	   7 (12.5%)	   8 (19.5%)	  
Current or past 
smoking 
problems 
 
14 (14.3%)	   6  
(10.7%)	  
8 (19.5%)	  
Stroke  11 (11.2%)	   4 (7.1%)	   7 (17.1%)	  
Amputation 10 (10.2%)	   7  
(12.5%)	  
3 (7.3%)	  
Diabetes 8 (8.2%)	   4 (7.1%)	   3 (7.9%)	  
Kidney disease 6 (5.1%)	   2 (3.6 %)	   4 (9.8%) 	  
Heart problems 6 (61%)	   4 (7.1%)	   2 (4.9%)	  
Others 13 (13.4%)	   9  
(16.2%) 
	  
4 (9.8%)	  
Duration of prostate 
cancer 
     
Less than 1 
month 
1 (0.9%)	   0 (0.0%)	   1 (1.9%)	  
χ2 = 1.38 .93 
1 to 3 months 30 (25.6%)	   17 (27%)	   13 (24.5%)	  
3 to 6 months 4 (3.4%)	   2 (3.2%)	   2 (3.8%)	  
6 months to 1 
year 
12 (10.3%)	   7 (11.1%)	   5 (9.4%)	  
1 to 2 years 32 (27.4%)	   17 (27%)	   15 (28.3%)	  
More than 2 
years 
38 (32.5%)	   20  
(31.7%) 
	  
17 (32.1%)	  
	   	  
172 
Table 3 (Continued) 
 
Variables 
 
Total 
Sample 
N (%) 
 
Hispanic 
n = 63 
n (%) 
 
NonHispanic  
n = 53 
n (%) 
 
 
Statistic 
 
p value 
Prostate cancer stage      
Stage I 21 (18.3%) 14(22.6%) 7 (13.5%) χ2 = 1,67 .64 
Stage II  44 (38.3%) 22(35.5%) 22 (42.3%)   
Stage III 46 (40.0%) 24(38.7%) 21 (40.4%)   
Stage IV 4 (3.5%) 2(3.2%) 2 (3.8%) 
 
  
Last PSA level [M 
(SD)] 
 
3.26 (2.01) 3.0 (1.90) 3.57 (2.15) t = 1.33 .19 
 
Prostate cancer stage 
Prostate cancer 
treatment 
     
Radiation 
therapy 
29 (25.4%)	   16  
(25.4%)	  
12 (24.0 %)	  
χ2 = 2.80 .73 
Hormone 
therapy 
23 (19.7%)	   13  
(20.6 %)	  
10 (20%)	  
Watchful 
waiting 
21 (17.9%)	   11  
(17.5%)	  
10 (20%)	  
Prostate surgery 16 (13.7%)	   9 (14.3%)	   7 (14%)	  
More than 1 
treatment option 
22 (18.8%)	   11  
(17.5%)	  
11 (22%)	  
Other 3 (2.6%) 3 (4.8%)	   0 (0.0%)	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Table 4   
Participation of Men in Treatment Decision (N = 117) 
 
Variables 
 
Total 
Sample 
N (%) 
 
Hispanic 
n= 63 
n (%) 
 
NonHispanic  
n= 53 
n (%) 
 
 
Statistic 
 
p value 
 
Participated in 
treatment decision 
 
65  
(55.6%) 
 
30  
(51.7%) 
 
34 
(69.4%) 
 
 
χ2 = 3.44 
 
.06 
Preferences taken into 
treatment decision                                                                                                                                                                                                                                                               
52  
(44.4%) 
27  
(49.1%)
25 
(58.1%)
 
χ2 = 1.02 .37 
Concerns discussed 
prior to making 
treatment decisions 
 
62  
(53 %) 
31 
(54.4 %) 
31  
(60.8 %) 
χ2 = .45 .50 
 
A t-test showed that there was no difference in mean PSA levels among Hispanic 
and nonHispanic participants.  Chi-square analysis also showed no significant differences 
in comorbidities, duration of prostate cancer, stage of prostate cancer and treatment 
option among Hispanic and nonHispanic participants.   
Around two thirds of the participants participated in choosing the treatment option 
for prostate cancer (see Table 4).  The preferences of the treatment were taken into 
consideration in less than half the sample (n = 52, 44.4%).  The concerns about the 
prostate cancer treatment were discussed with 62 (53.0%) participants.  Chi-square 
analysis showed that there were no differences in the participation in the treatment 
decision between Hispanic and nonHispanic men in this sample. 
Sexual problems before the diagnosis of prostate cancer and after the diagnosis of 
the disease as well as sexual enhancement regimens used were examined.  Less than 50% 
174 
of the sample answered the question related to having sexual problems prior to the 
diagnosis of prostate cancer.  Out of those who answered, 31 (44.9 %) reported having  
sexual problems prior to the diagnosis of prostate cancer.  After the diagnosis of prostate 
cancer and during recent times, the majority of men reported that their sexual desire (n = 
88, 75.2%), ability to have an erection (n = 89, 79.5%), and ability to reach an orgasm (n 
= 92, 78.6%) were poor or very poor on a five point Likert scale.  Only 9 men (7.7%) had 
an erection that was firm enough for intercourse.  Also, only 29 men (24.8%) reported 
having an erection whenever they wanted.  Regarding the use of sexual enhancement 
regimens, men used medications or pills (n = 37, 34.9%), injections (n = 34, 32.1%), 
vacuum erection device (n = 15, 14.2%), penile implants (n = 10, 9.4%), and others (n = 
10, 9.4%).  Chi-square analysis demonstrated that there were no significant differences in 
the use of sexual enhancement regimens between Hispanic and nonHispanic men.   
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Table 5   
Sexual Issues Related to Prostate Cancer (N = 117) 
 
Variables 
 
Total 
Sample 
N (%) 
 
Hispanic 
n= 63 
n (%) 
 
NonHispanic  
n= 53 
n (%) 
 
 
Statistic 
 
p value 
Sexual problems before 
prostate cancer 
31 (44.9%) 15 
(40.5%) 
 
16 (50.0%) χ2 = .62 .43 
Use of sexual 
enhancement regimens 
     
Medication or 
pills 
37 (34.9%) 22 
(38.6%) 
15 (31.3%) 
χ2 = 9.81 .04 
Injections 
(intracavernous 
injections) 
34 (32.1%) 16 
(28.1%) 
17 (35.4%) 
Vacuum erection 
device  
15 (12.8%) 8 (14%) 7 (14.6%) 
Penile implants 10 (8.5%) 3 (5.3%) 7 (14.6%) 
Others 10 (8.5%) 8 (14%) 2 (4.2%) 
 
Reliability of Study Instruments 
Reliability analysis was computed for the study instruments: University of 
California Los Angeles Prostate Cancer Index (UCLA PCI), Conformity to Masculine 
Norms Inventory (CMNI), Dyadic Adjustment Scale (DAS), and Quality of Life (Short 
Form Health Survey version 2.0 [SF36v2]).  Cronbach’s alpha for the UCLA PCI, DAS, 
and SF36v2 were .53, .76, and .85 respectively.  Theta was calculated to study the 
reliability of CMNI and was .84.  A t-test was conducted to identify differences among 
the means of the major study instruments.  Results showed that there were no significant 
differences in the means of UCLA PCI, CMNI, DAS, and SF36v2 between Hispanic and 
nonHispanic participants. 
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The instruments were administered in English and Spanish versions.  A total of 62 
men (53%) answered the questionnaire in Spanish.  A t-test was conducted to examine 
differences in the means of UCLA PCI, DAS, and SF36v2 between English and Spanish 
versions of the instruments.  There were no significant differences in the means of the 
English and Spanish UCLA PCI, DAS, and SF36v2.  
Description of Major Study Variables  
The study included five independent variables and one dependent variable.  The 
variables were measured using valid and reliable instruments.  The independent variables 
were age, ethnicity, sexual dysfunction, urinary incontinence, masculinity, and 
relationship with the partner.  The dependent variable was quality of life of men with 
prostate cancer.  Age and ethnicity have been described as part of the description of the 
sample.  This section will focus on sexual dysfunction, urinary incontinence, masculinity, 
relationship with the partner, and quality of life (see Table 6). 
Table 6  
Description of Major Study Variables (N = 117) 
Variables  M (SD) 
 
Urinary Functioning 
31.58 (10.61) 
 
Sexual Functioning 
31.04 (9.48) 
 
Conformity to Masculine Norms Inventory (CMNI) 
30.95 (7.194) 
 
Dyadic Adjustment Scale (DAS) 
105.93 (10.46)  
 
Quality of life (QOL) 
60.58 (9.50) 
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Sexual Dysfunction 
 Sexual dysfunction was measured by the sexual function subscale of the UCLA 
PCI.  The majority of men described their sexual desire (n = 78, 77.3 %), ability to have 
an erection (n = 93, 79.5%), and ability to have an orgasm (n = 92, 78.6%) as “poor” or 
“very poor”.  Fifty two men (44.5%) rated the quality of their erection to be completely 
absent or not firm enough for sexual activity.  Only 9 (7.7%) reported a quality of 
erection that was “firm enough for intercourse”.  Twenty nine (24.8%) said that they had 
an erection whenever they wanted.  Then again, only 5 (4.3%) were “often” (i.e., more 
than half the time) awakened with an erection at night or in the morning.  Items inquiring 
about sexual behaviors during the last 4 weeks showed that 53 participants (48.3%) had 
vaginal or anal intercourse.  Most men identified their ability to function sexually (n = 92, 
78.6%) during the last 4 weeks as “poor” and “very poor”.  Over two fifths (n = 42, 37%) 
and (n = 41, 36.3%) of men who participated in the study classified their sexual 
functioning as a “big problem” and “moderate problem”, respectively, in the past 4 
weeks.  The mean score of the sexual functioning subscale of the UCLA PCI was 31.04 
(SD = 9.48). 
 Pearson r correlation analysis showed no relationship among sexual function, age, 
and last PSA level.  A t- test analysis demonstrated that there were no differences in 
sexual functioning between Hispanic and nonHispanic participants.  Analysis of Variance 
(ANOVA) showed no differences in sexual functioning and relationship status, presence 
of comorbidities, duration of prostate cancer, stage of prostate cancer, treatment option, 
presence of sexual problems before acquiring prostate cancer, and use of sexual 
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enhancement methods (i.e., medications or pills, injections, vacuum device, penile 
implants, or others). 
Urinary Dysfunction 
 During the past four weeks, 59 (50%) of the participants had urinary leakage 
every day with 57 (48.7%), 49 (91.9%), and 11 (9.4%) reporting occasional dribbling, 
frequent dribbling, or no control what so ever, respectively.  The majority of men (n = 98, 
84.5%) used one or more pads for urinary leakage in the past four weeks.  Eighty six 
(73.5%) considered their dribbling urine or wetting to be a moderate or big problem.  
Similarly, 91 (77.8%) identified their urinary leakage interfering with sexual activity as a 
moderate and big problem.  However, only 57 (48.7%) considered their urinary function 
to be a moderate to big problem during the last 4 weeks.  The mean score of the urinary 
functioning subscale of the UCLA PCI was 31.58 (SD = 10.61). 
 Pearson r correlations showed no significant relationships between urinary 
functioning, age, and the last PSA level.  There were no significant differences in urinary 
functioning between Hispanic and nonHispanic men in this study.  There was a 
significant difference in urinary functioning and duration since the diagnosis of prostate 
cancer (F(4, 100) = 3.23, p = .015).  Tamhane post hoc analysis showed that the 
significant difference was between those diagnosed 6 months to 1 year ago and those 
diagnosed more than 2 years ago (Mertler & Vannatta, 2013).  Men diagnosed more than 
2 years ago had more urinary functioning issues.  There was also a significant difference 
in urinary functioning among the different prostate cancer stages (F(3, 10094) = 4.08, p = 
.009).  Tamhane post hoc analysis revealed that there were significant differences 
between stage II and Stage III where the former had more urinary functioning issues.  
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There was also a difference between stages III and IV, and the latter group had the most 
urinary functioning issues.  There were also significant differences in urinary functioning 
among the different treatment options (F(5, 97) = 3.18, p = .01).  Post hoc analysis 
showed that those undergoing hormonal therapy complained of urinary functioning issues 
more than those who had prostate surgery.  There were no significant differences in 
urinary functioning and relationship status, comorbidities, presence of sexual problems 
before the diagnosis of prostate cancer, and the use of different sexual enhancement 
regimens.   
Masculinity 
 The CMNI scores ranged from 16 to 44.  The mean score of the conformity to 
masculine norms was 30.95 (SD = 7.19).  Correlation analysis showed that there was no 
significant relationship between CMNI and age and last PSA level.  A t-test showed no 
difference in the conformity to masculine norms between Hispanic and nonHispanic men 
in this study.  One way ANOVA showed no significant differences in CMNI scores 
among relationship statuses, number of years in the relationship, educational status, 
duration of acquiring prostate cancer, stage of prostate cancer, use of sexual enhancement 
regimens, and having sexual problems before the diagnosis of prostate cancer.   
Relationship with the Partner 
 The total DAS scores ranged between 76 and 124.  The mean total  
DAS score was 105.93 (SD = 10.46).  Examining the DAS subscales, participants in this 
study scored highest on the consensus subscale (M = 48.95, SD = 6.79) followed by 
satisfaction (M = 32.93, SD = 4.41), cohesion (M = 15.81, SD = 4.20), and affectional 
expression (M = 8.18, SD = 2.39) subscales. 
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 A t- test showed no significant differences in DAS scores between Hispanic and 
nonHispanic men.  Correlation analysis demonstrated no relationship between total DAS 
scores, age, and last PSA levels.  One way ANOVA showed no significant differences in 
DAS scores among relationship statuses, number of years in the relationship, educational 
status, duration of acquiring prostate cancer, stage of prostate cancer, and having sexual 
problems before the diagnosis of prostate cancer.  One way ANOVA showed a 
significant difference in mean DAS scores among the use of different sexual 
enhancement regimens (F(4, 94) = 2.55, p = .044).  However, post hoc analysis did not 
show significant differences among the different groups of sexual enhancement regimens. 
Quality of Life 
Over two thirds (n = 75, 64%) of men rated their general health as “good” or 
“very good”.  Only 30 (25.6%) thought that their general health was worse than one year 
ago.  Most men described their health as limiting a little vigorous activities (n = 65, 
55.6%), moderate activity (n = 51, 43.6%), lifting or groceries (n = 54, 46.2%), climbing 
several flights of stairs (n = 55, 47%), and walking one mile (n = 55, 47%).  Men had no 
health related limitations related to walking several hundred yards (n = 61, 52.1%), 
bathing or dressing (n = 54, 47%).  The QOL scores ranged between 36 and 78 and had a 
mean of 60.58 (SD = 9.50).  The subscale of QOL that demonstrated the highest mean 
was role limitations due to physical health (M = 72.01, SD = 22.02), and the lowest mean 
was in the mental health subscale (M = 51.62, SD = 10.04). 
Pearson r correlations showed no significant relationship between QOL scores, 
age, and PSA levels.  There were no significant differences in QOL scores among 
Hispanic and nonHispanic men in this study.  One way ANOVA showed no significant 
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differences in QOL scores among relationship status, duration of the relationship, 
educational status, duration of prostate cancer, stage of prostate cancer, and treatment 
option.  One way ANOVA also showed significant difference in QOL scores between 
those who had sexual problems before the diagnosis of prostate cancer and those who did 
not (F(1, 66) = 3.83, p = .05).  Those who did not have sexual problems before the 
diagnosis of prostate cancer had higher QOL scores than those who did.  There were 
differences in QOL scores among those who use different sexual enhancement regimens 
(F(4, 99) = 3.55, p = .009).  Post hoc analysis showed that those taking medications or 
pills or using intracavernous injections had significantly higher QOL scores than those 
with penile implants.     
Correlational analysis was conducted between the QOL subscales, urinary 
function, and sexual function.  Findings showed that there was a significant negative 
relationship between urinary functioning and the social functioning subscale (r = -.24, p = 
.01).  There was also a significant positive correlation between sexual functioning and 
bodily pain (r = .20, p = .03) and a negative correlation between sexual functioning and 
general health subscale (r = -.27, p = .005).  Physical health scores were positively 
correlated with vitality (r = .20, p = .03) and negatively correlated with bodily pain (r = 
.38, p < .001).  The role limitations due to physical health subscale was positively 
correlated with role limitations due to emotions (r = .43, p < .001), mental health (r = .25, 
p = .006), social functioning (r = .20, p = .03), and bodily pain (r = .36, p < .001).  There 
was a significant positive correlation between role limitations due to emotions and 
vitality (r = .40, p < .001), mental health (r = .31, p = .01), and bodily pain (r = .19, p = 
.04) subscales.  Vitality was significantly associated with bodily pain (r = .34, p < .001), 
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social functioning (r = .28, p = .003), and mental health (r = .36, p < .001).  Social 
functioning was also correlated with mental health (r = .39, p < .001). 
A physical health component and a mental health component of QOL were also 
computed.  The physical health component included physical functioning, role limitations 
due to physical health, bodily pain, and general health.  The mental health component 
was composed of the vitality, social functioning, role limitations due to emotions, and 
mental health subscales.  Pearson r correlations were computed to examine the 
relationship between the physical and mental health components of QOL, urinary 
function, and sexual function.  The findings demonstrated that there was a significant 
positive relationship between both components of QOL (r = .51, p < .001). 
Relationship Between Major Study Variables 
RQ1:  Are there relationships between age, ethnicity, sexual dysfunction, urinary 
incontinence, masculinity, and perception of the relationship with the partner, and 
quality of life? 
H1:  There is a relationship between age, ethnicity, sexual dysfunction, urinary 
incontinence, masculinity, and perception of the relationship with the partner, and 
quality of life. 
 Pearson r correlation was computed to examine the relationships between age, 
ethnicity, sexual dysfunction, urinary incontinence, masculinity, and perception of the 
relationship with the partner, and quality of life (see Table 7).  The dummy coded 
ethnicity variable was used in the correlation analysis.  Age and ethnicity were not 
associated with any of the major study variables.  There was a moderate significant 
negative relationship between urinary and sexual functioning.  There was a significant 
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strong negative relationship between partner relationship and masculinity.  There was 
also a weak negative relationship between DAS and QOL (see Table 7).   
Table 7   
Relationships Among Age, Ethnicity, Sexual Dysfunction, Urinary Incontinence, 
Masculinity, and Perception of The Relationship with the Partner, and Quality of Life 
 
Variables 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
  
 Age 
  
 
1 
      
  
 Ethnicity 
 
 
 
1 
     
  
 Sexual 
Functioning 
  
   
1 
    
  
. Urinary 
Functioning 
.  
   
-.30** 
 
 
1 
   
.  
. Masculinity 
     
1 
  
.  
. DAS 
     
-.41*** 
 
 
1 
 
.  
. QOL 
      
-.21* 
 
 
1 
 
Contributions to QOL 
RQ2:  What are the relative contribution of age, ethnicity, sexual dysfunction, 
urinary incontinence, masculinity, and perception of the relationship with the 
partner with men’s quality of life? 
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H2:  Age, ethnicity, sexual dysfunction, urinary incontinence, masculinity, and 
perception of the relationship with the partner independently and combined 
contribute to the quality of life of men diagnosed with prostate cancer. 
 Hierarchal multiple regression was conducted to determine the relative 
contribution of age, ethnicity, sexual dysfunction, urinary incontinence, masculinity, and 
perception of the relationship with the partner with men’s quality of life.  The dummy 
coded ethnicity variable was used in the regression.  The assumptions of regression were 
tested prior to running the regression analysis.  As discussed in the data screening section 
earlier, presence of outliers were examined and corrected.  Exploring multivariate 
outliers, Mahalanobis Distance was computed, and outliers were examined using chi- 
square critical value at p < .001 (Mertler & Vannatta, 2013).  There were no cases that 
exceeded the chi-square critical value.  Univariate normality of the major study variables 
was assessed using histograms and Q-Q plots as described in the data screening section 
above. Additionally, Kolomogorov-Smirniv test was not significant; hence the 
assumption of normality was met (Mertler & Vannatta, 2013). Multivariate normality and 
linearity was examined using scatterplot.  Multicollinearity was examined in the previous 
section by examining the correlation between the independent variables.  Significant 
correlations were of moderate strength and therefore did not cause a multicollinearity 
threat (Mertler & Vannatta, 2013). 
 Examining the correlations between the independent variables and the dependent 
variable led to decisions about what variables were included in the regression equation 
(Mertler & Vannatta, 2013).  DAS was the only variable that was significantly correlated 
with QOL and therefore it was included in the regression equation.  Age and ethnicity 
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were included in the regression equation since they were the demographic variables. 
Masculinity, being significantly correlated with DAS, will be included to see how it 
contributes to QOL.  There was a significant negative correlation between urinary and 
sexual functioning; however, these two variables were not correlated with any of the 
other independent or dependent variables.  For this reason, one of them was eliminated.  
Founded on the literature that has documented sexual functioning as a major problem for 
men with prostate cancer, urinary functioning was not included in the regression equation 
(Hoznek et al., 2005; Wei et al., 2002). 
 Hierarchical multiple regression was conducted using the Enter method.  Age, 
ethnicity, masculinity, sexual functioning, and relationship with partner were entered into 
the regression equation.  Tolerance statistics and measure of multicollinearity indicated 
that all independent variables were greater than .1 and therefore tolerated in the model.  
The overall regression model was significant (F(5, 91) = 2.39, p = .04) and accounted for 
11.8% % of variance in QOL (R2adj = .07, ΔR2 = .12, p = .04).  Examination of the beta 
weights suggested that DAS (β = -.25, t (91) =- 2.28, p = .03) significantly contributed to 
the model (see Table 8). 
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Table 8 
Relative Contributions to QOL in Men with Prostate Cancer 
 
Variable 
B SEB Β T p 
 
Age 
 
.15 
 
.12 
 
.13 
 
1.32 
 
.19 
 
Ethnicity  
 
2.76 
 
1.94 
 
.14 
 
1.42 
 
.16 
 
Relationship with 
partner 
 
-.22 
 
.10 
 
-.25 
 
-2.28 
 
.03* 
 
Masculinity 
 
-.20 
 
.15 
 
-.15 
 
-1.38 
 
.17 
 
Sexual functioning 
 
.12 
 
.11 
 
.11 
 
1.14 
 
.26 
Note.  Ethnicity was dummy coded as nonHispanic “0” and Hispanic “1”; relationship 
with partner was measured using DAS, masculinity was measured using CMNI, sexual 
functioning were measured using UCLA PCI. 
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CHAPTER V 
DISCUSSION 
Quality of life is an essential outcome measure for the quality and satisfaction of 
care provided to patients (Montazeri, 2009; Wilson & Cleary, 1995).  Patients diagnosed 
with chronic conditions discuss their desire to have their health conditions treated and 
aspire to retain their physical functioning and social roles.  Enhanced QOL also 
contributes to improved mortality rates (Chida & Steptoe, 2008).  This study focused on 
examining the relationship between age, ethnicity, sexual dysfunction, urinary 
incontinence, masculinity, and perception of the relationship with the partner on the QOL 
in men diagnosed with prostate cancer.  Prostate cancer, the leading cause of cancer in 
men, has positive survival rates and constitutes a challenge with its side effects (Jemal et 
al., 2006; Jemal et al., 2010; Siegel et al., 2013).  These men are generally around 50 
years of age and older, do not look or feel sick, but endure urinary and sexual 
dysfunctions as a result of their prostate cancer (Hoznek et al., 2005; Wei et al., 2002).  
Consequently, the normalcy of their life is disrupted, and their QOL is disputed (Howlet 
et al., 2010; Monga, Kerrigan, Thornby, Monga, & Zimmermann, 2005).  Research with 
men with prostate cancer has suggested that the disease and treatment side effects 
contribute to issues with physical functioning, relationships, social roles, and QOL 
(Kaasa, Mastekaasa, & Lund, 2003).  Studies have discussed the relationship between 
prostate cancer treatment side effects on each of masculinity (Burns & Mahalik, 2006; 
Fergus, Grey, & Fich; 2002), partner relationship (Galbraith, Pedro, Jaffe, & Allen, 2008; 
Sanders et al., 2006), and QOL (Howlet et al., 2010; Monga, Kerrigan, Thornby,  Monga,  
& Zimmermann, 2005) alone.  However, few studies have specifically focused on the 
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relationships among prostate cancer treatment side effects (i.e., sexual dysfunction, 
urinary incontinence), masculinity, and relationship with the partner together on QOL in 
men.   
South Florida, being a multiethnic region, constituted an interesting setting for 
this study.  The majority of research examining the QOL in men with prostate cancer has 
been conducted with predominantly Caucasian samples of men.  However, this study 
included men from minority ethnic populations such as Latin American and Caribbean 
Hispanic origins in addition to other ethnicities (i.e., Cubans, Venezuelans, Columbians, 
Haitians, and others).  Another demographic specificity of South Florida includes the 
increased numbers of retirees and older adults which was reflected in the average age of 
men in this study.  As such, this study was fundamental in this setting since older men are 
at a higher risk for developing prostate cancer (PCF, 2011), and they have a different 
experience with regards to their perceptions of QOL (Harden, Northouse, & Mood, 2006; 
Oliffe, 2005). 
Discussion of Findings 
Age 
 The average age of men in this sample was close to 70 years and ranged from 52 
to 85 years.  With prostate cancer risk increasing after the age of 50 years, the older age 
of the sample was expected (ASC, 2011; PCF, 2011).  Additionally, 16% of the 
population in Miami is reported to be above the age of 65 years old (U.S. Census, 2010).  
With the increased percentage of older people in Miami, the health care concerns and 
QOL perspectives of this population is essential.  This sample contributed to the 
understanding of the QOL concerns of older men with prostate cancer in Miami. 
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The sample in this study was older than many of the samples in the majority of 
studies on prostate cancer and treatment side effects (Choo et al., 2010; Penson et al., 
2005; Resnick et al., 2013; Sacco et al., 2006; Stanford et al., 2000).  Few studies have 
included samples of men who had a similar age range or older (Harden et al., 2006; 
Hawes et al., 2006; Stansburry et al., 2003).  With age being a significant risk factor for 
prostate cancer (PCF, 2011), it is important to understand differences in priorities of men 
regarding their QOL in men who are 65 years and older especially that they constitute 
65% of men diagnosed with the disease (PCF, 2011). 
Studies that have examined men with prostate cancer and masculinity (Fergus et 
al., 2002; Grunfed et al., 2013; Oliffe, 2005) and partner relationships (Boehmer &Clark, 
2001; Fergus et al., 2002; Galbraith et al., 2008; Gray et al., 2000; Sanders et al., 2006) 
also included samples of men who were younger than the men in this sample.  Harden 
and colleagues (2006) suggested that age contributed to men’s perspectives of 
relationships, intimacy, and other issues.  However, this study showed that age did not 
contribute to men’s perceptions of relationship dynamics.  It is vital to understand the 
perceived QOL in men with prostate cancer in an aging population as it was estimated 
that the number of Americans aged 65 and older are expected to double in the next 25 
years (CDC, 2013).  Additionally, the increased racial and ethnic diversity in older adults 
was projected to increase, and the proportion of Hispanic older adults is anticipated to be 
12% and 20% in 2030 and 2050 compared to the reported proportion of 7% in 2010 
(CDC, 2013).  Thus, this study contributed to understanding the QOL perspectives of 
older multiethnic men with prostate cancer. 
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Age was has been shown contribute to increased reporting of urinary incontinence 
(Sacco et al., 2006) and sexual functioning (Rondorf-Klym & Colling, 2003; Penson et 
al., 2005; Sanda et al., 2008).  However, findings from this study did not indicate that 
older age affected the presence of urinary and sexual dysfunctions.  Questions in this 
study did not directly ask about the beliefs and engagement of older men regarding sexual 
functioning.  Nevertheless, many men reported the use of sexual enhancement regimens 
which could be suggestive of an interest in sexual activity.  These results can challenge 
the findings of Oliffe (2005) who reported that older men were expected to have less 
emphasis on sexuality.  Then again, during the administration of the surveys, men would 
not emphasize in their discussions with the researcher their sexual dysfunction and focus 
on other QOL issues such as their relationships with their partners (Harden et al., 2006).  
This reluctance to disclose sexual dysfunctions was similar to the inicidental findings 
reported by Oliffe (2005). 
Ethnicity 
Men in this sample were generally Hispanic who mostly were born in the United 
States, Cuba, Haiti, Columbia, and Venezuela.  The majority of men reported that their 
families were originally from Cuba and Haiti.  These findings were reflective of the 
65.75% Hispanic population in Miami of which 34.14% came from Cuba as reported by 
the U.S. Census Bureau 2010.  Interestingly, more than half the population in Miami was 
reported to be foreign born (U.S Census).  This was a significant finding since few 
previous studies have examined the QOL in Hispanic men with prostate cancer (Stanford 
et al., 2010).  Understanding the perceptions of Hispanic men diagnosed with prostate 
cancer is important for healthcare providers in multiethnic and multiracial Miami to 
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provide better care.  These findings were unique since the majority of Hispanics were 
Cuban or of Latin American decent, unlike the Hispanics or Latinos in studies reported in 
the literature who were predominantly of Mexican descent.  Distinctively, this sample 
included a number of men from Haiti and those who identified themselves as Black 
Caribbean which is a growing population in Miami and the United States; however, this 
demographic trend has not been represented in the literature.  Future research would 
benefit from examining the contributions of QOL in men from different racial and ethnic 
groups that are growing in the United States.   
Despite African American men having the highest risk for prostate cancer, few 
African American men participated in this study.  However, the representation of African 
American men in this study (14.7%) was representative of the demographics of Miami of 
22.31% (U.S. Census, 2000).  Few studies have compared the outcomes of men with 
prostate cancer from different racial and ethnic backgrounds (Stanford et al., 2000).  
Stanford and colleagues  (2000) discussed better sexual functioning in African American 
and Hispanic men compared to Caucasian men after undergoing surgery.  The findings 
from this study did not show any difference in outcomes (i.e., urinary and sexual 
functioning) between Hispanic and non Hispanic men.  Additionally, there were no 
differences in choice of treatment or use of sexual enhancement regimens.   
In a sample that was predominantly Hispanic, an emphasis on machismo and 
caballerismo was anticipated.  As a result, Hispanic men were projected to emphasize the 
socially constructed Hispanic male gender role thus reflecting hypermasculinity such as 
increased strength, family protection, and sexual prowness.  Quite the opposite, this study 
showed that Hispanic and nonHispanic men had similar reports about sexual problems, 
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use of sexual enhancement regimens, and sexual dysfunction.  It is worth noting that the 
majority of men did not answer the question about their sexual functioning prior to the 
diagnosis of prostate cancer.  This unanswered question might have been a reflection of 
machismo since a little less than half of the participants who answered reported some 
problems.  Subsequently, the questions remain:  Did machismo decreases with age?,  or 
Did the disease process make these men redefine quantity versus quality of life? (Harden 
et al., 2006).  These questions could be at the foundation of future research.  Furthermore, 
men in this study were married or partnered; hence they were believed to have a source of 
support that may explain the argument of exhibiting less emphasis on sexual prowness. 
Sexual Dysfunction 
 Sexual dysfunction after the diagnosis and treatment of prostate cancer was 
reported to be an inevitable consequence (Hoznek et al., 2005; Penson et al., 2005; 
Stanford et al., 2000; Wilt et al., 2008).  The majority of men in this study reported sexual 
dysfunction similar to rates that have been reported in the literature (Alemazoffar et al., 
2011; Hoznek et al., 2005; Penson et al., 2005; Sacco et al., 2006; Sanda et al., 2008; 
Wilt et al., 2008).  Decreased potency and the inability to perform sexually were 
considered to be of the most bothersome consequences of the disease (Meyer et al., 2003; 
Monga et al., 2005; Moul et al., 2001).  Irrespective of the treatment option, studies that 
have followed men more than 18 months after prostate cancer have reported sexual 
dysfunction (Alemazoffar et al., 2011; Choo et al., 2010; DiBlasio et al., 2008; Stanford 
et al., 2000). 
 The findings from this study emphasized that men endure sexual issues and 
problems after the diagnosis and treatment of prostate cancer.  Most men reported 
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decreased sexual desire, erection problems, and the inability to reach orgasm.  Erectile 
dysfunction was established to be the main reason behind these sexual issues and 
dysfunctions.  Few men in this study discussed that they can have and/or maintain an 
erection that is adequate for sexual intercourse.  Data about sexual functioning prior to 
prostate cancer was not insightful of the men’s status since the majority did not answer 
the respective question.  Research has suggested that there was a relationship between 
sexual functioning before and after prostate cancer (Alemazoffar et al., 2011; Moul et al., 
2001; Penson et al., 2005).  Men who had better sexual functioning at baseline were 
found to have better sexual functioning after prostate cancer treatment when compared to 
men who reported baseline sexual dysfunction (Alemazoffar et al., 2011; Moul et al., 
2001; Penson et al., 2005).  However, this study could not confirm the findings from the 
literature.  Participants who reported having sexual problems prior to the diagnosis of 
prostate cancer had similar sexual issues as those who did not have sexual problems prior 
to prostate cancer.  Baseline sexual functioning had no association with the dysfunction 
issues endured after prostate cancer.  Future studies examining the impact of baseline 
sexual functioning on their post treatment status in Hispanic men is essential.  
Additionally, using a mixed methods study to answer this research question would 
provide a full view of the issue. 
 Despite the reported sexual issues, around half of the sample reported having had 
intercourse during the last month.  As such, men were still trying to maintain a sexual 
experience which could be explained by the discussions about the importance of sexual 
activities by men (Oliffe, 2005).  This was an interesting finding since the majority of 
men shared that they considered that their sexual functioning was a major problem for 
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them, and very few were able to have an erection whenever they wanted.  Men in this 
sample were married or partnered and, therefore, sexual performance may have been 
considered to be an expectation.  Hence, engagement in sexual activities was important 
for these men.  Many men were using sexual enhancement regimens to support their poor 
performance.  Penson and colleagues (2005) suggested that most men diagnosed with 
prostate cancer use sexual enhancement regimens, namely Viagra®, vacuum erection 
devices, and intracavernous injections.  The use of these sexual enhancement regimens 
was found to assist in men’s satisfactory sexual performance (Incrocci et al., 2001; 
Penson et al., 2005).  However, the use of sexual enhancement regimens by men in this 
study did not enhance the sexual performance of men. 
 Age was also suggested to influence the sexual performance of men after prostate 
cancer (Alemazoffar et al., 2011; Choo et al, 2010; Penson et al., 2005).  Men 60 years 
old or younger were found to have a lower risk of developing sexual dysfunction (Moul 
et al., 2010).  Men older than 60 years had issues returning to baseline sexual functioning 
(Alemazoffar et al., 2011; Choo et al, 2010; Penson et al., 2005).  Findings from this 
study did not show that age influenced sexual function or dysfunction of men.  
Nonetheless, these men were generally older than men included in other studies and 
therefore this sample might have highlighted a population that is older and therefore has 
similar sexual issues.  The lack of a wider age range in the sample might have contributed 
to undermining the contributions of age to the sexual dysfunction of men. 
 Few studies reported in racial and ethnic differences in sexual outcomes after 
prostate cancer treatment (Alemazoffar et al., 2011; Penson et al., 2005; Siegel et al., 
2001).  Race/ethnicity was found to contribute to the sexual functioning after prostate 
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cancer surgery.  White men were reported to have decreased potency more than African 
American and Hispanic men (Siegel et al., 2001).  Findings from this study showed that 
there were no differences between Hispanic and nonHispanic men after treatment for 
prostate cancer.  Despite the norms of sexual prowness and machismo exhibited by 
Hispanic men, findings did not corroborate the anticipated emphasis on sexual 
functioning. 
Urinary Dysfunction 
 Dribbling or urinary incontinence are common side effects after the treatment of 
prostate cancer (Penson et al., 2005; Stanford et al., 2000).  Studies defined the rate of 
incontinence by identifying the need to use continence pads in addition to their frequency 
(Sacco et al., 2006).  Over time, studies have reported an improvement of urinary 
continence (Lepor et al., 2004; Penson et al., 2005; Stanford et al., 2000; Wei at al., 
2002).  Findings from this study showed that around half of the sample complained of 
urinary dribbling every day.  The other half of the sample was divided between 
occasional dribbling and total loss of bladder control.  So, the majority were using 
continence pads at least once daily.  The literature has suggested that at 18 months and 
on, men reported major improvements in their urinary functioning (Lepor et al., 2004; 
Sacco et al., 20006).  This improvement was not identified in this cross sectional study.  
The majority of men in this study were diagnosed with prostate cancer more than 1 year 
ago.  However, men were not asked whether they had urinary issues such as dribbling or 
decreased control prior to their diagnosis.  Additionally, this study did not assess the 
improvement of urinary functioning from the time of initiation of the prostate cancer 
treatment.  Future studies should consider assessing baseline urinary functioning in 
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addition to status immediately after initiation of treatment and forward.  Studies have 
suggested rates of more than 80% improvement in urinary dysfunction with time (Sacco 
et al., 2006; Stanford et al., 2000), but urinary dysfunction can continue to be present up 
to 5 years after the treatment (Palmer et al., 2003).  However, this study showed that men 
diagnosed with prostate cancer more than 2 years prior had more urinary issues than 
those diagnosed 6 months to 1 year ago.  This finding was not in accordance with what 
has been reported in the literature.  It is worth noting that men were asked about their 
urinary functioning in relation to the time since diagnosis of prostate cancer and not since 
the initiation of treatment of prostate cancer.  Identifying the time of initiation of 
treatment may contribute to explaining these results.  Overall, the urinary dysfunction in 
this study was perceived to be a moderate to big problem. 
This study did not investigate the effect of dribbling on different activities of daily 
life.  However, urinary dysfunction was suggested to interfere with men’s sexual 
performance and as such was considered to be a moderate to big issue.  Research has 
discussed the prevalence or dribbling and stress incontinence in men with prostate cancer 
that may occur during sexual intercourse (Palmer et al., 2003).  Consequently, urinary 
incontinence may be a source of embarrassment and disruptive to sexual performance.  
Hence, men in this study identified that urinary and sexual dysfunctions were associated 
with each other.  Perhaps this association could be the result of their concurrence as a 
side effect of the treatment options (Potosky et al., 2000; Wei et al., 2002) or due to the 
interference of urinary dysfunction with sexual performance (Palmer et al., 2003). 
Age has been found to influence the return of urinary functioning to baseline 
(Penson et al., 2005; Sacco et al., 2006; Stanford et al., 2000).  Studies have shown that 
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older men had slower or no improvement of their urinary functioning after the treatment 
of prostate cancer.  The decreased prognosis of regaining continence was explained by 
age and possible presence of comorbidities that may add to the cause of incontinence 
(Penson et al., 2005; Sacco et al., 2006; Stanford et al., 2000).  Findings from this study 
showed that age did not have any association with urinary functioning of men with 
prostate cancer.  Again, similar to the discussion related to sexual functioning, a primarily 
older sample of men might have decreased the presence of variability in age and urinary 
functioning. 
Research has not emphasized the difference in urinary functioning among men 
from different racial/ethnic groups.  This study suggested that there were no differences 
in urinary functioning between Hispanic and nonHispanic men.  Findings showed that 
there were differences in urinary functioning in men with advanced stages of prostate 
cancer.  This can be as a result of the treatment option or the initiation of multiple 
treatment options.  Research has not emphasized urinary functioning of men with respect 
to the stage of prostate cancer.  Also, men who underwent hormonal therapy reported 
more urinary issues than men who underwent prostate surgery.  This was contrary to 
what was has been reported in the literature (Basario et al., 2002; DiBlasio et al., 2008; 
Monga et al., 2005; Potosky et al., 2000, Stanford et al., 2000).  Perhaps men in this study 
started hormonal therapy as a second line treatment option or as a result of recurrence of 
the disease.  Men might have selected hormonal therapy as their current treatment option 
and did not consider themselves as having multiple treatments since they have undergone 
one option at a time.  Future studies should consider clarifying the question about 
treatment options to include prior and current multiple treatment options. 
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Masculinity 
Masculinity is a socially constructed expectation that embrace a set of norms and 
behaviors that are anticipated to be exhibited by men (Connel, 2010; Kimmel, 2000).   
These norms and beliefs can be influenced by environmental factors as well as social and 
cultural beliefs (Connel, 1995).  Men not complying by these expectations have been 
viewed to be subordinated and weak (Charmaz, 1995; Connel, 1995, Ferrel, 1993; Oliffe, 
2005).  Masculine norms also reflect on health care perceptions and practices (Addis & 
Mahalik, 2003; Mahalik et al., 2007).  Of the many expectations of a masculine man, 
sexual prowness and ability to satisfy a partner are crucial qualities (Gray et al., 2002; 
Khan et al., 2008; Kimmel, 2000).  Most studies that have examined the meanings of 
masculinity in men with prostate cancer were qualitative in nature.  These studies focused 
on relating masculine norms to the perception of sexual and urinary functioning after the 
diagnosis and treatment of prostate cancer (Burns & Mahalik, 2008; Chapple & Ziebland, 
2002; Fergus et al., 2002; Oliffe, 2005). 
Men with prostate cancer discussed their discomfort in revealing to their 
physician symptoms that could undermine their strong masculine image (i.e., sexual and 
urinary dysfunctions) (Mahalik et al., 2007; O’Brien et al., 2005; Oliffe & Thorne, 2007).  
Sexual dysfunction was considered to be a challenge that led to feelings of shame and 
embarrassment (Fergus et al., 2002).  In men with strong masculine norms, sexual 
dysfunction was found to negatively influence men’s social and role functioning (Burns 
& Mahalik, 2008).  As a result, men perceived the diagnosis of prostate cancer and the 
related sexual dysfunction as a threat to their masculinity and image (Fergus et al., 2002).  
The use of sexual enhancement regimens was recognized to support men’s performance; 
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however, the consequential sexual experience was reported to lose its spontaneity and 
was described as a disruptive experience (Fergus et al., 2002).  Urinary functioning was 
also identified to be a symptom that would cause embarrassment since it necessitated 
frequent bathroom breaks.  Additionally, the fear of urinary leak threatened men’s 
masculine image and how comfortable they were with their social role (Gronfed et al., 
2013). 
Findings from this study showed that conformity to masculine norms was not 
influenced by sexual functioning, urinary functioning, or QOL.  The anticipated values of 
machismo and strong masculine norms were thought to be prevalent in Hispanic men, 
thus influencing the impact of sexual and urinary dysfunction on the QOL in men with 
prostate cancer.  However, the findings did not support this premise.  Studies suggested 
that older men placed less emphasis on the impact of sexual dysfunction on their lives 
(Chapple & Ziebland, 2002; Oliffe, 2005).  Therefore, a generally older sample of men 
might not place emphasis on decreased sexual functioning.  On the other hand, it might 
be the machismo trait that promoted men to report that their sexual issues were not 
affecting their QOL.  The fact that men in this study were married or partnered also 
provided them with a supportive medium.  Research has demonstrated that wives were 
the main source of social support for men diagnosed and treated for prostate cancer 
(Giarelli et al., 2003; Gray et al., 2002). 
Relationship with the Partner 
Female partners have been recognized to be an essential source of support to men 
with prostate cancer (Gray et al., 2002).  The diagnosis of prostate cancer did not only 
affect men, it also influenced the QOL of their female counterparts (Badr & Carmack 
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Taylor, 2009; Galbraith et al., 2008; Giarelli et al., 2003; Gray et al., 2002; Hawkins et 
al., 2009).  In other words, it was considered to be a diagnosis for the couple.  Sexual 
dysfunction and issues have caused relationship problems (Hawkins et al. 2009) and a 
transformation in the woman’s role within the relationship (Badr & Carmack Taylor, 
2009).  Women found themselves assuming the role of the care giver and losing their 
feminine sexual image of the lover (Badr & Carmack Taylor, 2009; Hawkins et al., 
2009).  Sexual performance was perceived to be essential for a harmonious relationship.  
With decreased sexual abilities, intimacy issues arose that contributed to decreased 
satisfaction with the relationship (McCabe & Matic, 2008).  As a result, couples 
discussed the development of problems and issues within the relationship that were the 
result of decreased communication and intimacy (Badr & Carmack Taylor, 2009; 
Galbraith et al., 2008; Giarelli et al., 2003; Gray et al., 2002; Hawkins et al., 2009). 
Findings from this study showed that the relationship satisfaction was important 
for men diagnosed and treated for prostate cancer.  However, relationship satisfaction 
was not affected by the sexual and urinary dysfunction caused by prostate cancer 
treatment.  Despite the high prevalence of sexual dysfunction, men’s perceived 
relationship with their female partners was not affected.  These findings were contrary to 
what has been reported in the literature (Badr & Carmack Taylor, 2009; Galbraith et al., 
2008; Giarelli et al., 2003; Gray et al., 2002; Hawkins et al., 2009).  Men’s decreased 
sexual functioning was confounded by a response that contributed to decreased 
communication and intimacy (Boehmer & Clark, 2001; Hawkins et al., 2009; McCabe & 
Matik, 2008) that led to decreased relationship satisfaction (Hawkins et al., 2009; 
McCabe & Matik, 2008).  Studies discussed a change in roles in the relationship that 
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might have predisposed the decreased satisfaction with the relationship (Fergus et al., 
2002; Galbraith et al., 2008; Giarelli et al., 2003; Gray et al., 2002; Hawkins et al., 2009).  
Women were perceived to be a major source of social support (Giarelli et al., 2003), but 
at the same time they lost their sexual image (Badr & Carmack Taylor, 2009; Harden et 
al., 2002).  Women reported that they were no longer feeling that they were the lovers 
and, therefore, intimacy was scarce (Sanders et al., 2008). 
Men in this sample were older, and the majority had been in their current 
relationship for more than 1 year.  As a result, these couples have lived with the prostate 
cancer diagnosis and treatment side effects; hence, they may have developed coping 
strategies.  On another note, older men were found to discuss the interruption of life 
activities that is caused by sexual and urinary functioning (Harden et al., 2006).  
However, they still reported decreased relationship satisfaction (Harden et al., 2006) and 
emotional burden on the couple (Fergus et al., 2002; Galbraith et al., 2008).  Thus, the 
diagnosis and treatment of prostate cancer caused a challenge to the relationship and 
subsequently affected the QOL of these men. 
Quality of Life 
Quality of life is a measure of disease and treatment outcome in addition to being 
a basic human right in health care (U.S. Department of Health & Humans Services, 
1990).  Being a multidimensional concept (Cella 1994), QOL is considered to refer to the 
normal functioning and general wellbeing including physical, social, psychological, and 
other dimensions that would lead to an overall satisfaction with life (Ferran et al., 2005).  
Men with prostate cancer have positive survival rates (Jemal et al., 2006; Jemal et al., 
2010; Siegel et al., 2013) but endure sexual and urinary dysfunctions (Penson et al., 2005; 
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Stanford et al., 2000) that have an impact on their QOL (Howlet et al., 2010; Penson et 
al., 2003; Potosky et al., 2004; Rondorf-Klym & Colling, 2003; Sanda et al., 2008).  
Sexual and urinary dysfunctions were found to affect the practicality of resuming life 
routines due to the need of frequent bathroom breaks (Gronfed et al., 2013) in addition to 
affecting their masculine image (Burns & Mahalik, 2008; Fergus et al., 2002; Gray et al., 
2002; Oliffe, 2005) and the status of the relationship with the partner (Galbraith et al., 
2008; Hawkins et al., 2009; McCabe & Matic, 2008; Sanders et al, 2008) as a result of 
their inability to perform sexually. 
Irrespective of the treatment option, men endured sexual and urinary dysfunctions 
and as a result their QOL was challenged (Bradeis, et al., 2000; Sanda et al., 2008).  
Findings from this study suggested that there were no differences in QOL among men 
undergoing surgery, radiation, hormonal therapy, watchful waiting, or multiple 
treatments.  Moreover, the majority of men complained of sexual and urinary 
dysfunctions in a similar manner and therefore the treatment option did not offer any 
functional outcome differences (Bradeis, et al., 2000; Monga et al., 2005; Penson et al., 
2003; Sanda et al., 2008; Stanford et al., 2000 Wei et al., 2002).  These results supported 
the notion that the treatment of prostate cancer is an individualized plan based on the 
patient’s wishes and disease status.  Interestingly, only half the men in this study 
participated in choosing the treatment option or had their preferences discussed.  
Additionally, men’s concerns were not discussed in relation to what to expect after the 
treatment of prostate cancer.  These results highlighted the communication issues 
between men and their physicians discussed in the literature where both men were not 
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elaborate in discussing the treatment expectations prior to the choice of the treatment 
option (Oliffe & Thorne, 2007). 
Men in this study considered their health to be good or very good.  Few men 
considered their health to have deteriorated during the past year.  Studies with men with 
prostate cancer treatment side effects have suggested that sexual and urinary dysfunction 
were not considered to decrease the general health ratings of older men (Bradeis, et al., 
2000; Monga et al., 2005; Penson et al., 2003; Sanda et al., 2008; Stanford et al., 2000 
Wei et al., 2002).  Men believed that sexual dysfunction was bothersome thus making 
them feel that their general health was jeopardized (Penson et al., 2003; Sanda et al., 
2008; Stanford et al., 2000 Wei et al., 2002). 
Studies have examined the perceived QOL of men based on their baseline sexual 
functioning prior to the diagnosis of prostate cancer (Alemozaffar et al., 2011; Chen et 
al., 2009).  Results from this study showed that men with sexual problems prior to the 
diagnosis of prostate cancer had lower QOL.  These findings were contrary to what has 
been reported by other studies (Alemozaffar et al., 2011; Chen et al., 2009) especially  
research that suggested that baseline sexual and urinary functioning predicted functioning 
after the treatment (Alemozaffar et al., 2011; DiBlasio et al., 2008; Penson et al, 2005).  
This study did not show that baseline functioning affected post treatment sexual 
functioning.  Men with no sexual issues prior to the diagnosis of prostate cancer might 
have been comforted by being treated for the disease and having positive survival rates.  
As a result, their QOL, after the treatment and despite enduring sexual and urinary side 
effects, was reflective of their contentment of having a positive prognosis.  On the other 
hand, those who had sexual issues at baseline might have been struggling with their QOL 
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and with the added challenge of prostate cancer, their QOL was additionally affected.  
Future research is warranted to further understand the changes of sexual and urinary 
functioning from baseline and the effects on men’s QOL. 
The use of sexual enhancement regimens was common among men in this study.  
Men who used medications, pills, and intracavernous injections were found to have a 
better QOL than those who had penile implants.  Studies have not emphasized QOL 
outcomes comparing sexual enhancement regimens.  However, medications, pills, and 
intracavernous injections are methods that might provide a sexual experience that is 
closer to the baseline norm to which the men were accustomed.  Studies have discussed 
the discomfort that men had when their sexual performance did not feel normal or was 
not a spontaneous performance (Bakhour et al., 2001; Fergus et al., 2002; Galbraith et al., 
2008; Oliffe, 2005).  Future research examining the association between the different 
sexual enhancement regimens on men’s QOL is important to better direct men on what 
option would be best for them. 
With respect to the effect of urinary functioning on the QOL of men, results 
showed that men who have more incontinence issues reported decreased social 
functioning.  These results were similar to findings reported by previous studies (Harden 
et al., 2006; Gronfed at al., 2013).  Having to take frequent bathroom breaks affected 
men’s social life at home (Harden et al., 2006) and at work (Gronfed at al., 2013).  Men 
discussed having to change lifestyles or interrupt activities needing bathroom breaks or 
fearing the embarrassment of urinary leakage.  As a result, their normal life activities 
were broken up that was reflected on their decreased social functioning. 
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Sexual dysfunction was considered to be the most important outcome of prostate 
cancer (Howlet et al., 2010; Penson et al., 2003; Potosky et al., 2004; Sanda et al., 2008).  
Accordingly, sexual issues were found to be directly related to men’s ratings of their 
general health.  Considering that sexual functioning is important for men (Fergus et al., 
2002; Meyer et at., 2003), inability to perform sexually can be perceived as a health 
condition.  Hence, men considered their general health to be affected.  This finding 
highlights the importance of sexual functioning in relation to men’s perception of their 
overall health. 
Examinination of QOL includes assessing the physical and mental health 
functioning of men.  Findings showed that there was an association between physical and 
mental health functioning in men with prostate cancer.  Men with decreased physical 
health functioning reported decreased mental health functioning.  As a result, physical 
functioning was related to these men’s vitality and ability to feel well enough to continue 
their routine daily life activities.  Having role limitations as a result of physical 
functioning, men’s mental health and emotional status were affected and so was their 
social functioning.  Research has suggested that sexual and urinary dysfunctions were 
found to impact the physical functioning of men and therefore negatively influence their 
QOL (Howlet et al., 2010; Steineck et al., 2002).  As a result, these men believed that 
they cannot fulfill their expected role of being a sexual being and abiding by their 
perceptions of masculinity (Bokhour et al., 2001; Chen et al., 2009; Howlet et al., 2010).  
Furthermore, they believed that normal life activities had to be interrupted and planned 
around their urinary dysfunction and fear of urinary leakage (Fergus et al., 2002; Fronfed 
et al., 2010; Korfage et al., 2008).  Accordingly, their QOL of life was challenged which 
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was reflected on their relationship satisfaction.  With men perceiving that they cannot 
perform their expected role in the relationship, they considered that the relationship was 
not satisfactory anymore (Badr & Carmack Taylor, 2009; Galbraith et al., 2008; Giarelli 
et al., 2003; Gray et al., 2002; Hawkins et al., 2009).   
Perceived Impact on QOL 
 Quality of life, being a multidimensional concept, is influenced by a multitude of 
factors including individual characteristics, symptoms, general health perceptions, 
environmental and social factors, and others (Ferrans et al., 2005).  In view of this 
conceptualization, QOL in men with prostate cancer was hypothesized to be influenced 
by age, ethnicity, prostate cancer treatment side effects (i.e., sexual and urinary 
dysfunction), masculinity, and perceived relationship with the partner.  Studies 
emphasized the challenges that men face when dealing with sexual and urinary 
dysfunction (Howlet et al., 2003; Penson et al., 2003; Potosky et al., 2004; Rondorf-Klym 
& Colling, 2003).  Additionally, the majority of these studies discussed the influence of 
these side effects on the QOL of men irrespective of the treatment option (Howlet et al., 
2003; penson et al., 2003; Potosky et al., 2004; Rondorf-Klym & Colling, 2003).  These 
side effects also had an effect on the masculine image of men (Burns & Mahalik, 2008; 
Fergus et al., 2002; Gray et al., 2002; Oliffe, 2005) and their relationship satisfaction 
(Galbraith et al., 2008; Giarelli et al., 2003; Gray et al., 2002; Hawkins et al., 2009).  
Relationship satisfaction was also found to be related to men’s perceived QOL (Bokhour 
et al., 2004; Sanda et al., 2008). 
Findings from this study showed that there was a relationship between sexual and 
urinary functioning.  Men who had more sexual issues reported less urinary dysfunction.  
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The literature has discussed the extent of sexual and urinary dysfunction in relation to 
treatment option and across time (Penson et al., 2003; Potosky et al., 2004; Sanda et al., 
2008).  These findings showed no functional differences among different treatment 
options.  However, it can be explained that men with sexual problems might have 
considered them as a greater problem (Penson et al., 2003; Steinek et al., 2002). 
Prostate cancer treatment side effects were reported to challenge men’s 
masculinity (Burns & Mahalik, 2008; Fergus et al., 2002; Gray et al., 2002; Oliffe, 2005) 
and relationship satisfaction (Galbraith et al., 2008; Giarelli et al., 2003; Gray et al., 
2002; Hawkins et al., 2009).  Findings from this study showed that men with stronger 
masculine norms were less satisfied with their relationship.  Stronger masculine norms 
were reflected by beliefs of sexual prowness and ability to satisfy a partner sexually 
(Gray et al., 2002; Khan et al., 2008; Kimmel, 2000).  The inability to comply with these 
perceived social norms might allow them to feel less of a man (Chapple & Ziebland, 
2002; Connel, 2010; Fergus et al., 2002; Kimmel, 2000; Oliffe, 2005).  Accordingly, they 
believe that their role within the relationship was be jeopardized.  Stronger masculine 
norms were usually aligned with the concepts of hypermasculinity and machismo.  In a 
sample that was predominantly of a Hispanic background, this finding suggests that 
machismo may still govern how men view their relationship.  Men with strong beliefs in 
complying with the values and norms of machismo would expect to maintain their strong 
role in the relationship.  Having sexual and urinary dysfunction would cause a threat to 
their role and therefore they might perceive that they are less satisfied with their 
relationship.  That is, these men must be struggling to maintain their image as a strong 
man in the relationship and therefore problems might arise.  Issues of communication and 
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intimacy were discussed in the literature among men with prostate cancer (Badr & 
Carmack Taylor, 2009; McCabe & Matic, 2008).  As such, the inability of men to live up 
to their expected role might heighten intimacy and communication issues and therefore 
cause a challenge to the relationship.  Future research is needed to help understand the 
dynamics and perceptions of men’s roles within their relationship after the diagnosis and 
treatment of prostate cancer. 
Results suggested that men with better relationship satisfaction reported decreased 
QOL.  This finding was opposite to what was discussed in the literature where better 
partner relationships was related to improved QOL as a result of the supportive role that 
women provided (Galbraith et al., 2008; Giarelli et al., 2003; Gray et al., 2002; Hawkins 
et al., 2009).  Again, the concepts of machismo might have created a pressure on men to 
abide by their expected role.  Therefore, men with an unsatisfactory relationship might 
not have had to challenge themselves to maintain their image and therefore accepted their 
treatment side effects and reported a better QOL.  On the other hand, men who had a 
good relationship with their partner might have been eager to maintain their machismo 
image and were bothered by their treatment side effects.  These side effects were thought 
to pose a threat to the harmony of their relationship.  As a result, they were not able to 
accept their sexual and urinary dysfunctions and hence reported decreased QOL.     
In the end, what mattered most to the QOL of men with prostate cancer was their 
relationship with their partner.  Their female counterpart was a major source of support 
who influenced their perception of QOL.  Similar to what has been reported in the 
literature, the partner relationship is important for men diagnosed with prostate cancer 
(Galbraith et al., 2008; Giarelli et al., 2003; Gray et al., 2002; Hawkins et al., 2009).  The 
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majority of men in this study were in their current relationship and had prostate cancer 
for more than one year.  Therefore, they may have developed an understanding of how 
their treatment side effects were going to affect their life.  The literature has emphasized 
the supportive role of the female partners of men with prostate cancer (Galbraith et al., 
2008; Giarelli et al., 2003; Gray et al., 2002; Hawkins et al., 2009) which in turn directly 
influenced their QOL.  An in-depth appreciation and proper communication between the 
couple would allow men to be adjusted to their treatment side effects.  Accepting their 
treatment side effects and realizing the changes and challenges that they would have to 
live with was stressful on their relationship.  Also, finding ways to deal with their side 
effects and maintaining a strong relationship would lead to an improved QOL. 
Limitations of the Study 
 Several potential limitations of this study were identified.  This was a cross-
sectional design and self-administered survey study and therefore the findings represent 
the perception of men at one point in time.  Thus, generalizations and conclusions about 
changes or trends over time cannot be made.  Additionally, the survey included recall 
questions about sexual problems prior to the diagnosis and functional outcomes up to 4 
weeks prior to answering the survey.  There might have been a recall bias in some of the 
responses.  A convenience sample was used to collect data and consequently there might 
have been a self-selection bias.  Data about men who did not choose to volunteer or 
accept to participate in the study were not collected.  This potential bias in sampling 
would also limit the ability to generalize findings. 
 The self-administered surveys might have resulted in response bias or social 
desirability bias.  In other words, the questions included sensitive information about 
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sexual and urinary functioning, partner relationship issues, and masculine norms.  
Therefore, men might have provided some answers that would have been socially 
acceptable and desirable; thus posing potential inaccuracies of the results.  The media 
presents the image of a strong older man at older ages and presents sexual enhancement 
regimens and gadgets.  As a result, men are cultured into what is their socially expected 
masculine image.  Additionally, Hispanic men are also confronted with the norms of 
machismo which add to what a “real” man should believe.  These concepts might have 
biased men’s answered to some of the survey questions. 
 Also, self-administered survey included self-identified men who do not have sex 
with men.  Emphasis was not made to exclude bisexual and transgender men.  Inclusion 
criteria focused on men who reported to be in a relationship with a woman and who do 
not identify themselves as men who have sex with men.  There might be social 
desirability and inaccurate reporting bias that might have influenced the results.  Future 
research would benefit from examining the QOL in gay, bisexual, and transgender men 
diagnosed with prostate cancer. 
 Data was collected using a diverse sample of men who are from different ethnic 
and racial backgrounds.  There might be intraethnic differences within the Hispanic 
cuture that might have influenced the results.  However, the sample size was small to be 
able to identify groups and compare QOL in men from different ethnic backgrounds.  
Therefore, generalizations about the different ethnicities can be suggested but cannot be 
generalized.  Few men were born in the United States, whereas many men migrated 
during their early or late adulthood.  Data about the date and of migration to the U.S. was 
not collected.  Also, information about acculturation was not gathered.  Therefore, there 
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might be acculturation and cultural differences within the same ethnicity especially 
between men who were born in the U.S. and those who were not.  Future research is 
warranted to examine the contributions of culture and acculturation to QOL in men with 
prostate cancer. 
 Another major issue that was encountered during the course of the study was the 
ability to obtain the support (“buy in”) of physicians to allow recruitment of clients at 
their clinics.  Many urologists did not feel comfortable with their clients participating in a 
research study that was not administered by their clinic.  Hence, the clients were recruited 
from clinics who accepted that a previously agreed on number of clients to participate in 
the study. Therefore, the convenience sample that was included could have been biased 
by the timing and clinics where the study was conducted.  This adds to the issues that 
challenge the ability to generalize the findings of this study. 
Studies have examined masculinity using qualitative research designs.  This study 
used the CMNI which has been psychometrically tested (Mahalik et al., 2003).  However, 
not many studies have used the short version which was used in this study.  Additionally, 
the tool was translated to Spanish and used for the first time in this study.  As a result, 
comparison with other studies and the ability to generalize the findings is not possible. 
 The study included psychometrically tested instruments that assessed the concepts 
at one point in time.  As such, the development of a timeline that explained the trend or 
course of the events and perceptions along the course of diagnosis and treatment of 
prostate cancer could not be achieved.  Also, only men were interviewed.  The exclusion 
of the female counterparts precluded gathering information about the whole picture of the 
partner relationship and QOL issues. 
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 Men diagnosed with prostate cancer and meeting the inclusion criteria were 
included in the study.  Data about time since diagnosis and type of treatment were 
gathered; however the study did not limit the inclusion to those with a specific treatment 
option or duration since diagnosis.  Therefore, the results may not be generalized to all 
men diagnosed and treated for prostate cancer.  The diverse population and small sample 
within each group size does not allow statistical analysis to compare QOL in men with 
different treatment options and those with different time since diagnosis. 
 Finally, the surveys were administered at the participating urology clinics during 
the wait time before a physician’s appointment.  So there were some cases in which there 
multiple interruptions by telephone calls or questions asked by clinic staff.  Also, the 
participants might have been eager to complete the survey so as not to miss their 
appointment.  Luckily, many of these clinics had a waiting time that was suitable for the 
length of the survey, and there were no major complaints about the length of the survey 
and its interruption of clinic appointments. 
Implications for Nursing Practice 
 Prostate cancer prevalence is increasing and the positive disease outcomes allow 
men to live longer.  However, these men will have to recognize that their life will change 
due to living with potential short term or long term sexual and urinary dysfunctions.  As 
such, they will have to develop coping strategies in line with their socially constructed 
masculine norms and partner relations. 
 In Miami, the majority of the population is of Latin American and Caribbean 
origins.  This is a unique population that has not been adequately represented in the 
literature.  Their perceptions of prostate cancer treatment side effects and how the QOL is 
213 
impacted was not very well understood.  Research has highlighted the concepts of 
machismo and hypermasculinity in the Hispanic and Latin American cultures.  As a 
result, it was hypothesized that the perceptions of men in Miami regarding their QOL in 
light of prostate cancer would be affected by the treatment side effects, masculinity, and 
partner relationships.  However, the findings of this study did not support the proposed 
hypothesis.  Sexual dysfunction and masculine norms did not affect these QOL of these 
men.  The perceived partner relationship was the main variable that affected men’s QOL.  
Nevertheless, the importance of sexual dysfunction and masculine norms could not be 
underestimated since they appeared to have an influence on different features of these 
men’s lives.  They might not have been major concepts that affected QOL, but they were 
related to social functioning and partner relationship which would ultimately indirectly 
affect QOL. 
 It is important for health care professionals and nurses to recognize how men 
perceive what is important for their QOL.  Understanding what is the main contributor to 
QOL allows nurses to develop better educational programs to support men’s knowledge 
and concerns about the disease, treatment process, and life after the cancer.  Additionally, 
the findings of this study emphasize the importance of including the female partner as a 
major team player in the treatment of men with prostate cancer.  Including interventions 
that strengthen and support the partner relationship would strengthen men’s support 
system and therefore would enhance their QOL.  Finally, accounting for cultural and 
social variables is important to make the treatment and interventions acceptable to 
patients and their partners.  These findings set the foundation for future research that 
would assist in developing the best practice to enhance the QOL of men. 
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Implications for Future Research 
 Findings from this study provide an understanding of the perceived factors that 
influence the QOL in a sample of older men diagnosed with prostate cancer and from a 
multiethnic and multiracial sample.  The findings of this study could be used to further 
explore the QOL of these men.  Men in this study reported sexual functioning as being a 
problem that was not associated with masculine norms or did not affect their relationship 
satisfaction or QOL.  Future research is needed to further understand the beliefs of older 
men regarding sexual practices especially since they were utilizing sexual enhancement 
regimens.  As such, they are sexually active but the importance of maintaining their 
sexual functioning and how much it would affect their QOL is important to understand to 
be able to understand treatment and counseling strategies. 
 South Florida provides a unique diverse population.  Studies planned to examine 
the differences in the contributions to QOL in men with prostate cancer from different 
ethnic and racial groups is important.  Such studies will help understand the cultural 
differences among the major minority groups in South Florida and consequently will help 
inform health care practices.  Having the majority of the sample born outside the United 
States, it would be interesting to assess if acculturation has an influence on masculinity, 
relationship satisfaction, or QOL. 
 South Florida is also known to be a retirement destination, and the older age 
population is increasing.  It would be interesting to compare the major study variables 
among different age groups of men older than 65 years.  There may be cohort differences 
that may need to be considered or accounted for especially that the American Urologic 
Association advises prostate cancer screening to stop after the age of 75 years.  Also, 
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with older men, do the concepts of masculinity and machismo change or become less 
rigid?  It is important to understand how these concepts develop with older age and the 
diagnosis of prostate cancer.   
 Hispanic partnered men were recruited for this study.  Men’s conformity to the 
concepts of machismo were anticipated, and therefore the influences of prostate cancer 
treatment side effects were explained in relation to the relationship with the partner and 
QOL.  Findings of this study were somewhat different than what has been reported in the 
literature.  Future research using mixed methodologies would help explain the 
relationship dynamics and progression with the diagnosis of prostate cancer and initiation 
of treatment side effects.  Also, multiple method studies would highlight on the coping 
strategies of these men within their relationships and how they try to maintain their 
family role and machismo image.  Additionally, including the female partner in the study 
will help understand Hispanic women’s relationship expectations and coping strategies 
with their husband’s diagnosis. 
 Baseline sexual and urinary functioning are essential considerations in research to 
understand the post treatment outcomes of prostate cancer treatment.  Findings from this 
study showed that men were reluctant to provide baseline information about their sexual 
functioning.  Baseline sexual data provided did not predict post treatment outcomes 
which was contrary to what has been reported in the literature.  The current study did not 
assess the baseline urinary functioning of men.  A mixed methods study would provide 
information about the relationship between baseline sexual and urinary functioning and 
post treatment outcomes to inform future research.  It is important to understand the 
baseline information that would suggest post treatment functioning in order to better 
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educate men about the treatment side effects.  Also, future research is needed to examine 
the extent to which urinary dysfunction impacts the lives of men in relation to disruption 
to life activities and work in addition the financial burden of continence pads and other 
required modifications. 
 A prostate cancer treatment option is chosen based on the patient’s preference and 
the individualized prognosis of each man.  Surgery, radiation, hormonal therapy, or 
watchful waiting alone can be chosen.  However, at times and due to recurrence of the 
disease or the manner to which the cancer responds, a secondary treatment might be used 
or multiple treatment methods might be indicated.  In the current study, the item asking 
about treatment option did not clarify whether the answer indicated the current treatment 
or if there were multiple treatments or any previous treatment regimens.  Future studies 
need to clarify the course of treatment options to better explain the treatment side effects. 
 The finding of this study suggested that many men did not participate in the 
choice of treatment nor were their concerns accounted for.  Future studies are needed to 
examine if QOL differs among men who participate in treatment options and those who 
do not.  Does an educational intervention prior to the choice of treatment impact QOL 
after the initiation of treatment? 
Summary 
Prostate cancer, the leading cause of cancer in men, has positive survival rates and 
constitutes a challenge with its side effects (Jemal et al., 2006; Jemal et al., 2010; Siegel 
et al., 2013).  Studies have discussed the relationship between prostate cancer treatment 
side effects on each of masculinity (Burns & Mahalik, 2006; Fergus, Grey, & Fich; 
2002), partner relationship (Galbraith, Pedro, Jaffe, & Allen, 2008; Sanders et al., 2006), 
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and QOL (Howlet et al., 2010; Monga, Kerrigan, Thornby,  Monga,  & Zimmermann, 
2005) alone.  However, few studies have highlighted the relationship between prostate 
cancer treatment side effects (i.e., sexual dysfunction, urinary incontinence), masculinity, 
and relationship with the partner together on QOL in men.  The purpose of this study was 
to examine relative contributions of age, ethnicity, sexual dysfunction, urinary 
incontinence, masculinity, and perception of the relationship with the partner on the 
quality of life in men diagnosed with prostate cancer.  Data were collected using self 
administered questionnaires measuring demographic variables, sexual and urinary 
functioning (UCLA PCI), masculinity (CMNI), partner relationship (DAS), and QOL 
(SF-36).  A total of 117 partnered heterosexual men diagnosed with prostate cancer were 
recruited from four clinics in Miami, Florida.  Men were 67.47 (SD = 8.42) years old and 
identified themselves to be of Hispanic origin (54.3 %, n = 63).  Findings demonstrated 
that there was a moderate significant negative relationship between urinary and sexual 
functioning.  There was a significant strong negative relationship between partner 
relationship and masculinity.  Additionally, there was a weak negative relationship 
between DAS and QOL.  Hierarchal multiple regression showed that partner relationship 
(β = -.25, t (91) =- 2.28, p = .03) significantly contributed to the overall QOL.  These 
findings highlight the importance of the relationship satisfaction in the QOL of men with 
prostate cancer.  Nursing interventions to enhance the QOL of these men should consider 
strengthening the relationship and involving the female partner as an active participant. 
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